Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ADAMTS3	"ADAMTS-4, KIAA0366"	ENSG00000156140	"ADAM metallopeptidase with thrombospondin type 1 motif 3"	O15072	4	72280969-72569386	"Cancer-related genes, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Cone photoreceptor cells: 13.7;Leydig cells: 18.4;Rod photoreceptor cells: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.6;AN3-CA: 7.3;HEL: 12.9;K-562: 11.0;SH-SY5Y: 6.6;U-2 OS: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021368, HPA021369"	Uncertain		Approved	"Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA			"Intermediate filaments"		"HPA021368: AB_2670681, HPA021369: AB_2670682"	"unprognostic (1.93e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.60e-3)"	"unprognostic (5.92e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-4)"	5.3	2.6	3.3	4.4	5.6	2.1	7.8	0.3	4.6	4.4	2.3	1.1	1.9	0.5	9.6	14.4	1.0	7.5	1.9	2.8	1.3	0.9	4.7	2.7	3.1	2.0	0.7	2.2	7.5	1.0	12.4	1.1	8.2	2.2	2.6	1.1	3.9	1.4	3.4	0.8	1.5	0.9	4.6	1.8	1.9	1.6	5.6	1.3	0.6	4.4	0.8	1.0	2.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	7.3	0.1	0.3	0.1	0.6	2.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.6	0.0	1.8	0.0	1.6	12.9	1.0	0.0	0.2	0.0	0.0	1.7	0.1	0.6	0.1	3.1	0.0	0.0	11.0	0.0	0.0	0.0	1.1	0.0	2.0	0.0	3.8	0.0	2.5	0.0	4.3	0.0	0.5	6.6	0.0	0.5	0.2	1.4	0.1	0.1	0.1	5.4	8.1	0.0	0.6	0.0	0.0	0.0	1.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.6	0.3	4.6	1.3	0.9	0.7	2.2	2.2	1.3	0.0	4.3	0.0	1.0	0.5	0.8	0.8	0.0	0.0	2.3	1.8	13.7	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.2	1.6	0.7	1.1	0.0	0.0	0.0	0.0	2.5	0.0	1.3	18.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	4.2	0.2	11.9	0.0	0.7	1.0	0.4	0.0	0.0	0.0	0.0	0.0
ALS2	ALS2CR6	ENSG00000003393	"ALS2, alsin Rho guanine nucleotide exchange factor"	Q96Q42	2	201700554-201781189	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.8"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 45.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 66.8"	"Group enriched"	"Detected in many"	6	"basophil: 19.0;eosinophil: 5.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 19.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 53.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 158.8"	HPA046588	Enhanced		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA046588: AB_2679709"	"unprognostic (3.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.84e-1)"	6.9	5.3	8.2	4.2	14.7	7.8	8.1	66.8	15.6	5.9	5.6	10.1	5.5	7.4	10.3	10.7	4.7	6.7	6.4	19.9	8.3	7.3	10.4	18.3	7.9	4.1	6.8	11.0	6.8	5.6	8.8	16.8	7.2	13.6	6.6	6.0	8.5	5.2	5.5	12.2	6.9	8.4	7.4	8.3	5.3	6.7	6.1	9.0	3.5	7.5	5.9	4.5	5.5	5.3	1.2	1.0	19.0	1.2	1.7	1.8	0.7	5.1	3.6	8.8	8.2	6.0	6.5	6.6	9.2	12.4	12.2	14.2	8.4	5.1	0.6	4.0	9.6	8.3	5.3	5.0	9.3	15.5	1.7	5.1	12.2	3.5	4.8	7.4	9.6	53.0	5.6	5.2	10.2	8.8	9.5	12.3	4.9	5.8	3.7	9.2	4.1	3.4	12.7	7.3	3.2	5.5	2.8	4.9	1.8	7.7	7.1	4.1	5.4	5.3	5.8	8.2	22.1	3.7	4.0	7.3	10.8	5.2	3.7	4.6	4.1	5.6	2.1	7.9	1.9	6.8	19.0	0.7	5.5	1.7	1.2	1.8	1.2	1.2	1.2	1.0	1.2	1.3	1.5	0.6	1.7	0.8	0.5	1.8	0.7	8.2	14.7	66.8	15.6	8.3	7.3	6.8	11.0	13.6	9.0	11.9	18.4	1.9	3.3	4.7	14.7	26.3	7.6	13.4	3.4	8.7	27.5	4.6	0.0	5.6	13.0	7.7	5.2	0.0	2.8	2.4	5.9	3.8	45.1	17.1	4.9	7.9	4.6	15.4	3.5	5.3	7.2	5.3	0.0	1.0	6.7	6.8	5.9	3.7	7.8	4.8	14.7	0.0	4.1	6.5	2.8	5.3	5.6	4.3	3.8	3.3
ANAPC4	APC4	ENSG00000053900	"Anaphase promoting complex subunit 4"	Q9UJX5	4	25377213-25418498	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032519, HPA038395, HPA038396"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB032519: AB_2274023, HPA038395: AB_10794632, HPA038396: AB_10795356"	"unprognostic (1.36e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.06e-3)"	"prognostic favorable (5.73e-7)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.18e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.86e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.95e-2)"	"prognostic favorable (1.12e-6)"	12.2	15.4	14.5	15.7	14.9	14.7	14.5	16.4	16.4	22.7	13.0	14.8	25.4	10.5	29.2	21.4	13.0	32.3	11.0	10.7	12.6	10.6	12.6	13.0	13.0	16.6	15.8	10.4	18.8	15.3	15.3	22.4	13.7	13.5	15.4	15.5	14.7	13.3	36.5	12.3	13.0	14.4	23.4	16.2	18.2	13.0	9.6	14.2	19.6	13.4	7.3	15.9	18.3	13.4	8.5	6.4	13.8	11.3	9.4	13.8	6.0	12.4	7.3	12.9	13.5	13.7	15.3	18.6	14.9	11.2	14.1	13.7	11.7	20.0	20.5	8.0	12.7	18.1	10.1	13.7	12.6	16.4	7.2	10.6	19.9	13.1	10.9	9.2	15.4	16.3	11.8	9.5	12.5	7.6	10.1	12.2	18.2	28.6	6.2	17.9	9.7	19.8	25.2	18.0	11.0	9.2	14.3	21.8	15.2	11.9	13.6	14.6	8.7	11.1	6.7	9.2	13.9	9.9	16.7	12.4	12.2	7.7	9.3	17.1	8.3	14.4	19.6	13.1	22.1	11.4	1.8	7.4	13.8	10.1	8.7	13.8	8.5	9.1	11.8	6.4	7.0	8.3	10.3	3.0	9.4	11.3	4.1	11.0	6.0	14.5	14.9	16.4	16.4	12.6	10.6	15.8	10.4	13.5	14.2	8.9	12.6	4.2	15.2	11.4	12.1	11.5	12.7	65.6	18.2	7.0	9.8	46.1	5.0	8.6	3.3	9.0	7.4	0.0	10.5	10.3	11.6	5.8	24.3	6.4	15.4	20.6	12.1	14.1	14.5	2.5	9.5	11.0	16.9	11.8	7.7	11.6	7.3	3.5	14.2	4.5	12.9	19.4	9.9	11.4	14.0	8.2	19.9	17.5	11.3	6.5
APOBEC3C	"APOBEC1L, ARDC2, ARDC4, ARP5, bK150C2.3, PBI"	ENSG00000244509	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3C"	Q9NRW3	22	39014083-39020352	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 114.8"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB033048, HPA071523"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB033048: AB_2057401, HPA071523: AB_2686409"	"unprognostic (1.79e-3)"	"prognostic favorable (1.08e-5)"	"unprognostic (4.32e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (8.91e-10)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-1)"	"unprognostic (3.52e-3)"	13.3	28.0	2.3	15.6	3.4	9.2	8.0	1.1	2.0	21.4	13.1	4.2	27.5	4.5	18.2	23.5	19.6	20.9	13.8	13.0	2.2	2.0	6.3	4.5	11.7	20.9	3.3	2.0	26.4	5.3	0.7	3.3	7.7	3.2	20.7	12.0	12.9	12.3	114.8	3.4	6.9	11.8	17.2	4.2	32.2	8.1	45.6	2.4	16.2	8.7	17.0	45.5	21.8	12.7	48.1	19.7	49.3	42.6	35.2	61.3	26.2	10.6	10.5	1.8	20.8	11.7	24.3	9.1	7.9	15.4	11.6	15.6	10.0	12.2	31.8	5.3	15.5	7.4	11.0	1.8	33.3	11.4	12.0	9.0	30.6	0.5	8.3	12.7	19.9	30.8	26.3	19.4	15.2	3.8	5.8	6.5	0.2	18.7	40.6	23.3	0.1	7.9	10.8	2.8	0.1	23.2	13.9	4.8	26.4	7.7	14.2	0.5	1.4	11.4	0.0	5.7	4.8	0.1	7.3	3.3	6.3	10.8	3.3	3.4	11.0	11.3	2.6	19.3	12.9	16.3	13.6	20.3	49.3	61.3	40.2	42.2	44.6	33.6	54.6	19.7	48.1	11.5	41.1	2.7	35.2	42.6	16.7	30.5	26.2	2.3	3.4	1.1	2.0	2.2	2.0	3.3	2.0	3.2	2.4	3.0	21.0	91.0	37.0	22.3	0.0	17.3	28.1	13.4	12.5	7.0	0.0	3.2	0.0	25.1	1.9	8.9	11.9	116.8	1.2	1.5	27.8	15.7	55.4	0.8	53.0	0.0	25.3	28.8	42.1	4.1	53.5	30.8	42.2	70.3	16.2	24.7	7.9	12.7	35.7	1.0	0.2	25.8	28.8	1.6	1.5	14.3	1.6	91.6	16.1	44.2
BAG2		ENSG00000112208	"BCL2 associated athanogene 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 67.0;urinary bladder: 51.0"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 76.8;Early spermatids: 102.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			Cytosol	"Intermediate filaments"	"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavorable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (6.24e-3)"	3.4	3.5	3.7	8.7	2.8	1.2	4.6	4.1	3.4	18.4	24.5	0.8	14.8	1.9	29.4	9.5	13.4	5.9	6.9	17.2	3.3	3.5	3.7	3.8	4.1	2.3	3.3	2.3	15.4	1.5	0.6	4.5	6.7	3.4	23.7	4.3	2.6	1.5	15.1	9.9	1.7	5.7	67.0	3.4	1.3	7.4	6.7	2.6	1.6	7.6	6.0	1.9	51.0	17.1	5.9	1.4	0.9	0.4	3.3	6.1	1.9	9.5	5.3	2.2	7.9	5.6	16.1	6.3	15.4	14.7	11.1	10.7	6.8	4.9	3.2	14.8	24.3	9.1	1.7	12.8	1.3	10.7	10.1	9.4	9.3	8.0	15.3	8.6	8.1	2.1	7.8	0.7	9.1	8.6	6.7	8.6	7.4	18.6	4.5	10.9	0.7	5.7	6.8	8.5	0.2	5.5	5.3	6.3	6.3	13.3	1.5	2.9	2.6	6.9	0.5	5.5	10.8	1.2	7.1	11.7	6.4	10.4	13.4	15.2	3.1	2.9	7.0	5.6	3.2	0.6	0.1	0.3	0.9	3.3	0.4	3.9	5.9	3.1	3.3	1.4	4.3	6.1	5.1	0.3	3.3	0.1	0.5	3.2	1.9	3.7	2.8	4.1	3.4	3.3	3.5	3.3	2.3	3.4	2.6	3.0	3.0	20.8	4.4	2.2	6.0	33.9	0.0	6.7	2.3	3.5	11.8	76.8	1.7	8.4	102.4	3.6	0.3	0.0	3.0	11.5	50.7	7.0	4.6	13.2	13.1	9.5	1.7	1.8	3.1	24.6	28.7	4.0	6.8	14.4	0.2	6.1	6.8	0.6	36.4	22.7	15.5	6.5	35.4	43.2	6.8	3.3	15.8	8.4	0.6	1.8
BCAS4	"CNOL, FLJ20495"	ENSG00000124243	"Breast carcinoma amplified sequence 4"	Q8TDM0	20	50794894-50882676	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.9;lymphoid tissue: 31.6"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 114.6;B-cells: 70.5;granulocytes: 104.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.9;naive B-cell: 28.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 38.9;U-698: 34.6"					"Low region specificity"	"Detected in all"			HPA038812	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA038812: AB_10795141"	"unprognostic (3.48e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.30e-2)"	1.8	2.3	7.3	29.1	12.9	3.9	4.5	6.2	12.8	4.8	4.2	2.3	4.2	2.4	5.4	7.2	4.7	3.6	3.8	3.1	13.8	7.5	7.0	1.4	3.8	28.5	7.1	9.2	3.0	3.6	9.2	5.4	5.0	5.2	7.7	1.9	8.8	4.9	7.1	2.1	2.1	8.6	6.0	2.0	12.2	4.5	5.1	2.2	9.2	5.9	0.0	31.6	7.6	5.3	28.9	7.0	0.6	0.1	6.9	12.9	5.3	4.9	8.9	0.7	3.9	1.4	3.7	1.5	6.4	5.8	4.6	3.3	4.2	3.0	38.9	2.4	2.7	9.3	7.4	4.4	9.3	2.7	2.5	3.9	0.2	3.5	3.5	2.0	0.0	0.2	1.2	5.4	3.5	1.7	5.8	0.2	3.1	0.1	0.2	1.6	17.3	1.5	0.1	3.2	0.7	7.2	12.2	1.2	0.4	2.1	4.5	4.0	4.1	10.0	9.6	0.2	3.5	19.0	0.4	0.2	5.0	7.3	5.0	1.5	0.6	2.9	34.6	2.0	0.3	0.4	0.6	0.1	0.1	6.2	0.1	3.5	28.9	3.8	7.5	0.1	28.7	12.9	10.3	0.6	6.9	0.1	7.0	3.1	5.3	7.3	12.9	6.2	12.8	13.8	7.5	7.1	9.2	5.2	2.2	20.8	114.6	70.5	24.1	1.8	5.8	14.8	5.1	37.5	33.0	8.7	2.0	24.9	34.9	9.7	1.3	1.6	0.0	0.0	2.7	3.1	14.6	11.2	104.6	0.2	2.6	7.9	32.2	1.3	1.5	0.4	1.4	1.4	5.0	1.8	2.2	6.9	6.3	0.0	2.8	3.3	5.5	6.5	14.6	3.0	10.6	2.0	9.2	25.8	1.2	21.3
BICDL2	CCDC64B	ENSG00000162069	"BICD family like cargo adaptor 2"	A1A5D9	16	3027682-3036926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.1;pancreas: 54.1"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 19.4;Ciliated cells: 22.7;Club cells: 22.7;Collecting duct cells: 15.7;Ductal cells: 27.6;Exocrine glandular cells: 43.8;Pancreatic endocrine cells: 34.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"eosinophil: 2.6;neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.5"	"Cell line enhanced"	"Detected in some"		"A-431: 6.5;BEWO: 11.5;CAPAN-2: 10.6;HaCaT: 16.5;MCF7: 16.0;RT4: 7.6;SK-BR-3: 8.2;T-47d: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043251	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA			"Intermediate filaments, Actin filaments, Cytosol"		"HPA043251: AB_10794925"	"unprognostic (2.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.06e-3)"	"unprognostic (9.65e-5)"	"unprognostic (5.79e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.32e-2)"	"prognostic favorable (9.04e-4)"	0.4	0.0	0.4	2.5	0.4	0.0	2.9	0.4	0.4	6.2	7.9	0.4	8.3	5.7	1.0	2.0	31.1	2.2	11.0	0.4	0.4	0.0	1.2	0.4	5.3	0.4	0.4	0.4	0.9	54.1	3.6	0.9	0.5	0.4	5.1	3.5	0.4	13.9	8.3	1.1	13.7	6.9	1.0	0.4	0.4	10.2	0.5	0.4	0.4	2.3	8.6	12.4	6.1	12.0	0.1	0.1	3.5	0.0	0.2	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	1.9	10.6	0.0	0.0	0.0	0.0	16.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.1	0.0	4.6	0.0	0.1	0.0	0.2	0.0	7.6	0.1	0.0	0.0	8.2	0.0	0.2	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.2	0.0	0.1	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	11.9	19.4	0.0	0.0	0.0	0.0	0.0	0.0	22.7	22.7	15.7	0.0	4.0	3.3	27.6	0.0	0.0	0.0	0.0	43.8	3.8	0.0	0.0	2.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	34.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
C11orf95	MGC3032	ENSG00000188070	"Chromosome 11 open reading frame 95"	C9JLR9	11	63759892-63768775	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Cholangiocytes: 15.3;Leydig cells: 17.0"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045002			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA045002: AB_2679179"	"unprognostic (4.23e-3)"	"unprognostic (7.24e-3)"	"unprognostic (6.47e-2)"	"unprognostic (9.01e-3)"	"unprognostic (7.54e-2)"	"unprognostic (3.89e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.85e-2)"	"unprognostic (6.60e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.31e-3)"	7.3	4.7	6.0	3.0	6.3	0.6	9.3	3.4	7.9	11.1	4.3	1.9	7.2	2.1	10.5	4.6	4.2	6.8	7.0	5.2	4.3		6.3	3.8	3.5	3.4	0.1	3.7	14.2	5.3	4.7	1.6	7.3	2.5	5.9	2.0	3.3	5.6	7.4	4.4	1.2	1.9	8.8	1.5	3.5	1.9	3.8	1.0	4.9	6.6	3.4	3.2	5.0	15.1	0.6	0.7	1.0	1.5	2.3	0.9	0.3	2.1	2.9	22.3	7.4	11.6	13.5	3.5	8.2	5.9	3.9	2.7	7.1	1.4	6.9	12.0	7.8	2.9	4.9	9.6	3.3	4.4	6.7	6.5	4.6	4.8	3.2	4.1	2.2	3.8	10.0	1.1	6.3	2.1	12.8	8.6	6.3	5.8	3.1	6.2	2.8	8.2	11.4	10.4	1.3	8.5	19.6	4.2	2.2	5.6	2.7	9.4	19.9	3.9	4.2	10.9	9.5	5.9	5.4	13.4	7.9	7.4	10.1	4.7	2.9	3.7	8.5	2.1	5.7	4.0	0.0	0.1	0.0	0.8	1.5	0.4	0.0	0.2	0.9	0.0	0.6	0.4	0.6	1.0	2.3	0.3	0.7	0.0	0.3											0.0	4.0	1.4	1.0	4.5	4.1	6.0	15.3	1.4	1.2	0.0	0.0	5.4	3.3	2.4	0.1	5.1	0.6	0.0	1.8	0.4	9.9	1.3	1.1	6.8	1.3	6.4	4.7	10.4	2.1	1.2	17.0	2.1	3.3	5.4	3.2	10.2	2.4	0.0	7.4	3.3	2.9	12.9	7.8	0.4	3.8	3.0	1.3	0.0	2.1	0.9
C12orf54	MGC35033	ENSG00000177627	"Chromosome 12 open reading frame 54"	Q6X4T0	12	48482503-48496512	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	38	"testis: 34.8"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 2100.5"	"Group enriched"	"Detected in some"	9	"cervical cancer: 2.9;head and neck cancer: 2.1;lung cancer: 1.6;urothelial cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 2.8;HBEC3-KT: 9.4;hTCEpi: 2.6;hTERT-HME1: 5.6"									HPA073090			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA073090: "	"unprognostic (2.59e-3)"	"unprognostic (5.49e-2)"	"unprognostic (7.94e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.99e-2)"		"unprognostic (5.96e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.37e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.92e-1)"	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.6	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.0	34.8	0.1	0.1	0.1	0.1	0.9	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	9.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.6	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0.0	1.6	0.0	22.3	4.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.1	444.4	0.1	0.0	0.0	0.0	0.1	0.4	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2100.5	10.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	12.4	0.2	0.0	6.5	1.4	12.9	6.4	1.9	0.0	0.0	0.0	8.4
C17orf98	LOC388381	ENSG00000275489	"Chromosome 17 open reading frame 98"	A8MV24	17	38835088-38841455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 10.7"	"Cell type enriched"	"Detected in some"	14	"Early spermatids: 184.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 7.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051696	Uncertain		Approved	"Nucleoli,Intermediate filaments"		NA	NA			"Intermediate filaments"	Nucleoli	"HPA051696: AB_2681576"	"unprognostic (2.30e-1)"			"unprognostic (3.25e-4)"	"unprognostic (1.46e-1)"					"unprognostic (3.01e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.58e-2)"	"unprognostic (9.02e-2)"		0.1	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.0	10.7			0.0		0.0	0.0		1.3	0.5	0.4	0.4	0.2	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.2	0.3	0.0	0.0	7.9	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.0	1.2	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.1	0.0	1.0	0.5	0.0	1.3	0.3	0.5	0.0	0.2	0.2	0.5	0.7	0.0											0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	184.7	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	13.1	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.2	1.3	0.0	0.0	0.0	0.0	0.0
C19orf25	FLJ36666	ENSG00000119559	"Chromosome 19 open reading frame 25"	Q9UFG5	19	1461143-1479556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050270, HPA067491"	Approved		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA050270: AB_2681069, HPA067491: AB_2685849"	"unprognostic (5.82e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.51e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.14e-3)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.35e-2)"	"prognostic favorable (9.20e-8)"	"unprognostic (3.50e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-3)"	12.1	17.9	25.8	14.2	22.1	10.4	11.2	26.4	22.6	12.7	15.7	19.0	17.7	23.2	17.2	12.5	12.1	17.6	12.5	17.2	24.5	21.8	17.9	16.8	13.0	19.9	23.4	15.6	16.4	27.0	10.4	18.2	15.4	15.3	15.3	8.2	16.5	27.0	13.9	11.7	13.7	22.2	14.0	23.0	16.5	16.8	17.6	17.2	17.3	24.1	7.4	14.9	12.6	18.0	28.2	28.6	34.1	20.2	17.1	31.2	23.0	13.1	10.2	6.4	10.1	6.2	5.7	12.7	13.0	9.1	14.2	13.1	14.7	6.8	7.6	10.3	7.0	6.6	16.3	9.7	8.3	3.3	23.5	14.6	9.2	6.0	17.1	13.5	14.5	18.3	5.3	18.9	5.9	9.5	10.0	7.3	16.2	23.8	18.0	8.9	7.4	13.6	12.1	20.3	8.2	16.6	22.4	8.9	19.4	9.8	9.0	10.8	14.7	9.7	12.5	15.4	3.4	18.3	17.1	8.9	10.9	12.4	22.0	12.4	25.6	13.8	12.6	11.3	14.8	19.4	26.5	20.2	34.1	27.4	19.7	22.2	22.1	25.2	23.4	14.4	28.2	26.1	20.9	32.1	17.1	15.7	28.6	31.2	23.0	25.8	22.1	26.4	22.6	24.5	21.8	23.4	15.6	15.3	17.2	14.9	8.3	41.0	27.9	17.1	58.8	8.9	20.4	8.1	9.1	48.8	60.9	37.2	41.4	32.8	3.5	20.3	69.8	0.0	40.0	27.2	22.8	28.7	11.5	16.6	31.1	92.2	48.6	25.2	22.2	5.2	24.5	24.1	23.6	59.5	25.9	47.3	39.9	52.6	20.5	23.9	70.3	45.3	22.8	28.8	32.4	17.2	44.3	48.4	26.4	30.6
C19orf54	FLJ41131	ENSG00000188493	"Chromosome 19 open reading frame 54"	Q5BKX5	19	40740856-40751553	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059043, HPA059628"	Approved		Approved	"Intermediate filaments,Centriolar satellite"		NA	NA			"Intermediate filaments"	"Centriolar satellite"	"HPA059043: AB_2683886, HPA059628: AB_2684087"	"unprognostic (3.18e-3)"	"unprognostic (2.09e-2)"	"unprognostic (5.19e-2)"	"unprognostic (7.21e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.33e-2)"	10.1	15.7	8.6	10.6	11.8	9.2	11.2	5.0	10.6	7.6	10.1	15.6	16.7	17.9	8.7	16.6	9.2	7.6	10.1	8.4	7.5	5.9	11.8	21.3	13.4	13.3	11.1	6.9	7.0	12.9	13.7	9.6	10.2	10.9	9.5	13.3	9.2	10.1	16.4	22.5	10.1	17.2	9.2	16.8	15.0	10.4	11.4	11.0	13.4	12.2	7.8	10.6	10.3	7.2	1.6	8.2	1.8	6.5	0.7	2.9	2.4	5.1	12.7	10.0	8.6	5.4	7.9	7.8	3.6	5.3	6.3	6.6	8.6	8.3	12.2	9.7	4.9	3.5	8.8	16.4	6.9	6.2	7.5	14.7	7.8	14.4	10.5	18.1	5.3	5.8	12.2	3.5	6.5	15.3	9.2	4.3	16.5	9.5	17.4	5.3	6.6	6.9	6.1	7.6	12.6	4.1	12.1	11.2	9.1	7.6	9.7	8.3	5.2	14.3	5.8	5.4	12.7	6.0	6.7	3.7	8.7	8.8	4.2	2.7	18.8	11.5	8.7	8.9	11.4	5.7	0.1	6.0	1.8	2.0	5.1	0.7	1.6	1.6	0.9	8.2	1.4	1.6	1.4	0.9	0.7	6.5	4.3	2.9	2.4	8.6	11.8	5.0	10.6	7.5	5.9	11.1	6.9	10.9	11.0	3.0	6.2	3.7	3.1	1.4	1.4	5.8	2.5	1.4	0.0	5.2	2.0	6.3	3.3	2.5	5.9	2.8	7.8	0.0	2.2	5.8	2.1	2.4	0.0	5.5	7.4	0.0	1.2	1.3	8.0	2.0	2.3	5.3	0.0	9.0	4.2	2.0	2.6	3.4	1.1	5.1	3.6	0.0	1.1	9.8	9.1	1.5	4.7	2.5	5.3	1.6
C1orf159	FLJ20584	ENSG00000131591	"Chromosome 1 open reading frame 159"	Q96HA4	1	1081818-1116361	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 48.9;Late spermatids: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA010019, HPA075399"	Approved		Approved	"Nucleoli rim,Mitotic chromosome,Intermediate filaments"		Yes	No			"Nucleoli rim, Mitotic chromosome, Intermediate filaments"		"HPA010019: AB_1078885, HPA075399: "	"unprognostic (2.79e-1)"	"unprognostic (9.46e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.60e-3)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (1.34e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.26e-3)"	"prognostic unfavorable (1.77e-6)"	"unprognostic (4.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (1.62e-4)"	3.7	6.6	8.3	4.9	9.0	5.6	3.1	7.6	10.0	5.5	6.0	11.3	5.4	6.1	6.0	6.9	6.6	4.0	5.9	3.8	8.8	5.8	5.0	5.0	5.6	4.2	6.6	4.9	5.8	5.3	2.2	4.4	5.6	5.0	6.6	1.8	5.8	10.2	6.5	3.6	23.7	5.5	7.5	5.2	7.0	9.0	17.5	5.6	5.2	4.0	5.2	6.4	5.4	4.4	5.0	4.3	9.9	4.9	4.7	5.7	3.9	11.9	9.7	4.5	7.8	1.4	1.4	10.2	6.8	1.6	6.2	4.1	5.2	12.6	3.4	8.4	2.1	5.0	9.9	1.9	6.3	1.8	6.4	14.1	2.3	16.6	5.4	2.9	4.0	5.6	3.1	3.0	3.2	1.2	1.9	3.0	5.5	13.8	2.7	2.2	9.2	7.4	10.2	4.1	4.5	15.6	9.2	5.3	6.2	3.6	4.3	9.4	12.5	5.3	9.5	5.4	1.4	6.6	5.2	5.0	6.7	7.1	9.8	7.0	4.5	6.1	6.0	5.8	10.9	5.4	9.9	4.9	2.6	5.3	4.4	5.4	5.0	4.9	5.7	3.2	4.7	5.3	5.0	1.1	4.7	3.1	4.3	1.7	3.9	8.3	9.0	7.6	10.0	8.8	5.8	6.6	4.9	5.0	5.6	0.0	10.6	1.5	3.4	6.6	6.2	1.8	5.1	9.4	5.7	8.7	3.9	4.7	1.7	7.6	48.9	3.6	5.1	23.3	5.9	11.7	5.0	4.2	5.7	4.7	3.6	12.7	4.1	1.8	1.8	101.9	2.6	2.7	3.3	8.2	7.0	3.0	6.1	2.9	1.4	1.1	7.4	0.0	4.1	11.2	6.6	6.0	4.1	3.8	6.9	4.4
C6orf52		ENSG00000137434	"Chromosome 6 open reading frame 52"	Q5T4I8	6	10671418-10694797	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 17.7"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 33.5;Early spermatids: 33.2;Late spermatids: 22.3;Spermatocytes: 32.4;Spermatogonia: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 8.7;NB-4: 7.7"					"Low region specificity"	"Detected in all"			HPA051142	Uncertain		Approved	"Nuclear speckles,Intermediate filaments"		No	No			"Nuclear speckles"	"Intermediate filaments"	"HPA051142: AB_2681359"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.50e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.31e-3)"	"unprognostic (7.65e-2)"	1.6	2.4	5.6	1.4	4.8	0.9	3.0	2.7	4.3	1.2	1.5	4.4	5.5	7.7	1.4	9.0	0.9	8.0	1.2	0.7	4.9	5.3	3.8	1.4	1.7	1.1	4.5	3.2	1.9	7.7	1.5	2.9	1.5	4.4	3.1	1.0	0.7	1.8	1.7	1.2	2.5	2.1	0.9	4.0	1.0	1.6	17.7	2.6	1.6	2.1	1.0	1.6	1.0	2.0	0.7	1.0	4.7	1.0	1.4	6.2	0.6	1.1	2.7	2.5	2.2	0.9	0.0	4.4	0.2	0.1	0.3	0.6	3.0	2.4	0.1	4.0	0.0	2.9	0.2	2.4	0.0	1.0	1.4	4.2	0.6	0.5	0.4	0.0	0.8	0.4	0.5	3.9	1.1	1.5	0.3	0.0	2.5	4.7	0.3	1.1	8.7	1.8	7.7	2.3	1.6	3.0	1.5	0.2	1.0	1.2	0.6	5.0	3.1	0.9	0.6	4.9	2.6	0.2	1.5	0.4	2.0	0.7	1.5	1.8	3.6	7.5	1.5	3.5	1.1	1.9	0.0	0.5	4.7	1.2	1.0	0.4	0.5	1.5	1.3	1.0	0.7	0.7	0.6	0.6	1.4	0.7	0.8	6.2	0.6	5.6	4.8	2.7	4.3	4.9	5.3	4.5	3.2	4.4	2.6	0.0	2.4	0.0	1.7	1.3	1.8	0.5	2.5	33.5	1.2	3.5	2.0	2.4	5.0	3.1	33.2	1.0	1.1	0.0	5.3	2.1	1.5	1.5	0.0	1.6	1.0	1.6	2.9	2.5	0.3	22.3	2.0	0.7	3.3	2.8	0.5	3.8	2.8	2.9	0.0	8.1	0.6	0.0	2.1	32.4	23.4	1.3	1.1	0.0	1.8	0.7
C7orf26	MGC2718	ENSG00000146576	"Chromosome 7 open reading frame 26"	Q96N11	7	6590017-6608726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042899, HPA052175"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Intermediate filaments, Cytosol"	"HPA042899: AB_2678218, HPA052175: AB_2681750"	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (6.95e-5)"	"unprognostic (4.72e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.55e-1)"	19.8	17.1	13.4	21.7	17.7	29.2	20.0	20.6	26.9	19.0	17.9	21.1	21.5	19.4	23.0	15.4	14.7	19.9	15.6	12.8	14.4	14.1	15.4	18.4	19.3	24.1	18.8	20.2	20.6	23.9	17.2	16.6	14.0	15.4	21.1	11.5	16.4	21.2	16.6	18.7	21.9	16.4	19.6	13.1	27.3	18.6	16.8	16.1	31.7	18.3	18.5	20.6	17.6	19.6	4.2	6.4	4.6	3.4	3.3	6.1	1.9	11.1	9.4	6.6	15.4	10.7	6.0	8.7	6.7	5.9	9.7	6.0	8.7	4.7	13.3	8.8	5.0	18.5	12.4	8.7	6.2	4.4	5.1	12.6	4.9	5.9	9.2	12.6	11.8	15.9	6.9	9.3	5.8	6.1	5.2	10.6	14.4	12.9	10.1	5.7	18.8	10.2	24.4	13.0	5.6	12.5	20.9	5.2	11.2	6.3	9.8	8.6	16.0	6.5	21.7	9.0	7.1	9.9	17.8	7.6	8.1	26.6	8.8	14.6	12.3	12.1	12.2	5.4	13.1	23.8	1.1	3.4	4.6	4.7	3.3	6.1	4.1	5.7	6.0	2.6	4.2	5.9	4.9	3.4	3.3	3.3	6.4	5.4	1.9	13.4	17.7	20.6	26.9	14.4	14.1	18.8	20.2	15.4	16.1	8.9	7.5	6.1	8.2	13.5	6.1	5.3	10.2	4.0	5.7	1.8	5.9	10.4	0.0	7.5	5.8	9.3	8.4	0.0	8.8	9.1	9.3	8.5	1.1	6.4	11.6	4.8	12.1	14.7	10.3	3.2	7.5	9.8	6.8	4.6	12.3	6.7	9.2	10.5	8.1	6.3	6.1	6.5	13.2	11.2	13.8	11.2	8.1	14.6	10.2	6.0
CARD10	"BIMP1, CARMA3"	ENSG00000100065	"Caspase recruitment domain family member 10"	Q9BWT7	22	37490362-37519542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.6"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 21.7;Enterocytes: 29.9;Pancreatic endocrine cells: 26.6;Paneth cells: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.1;U-2197: 36.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029359, HPA055612"	Approved		Approved	"Vesicles,Intermediate filaments,Cytosol"		No	No			"Vesicles, Intermediate filaments"	Cytosol	"HPA029359: AB_10601354, HPA055612: AB_2682861"	"unprognostic (9.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (7.73e-6)"	"unprognostic (3.66e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.31e-2)"	"unprognostic (9.69e-2)"	8.1	6.8	3.5	4.5	2.3	0.0	10.2	1.5	2.7	5.7	16.4	2.4	4.1	23.7	9.8	6.4	6.8	5.9	14.1	7.6	1.7	1.1	14.0	10.5	7.0	2.4	1.6	1.3	6.8	8.9	1.6	1.7	4.9	3.8	5.6	6.2	5.6	12.6	3.2	8.0	7.3	33.6	4.1	1.3	3.3	7.0	11.1	1.3	0.7	5.6	13.5	3.9	4.9	9.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	13.1	9.6	1.8	1.3	0.0	3.9	8.7	1.2	2.8	5.6	4.4	6.0	9.4	0.0	4.7	2.3	5.4	18.5	2.1	24.1	1.7	0.0	5.2	0.3	6.1	9.2	2.4	0.2	0.8	1.3	5.0	10.7	13.8	4.5	11.3	0.0	1.3	0.0	4.2	4.5	0.0	0.8	3.1	7.1	5.8	0.0	17.2	1.3	8.3	2.3	0.6	1.0	9.2	4.1	0.9	2.2	4.4	0.7	14.9	4.2	12.3	36.1	6.9	0.0	0.0	0.0	13.4	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	3.5	2.3	1.5	2.7	1.7	1.1	1.6	1.3	3.8	1.3	0.0	1.3	0.0	3.4	7.6	0.2	3.1	10.2	0.0	1.2	3.5	0.0	0.1	1.7	21.7	7.8	14.7	29.9	0.0	17.3	1.5	1.1	3.6	0.0	3.9	0.1	0.0	7.5	12.3	0.0	4.3	0.0	0.4	5.0	0.0	17.6	0.0	26.6	21.0	0.7	10.5	0.1	0.0	1.2	0.5	3.4	3.3	0.0	0.0	8.1	7.1
CDC42BPA	"FLJ23347, KIAA0451, MRCK, MRCKA, PK428"	ENSG00000143776	"CDC42 binding protein kinase alpha"	Q5VT25	1	226989865-227318474	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Horizontal cells: 211.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB070414, HPA071252"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB070414: AB_11156796, HPA071252: AB_2686374"	"unprognostic (3.67e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-2)"	17.2	15.2	19.1	8.6	21.1	3.9	14.0	29.2	20.4	21.1	19.3	16.4	13.1	16.9	15.8	9.9	12.3	12.9	16.6	14.1	21.7	17.7	20.8	17.0	11.7	3.5	20.0	16.3	17.4	15.1	29.3	29.6	14.8	19.3	21.1	12.4	11.0	8.4	18.5	11.9	7.6	17.2	27.6	16.6	8.8	25.2	26.7	19.9	0.7	9.8	7.3	2.5	23.4	23.1	0.1	0.7	2.0	0.1	0.0	0.1	0.0	9.5	9.0	9.7	4.5	9.7	12.0	3.4	11.0	15.6	7.6	8.0	7.3	21.8	0.0	11.8	18.2	5.7	4.4	7.1	6.1	9.3	0.0	5.7	7.4	10.8	2.8	11.0	5.9	3.3	8.4	7.9	12.3	12.4	9.5	25.3	5.9	18.7	0.0	12.3	2.6	0.1	1.0	7.9	12.4	8.7	0.0	16.3	0.0	12.2	18.5	7.0	10.2	18.6	7.8	10.9	6.2	10.1	0.3	25.5	13.9	7.3	15.9	14.5	0.0	0.0	0.0	18.5	0.0	18.6	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	19.1	21.1	29.2	20.4	21.7	17.7	20.0	16.3	19.3	19.9	38.7	29.4	1.4	19.9	10.4	96.7	50.6	25.5	21.4	35.2	41.8	111.9	5.2	11.6	22.3	90.9	47.3	45.2	23.3	35.4	6.1	27.8	25.0	6.9	24.5	3.2	211.4	25.3	42.4	7.1	98.3	40.9	6.8	15.1	9.0	24.1	34.1	46.5	54.5	80.2	32.9	64.0	77.6	45.3	40.8	51.3	6.9	1.1	1.3	26.4	26.8
COL9A3	"DJ885L7.4.1, EDM3, FLJ90759, IDD, MED"	ENSG00000092758	"Collagen type IX alpha 3 chain"	Q14050	20	62816244-62841159	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 120.8;Late spermatids: 311.3;Muller glia cells: 91.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 53.7;Hep G2: 21.2;SK-MEL-30: 17.6;WM-115: 21.3"	"Low region specificity"	"Detected in all"							"HPA040125, HPA058323"	Supported		Approved	"Nucleoplasm,Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA040125: AB_10805604, HPA058323: AB_2683679"	"unprognostic (1.14e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.67e-1)"	2.2	2.0	11.2	2.3	16.3	1.2	1.5	1.5	8.9	1.7	3.4	26.4	1.6	2.3	1.8	1.5	1.6	1.2	1.4	2.1	14.9	9.8	1.4	1.3	1.3	1.4	18.4	8.1	1.6	5.4	1.1	5.3	1.9	12.4	1.7	1.3	37.2	38.9	3.4	1.5	1.8	2.5	1.4	25.0	1.2	1.8	6.4	15.2	0.0	18.1	1.4	1.2	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	53.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.5	21.2	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	2.4	2.9	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	17.6	1.8	0.1	1.9	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	16.3	1.5	8.0	14.9	9.8	18.4	8.1	12.4	15.2	3.0	0.0	13.7	1.7	2.9	1.0	1.2	0.0	0.0	0.0	5.2	9.8	4.0	1.7	1.3	120.8	3.1	0.9	0.0	0.0	35.4	10.4	0.9	0.0	2.4	2.1	0.0	4.1	3.1	2.7	311.3	3.7	1.3	3.3	0.0	2.6	91.3	0.1	6.2	1.4	9.5	2.5	0.0	1.1	2.5	4.1	6.0	3.3	0.0	1.5	0.8
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	66	"liver: 1139.7"	"Cell type enriched"	"Detected in some"	14	"Hepatocytes: 2991.5"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 1010.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.2;HDLM-2: 7.8;SiHa: 2.7;U-2 OS: 5.5;U-266/84: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	NA	NA	2920000000	5400000000	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217"	"unprognostic (3.74e-1)"	"unprognostic (5.31e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.57e-2)"			"unprognostic (1.33e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (4.17e-10)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.61e-2)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	17.2	0.1	0.1	0.0	0.1	1139.7	0.1	0.1	0.1	0.1	0.1	7.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.0	0.0	7.8	0.0	0.3	0.0	0.0	0.0	0.3	0.1	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.1	0.9	0.0	13.1	2.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	55.9	0.0	0.0	0.0	0.0	109.5	0.0	0.0	0.0	0.0	0.0	0.0	220.4	1.2	0.0	0.0	23.3	52.3	0.0	0.0	0.0	0.0	2991.5	0.1	0.0	0.0	82.9	72.1	0.0	0.0	0.0	0.0	17.2	0.0	0.0	97.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRTAP	"CASP, LEPREL3, P3H5"	ENSG00000170275	"Cartilage associated protein"	O75718	3	33113979-33147773	"Disease related genes, Predicted secreted proteins"			"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 172.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 67.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 55.8;monocytes: 67.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 122.6;ASC TERT1: 80.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043598, HPA044150"	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"	"Secreted to blood"	NA	NA			"Intermediate filaments, Actin filaments, Cytosol"		"HPA043598: AB_10960991, HPA044150: AB_10959594"	"unprognostic (5.29e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.85e-3)"	"unprognostic (7.36e-2)"	"unprognostic (4.73e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.28e-3)"	59.2	33.4	16.3	13.4	22.2	13.6	63.2	5.4	14.1	57.5	39.4	23.3	32.7	12.8	54.2	41.1	42.8	35.1	43.5	37.0	16.8	13.1	25.7	16.8	35.9	37.8	24.2	13.0	48.5	13.3	14.6	7.6	25.4	13.8	54.5	19.7	35.4	16.4	42.2	23.9	24.6	18.8	66.1	22.8	17.6	25.2	26.1	19.0	5.1	34.1	25.8	18.3	62.4	59.7	7.6	55.8	5.5	67.8	6.9	12.9	30.8	9.1	18.1	5.7	17.8	122.6	80.3	33.0	20.0	43.7	24.3	23.2	6.1	5.2	6.4	22.4	38.0	19.6	11.8	10.1	15.3	17.6	15.8	15.7	10.0	14.2	6.3	36.7	6.4	8.2	64.0	31.4	21.9	27.9	47.3	25.5	4.0	8.5	12.3	24.5	7.8	2.3	6.6	6.8	9.8	24.7	8.5	16.7	12.3	19.0	6.1	1.2	9.2	13.5	11.9	28.8	13.8	12.8	15.9	16.6	31.9	13.6	17.3	21.1	8.9	30.1	0.9	25.0	13.0	17.4	2.1	67.8	4.9	6.9	26.3	10.0	7.6	10.1	7.7	55.8	6.8	5.8	5.4	5.5	6.9	7.8	15.0	12.9	30.8	16.3	22.2	5.4	14.1	16.8	13.1	24.2	13.0	13.8	19.0	8.9	42.6	18.6	27.6	53.7	18.7	29.5	25.5	4.0	19.4	36.6	7.9	42.5	10.0	19.9	1.0	55.3	18.1	0.0	27.7	59.7	94.1	20.8	46.2	44.4	93.2	33.4	5.8	103.2	172.9	2.2	132.3	73.7	75.9	27.9	22.6	17.7	20.2	10.5	136.2	43.7	10.5	109.9	117.1	1.4	7.9	40.8	23.5	20.8	33.1	22.1
CTNS	"CTNS-LSB, PQLC4"	ENSG00000040531	"Cystinosin, lysosomal cystine transporter"	O60931	17	3636468-3661542	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046947			Supported	"Vesicles,Intermediate filaments"		NA	NA			"Vesicles, Intermediate filaments"		"HPA046947: AB_2679872"	"unprognostic (1.64e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.28e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.62e-3)"	"prognostic favorable (6.39e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	9.6	19.0	8.5	8.2	11.9	8.3	12.1	5.0	9.9	18.8	8.2	16.1	34.8	10.8	10.3	7.2	7.3	8.3	10.6	9.3	7.7	5.9	23.9	16.4	11.4	9.1	12.1	5.6	12.6	32.7	11.3	14.5	13.2	8.5	10.2	6.4	11.4	10.5	46.2	22.6	18.0	9.2	7.9	10.2	12.2	12.9	27.0	13.0	11.7	9.0	6.5	9.0	10.1	9.1	3.5	19.6	13.7	5.6	2.5	3.3	3.7	6.2	14.0	8.2	7.0	13.3	6.8	5.1	6.0	10.2	7.0	8.8	7.8	6.1	3.7	6.4	4.1	19.2	16.0	7.2	4.1	5.4	46.5	12.7	4.2	10.5	6.3	18.0	2.8	29.1	8.4	5.3	7.3	6.0	10.9	7.7	6.0	4.3	5.9	6.5	5.7	2.8	2.7	3.6	4.3	6.1	6.2	3.3	8.8	6.2	6.3	1.6	6.0	7.1	9.5	7.1	7.3	6.7	2.8	9.0	6.9	4.3	15.5	4.9	4.7	6.1	1.8	10.6	3.1	4.7	13.7	5.6	12.1	1.9	3.7	2.7	3.5	2.3	3.3	5.4	3.1	2.9	3.1	2.0	2.5	3.8	19.6	2.6	3.7	8.5	11.9	5.0	9.9	7.7	5.9	12.1	5.6	8.5	13.0	3.0	2.1	0.0	3.2	1.4	1.4	3.6	7.6	2.7	1.2	12.2	9.8	5.1	0.0	5.4	33.5	6.0	2.8	0.0	5.5	5.9	4.8	5.5	8.1	5.8	20.7	4.8	2.4	13.5	7.1	23.4	8.9	8.3	5.0	12.6	2.5	6.6	5.8	2.0	12.0	7.9	3.6	6.5	2.8	11.4	8.5	2.0	7.1	4.3	1.8	2.6
DDX60	FLJ20035	ENSG00000137628	"DExD/H-box helicase 60"	Q8IY21	4	168216293-168318807	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 22.8;BJ hTERT+ SV40 Large T+ RasG12V: 22.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA046952	Approved		Supported	"Intermediate filaments,Cytosol"		No	No			Cytosol	"Intermediate filaments"	"HPA046952: AB_10963572"	"unprognostic (4.05e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.22e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.44e-1)"	18.0	8.3	4.1	18.5	5.0	4.4	9.0	1.3	3.8	11.4	14.8	4.3	5.1	8.8	10.8	15.2	10.7	8.1	11.5	8.5	3.7	3.5	10.0	8.8	21.6	18.7	4.2	3.2	20.3	5.5	8.8	6.7	25.5	5.6	11.6	14.3	9.0	15.6	6.2	5.6	7.9	16.7	11.2	6.1	18.9	29.2	5.7	3.9	23.2	14.5	6.0	9.3	8.2	7.2	4.1	2.5	3.2	6.3	7.6	10.0	3.5	5.6	1.2	2.8	1.1	2.1	7.8	3.2	1.9	13.7	22.8	22.1	0.0	12.4	0.0	1.1	3.0	10.5	4.7	0.3	4.5	6.6	4.3	0.6	8.8	4.8	0.0	10.3	3.3	2.2	7.0	2.0	5.8	1.3	5.5	8.5	4.2	0.0	1.7	2.8	0.3	5.0	2.4	0.5	0.8	1.6	3.4	1.5	0.1	6.7	3.4	0.6	0.6	3.6	1.0	13.7	0.2	0.9	4.2	5.6	1.4	1.5	0.5	1.4	1.0	0.2	0.0	4.3	3.8	4.0	3.2	2.8	2.6	8.5	5.1	10.0	4.1	6.7	8.0	2.5	3.3	6.8	8.5	2.8	7.6	6.3	0.2	5.5	3.5	4.1	5.0	1.3	3.8	3.7	3.5	4.2	3.2	5.6	3.9	32.8	6.2	5.0	4.0	3.8	0.7	7.1	10.2	14.7	12.5	12.2	0.0	6.4	5.0	7.0	1.7	10.3	10.7	0.0	5.9	8.5	5.0	3.8	26.5	3.8	5.8	0.0	2.9	15.4	4.1	1.4	7.5	8.8	3.3	0.0	13.6	8.0	8.7	7.2	8.9	3.3	3.0	6.5	3.8	0.9	0.7	2.4	2.4	10.1	5.8	3.1
DHX57	DDX57	ENSG00000163214	"DExH-box helicase 57"	Q6P158	2	38797729-38875934	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 120.8;Late spermatids: 273.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036160	Uncertain		Approved	"Nucleoli,Intermediate filaments,Microtubules,Cytosol"		NA	NA			"Intermediate filaments, Microtubules"	"Nucleoli, Cytosol"	"HPA036160: AB_10670711"	"unprognostic (6.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.25e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.75e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.77e-1)"	9.6	11.2	9.7	8.5	16.7	7.0	10.4	11.9	16.4	14.1	9.4	9.9	9.8	4.2	13.9	17.1	8.4	11.2	9.5	9.3	9.6	11.0	11.2	7.2	7.9	9.2	8.9	9.5	13.2	9.5	18.9	17.9	11.2	13.1	10.5	9.2	11.6	7.8	14.2	11.5	11.1	6.9	11.8	7.7	9.9	7.9	27.7	8.3	13.9	11.8	8.1	11.1	10.5	8.3	7.1	5.2	1.7	10.1	3.3	6.0	4.2	16.9	13.6	15.3	11.5	10.1	12.4	12.5	11.8	11.7	11.2	11.1	10.9	5.2	5.0	11.9	12.0	12.7	8.8	17.2	13.1	18.5	20.5	12.7	9.7	9.2	14.9	9.1	10.2	5.6	11.8	7.9	14.5	9.1	7.9	14.9	3.7	12.4	7.1	12.1	12.4	10.2	9.4	19.0	7.3	8.1	5.1	20.2	9.8	10.3	6.5	12.6	18.6	11.8	12.2	13.8	11.2	8.6	5.6	11.5	11.2	13.0	8.5	12.7	7.4	8.3	2.1	8.7	7.1	7.4	1.7	10.1	1.7	4.5	6.9	6.0	5.7	4.0	3.5	5.2	7.1	4.8	3.0	0.5	3.3	8.0	1.7	3.3	4.2	9.7	16.7	11.9	16.4	9.6	11.0	8.9	9.5	13.1	8.3	3.0	7.5	8.2	2.2	2.4	23.0	5.9	5.1	28.1	13.6	22.7	53.0	6.0	0.0	6.9	120.8	4.3	1.6	23.3	6.4	5.8	5.6	1.6	10.4	5.7	6.1	17.5	11.3	9.2	13.6	273.7	14.7	9.5	1.7	5.4	5.5	11.2	6.9	3.5	13.1	4.9	28.3	0.0	3.9	15.2	6.4	2.3	2.4	6.9	5.1	1.3
DISC1		ENSG00000162946	"Disrupted in schizophrenia 1"	Q9NRI5	1	231626815-232041272	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	Schizophrenia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 105.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 12.4;TIME: 9.7;WM-115: 9.9"					"Low region specificity"	"Detected in all"			HPA048911			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA048911: AB_2732549"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.89e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-1)"	5.3	3.3	9.1	6.4	10.6	5.3	7.6	2.5	7.6	4.9	3.1	11.6	0.0	2.6	4.2	1.6	3.1	2.9	5.6	19.2	9.2	5.9	2.7	3.1	3.9	11.3	10.5	4.8	9.6	2.1	2.7	2.8	14.3	9.2	3.9	2.9	13.1	4.0	2.4	3.2	2.9	3.1	3.4	10.2	6.1	2.4	2.2	9.3	4.2	4.1	2.5	3.9	4.5	7.2	0.5	3.3	2.6	2.9	0.7	1.6	0.7	0.0	0.5	4.5	0.1	0.1	0.4	3.3	1.7	4.1	4.8	4.0	1.6	1.0	0.1	5.4	1.5	1.1	0.0	0.4	0.1	4.2	2.8	1.9	2.4	0.4	4.4	0.6	4.0	6.0	2.5	0.8	1.5	1.3	3.2	4.2	3.1	0.0	1.8	5.2	0.4	1.1	6.1	2.3	0.0	1.7	3.0	1.3	0.5	0.2	0.0	0.8	2.5	1.6	0.0	2.7	1.2	0.0	12.4	9.7	2.5	2.6	1.2	1.0	1.1	0.8	0.0	1.9	6.2	9.9	0.3	2.7	0.1	0.9	2.9	0.5	0.1	1.4	0.3	3.3	0.5	1.6	0.5	2.6	0.7	1.2	1.9	0.5	0.7	9.1	10.6	2.5	6.3	9.2	5.9	10.5	4.8	9.2	9.3	0.0	1.4	0.0	0.5	0.8	10.7	4.6	0.0	1.4	1.2	3.5	7.9	6.0	0.0	0.6	12.9	5.3	0.0	0.0	1.0	0.6	3.3	0.4	6.9	0.0	9.3	0.0	0.0	9.8	13.5	17.3	0.9	8.9	3.3	0.0	0.0	2.5	1.4	0.0	1.4	0.0	105.2	0.0	1.3	0.4	1.1	1.0	2.1	3.1	0.2	0.5
DMRTC1		ENSG00000269502	"DMRT like family C1"	Q5HYR2	X	72872025-72943814	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Group enriched"	"Detected in many"	17	"B-cells: 2.2;T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;Daudi: 3.6;JURKAT: 2.6;NTERA-2: 1.2;U-266/70: 1.2;U-266/84: 1.4;U-698: 2.0"									"HPA046874, HPA046992"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (1.83e-1)"													0.0	1.3		0.0		0.0	0.0		4.0	0.6	0.1			0.0	1.1	0.0	0.1	2.1	0.2	0.0			0.0	0.0	0.0	0.6			1.3	0.0	0.0		0.0		0.0	0.3		0.0	0.2	0.0	0.0	0.1	0.6		0.7	0.0	1.1			2.0		0.8	0.0		2.2	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	1.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.5	0.0	2.2	0.7	1.2	0.0	0.0	0.0	0.0	0.4	0.1											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMRTC1B		ENSG00000184911	"DMRT like family C1B"	Q5HYR2	X	72777009-72848802	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.1;ovary: 12.1;pituitary gland: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.8"	"Group enriched"	"Detected in many"	12	"B-cells: 2.1;T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.0;SK-BR-3: 1.0;SuSa: 2.2;U-266/70: 1.5"									"HPA046874, HPA046992"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (2.00e-1)"						"unprognostic (1.91e-2)"	"unprognostic (1.54e-1)"				"unprognostic (6.52e-2)"		0.3	4.6	11.0	1.7	15.1	0.1	0.7	4.5	14.3	1.7	0.6	2.2	1.4	0.5	2.2	9.6	0.3	3.3	0.6	0.2	8.6	14.2	1.6	0.2	1.1	1.4	4.9	9.1	12.1	5.2	1.5	12.1	0.2	2.2	3.8	0.8	2.4	1.0	1.9	0.2	0.5	0.5	0.6	2.2	1.3	1.2	7.1	2.9	0.7	3.9	0.2	2.1	0.3	0.2	2.1	0.0	0.0	0.0	0.2	2.8	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.8	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.4	0.0	2.1	2.1	2.8	0.0	0.2	0.0	0.0	0.0	0.2	11.0	15.1	4.5	11.4	8.6	14.2	4.9	9.1	2.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DNAH3	"DKFZp434N074, DLP3, Dnahc3b, Hsadhc3"	ENSG00000158486	"Dynein axonemal heavy chain 3"	Q8TD57	16	20933111-21159441	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 10.4;testis: 6.2"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 87.0;Early spermatids: 28.8"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.1;CACO-2: 1.0;CAPAN-2: 1.2;hTEC/SVTERT24-B: 1.4;U-698: 1.2"									HPA062493			Approved	"Nuclear membrane,Intermediate filaments"		NA	NA			"Nuclear membrane"	"Intermediate filaments"	"HPA062493: "	"unprognostic (1.68e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.57e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.2			0.0	0.2	0.0	0.0	10.4	0.0	0.0	0.5	0.7	0.0	0.0	1.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.3		0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	6.2			0.0		0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	1.0	1.2	0.1	0.4	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.9	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.6	0.2	0.1	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.7	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.6	0.0	0.5	0.2	0.0	1.6	0.0	87.0	9.1	0.0	0.0	0.2	0.0	0.0	28.8	0.3	0.9	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	5.3	0.5	0.0	0.0	1.9	0.1
DNAJA2	"CPR3, DNAJ, DNJ3, HIRIP4"	ENSG00000069345	"DnaJ heat shock protein family (Hsp40) member A2"	O60884	16	46955362-46973788	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049789, HPA060538"	Approved		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA		31000	"Nucleoli, Cytosol"	"Intermediate filaments"	"HPA049789: AB_2680883, HPA060538: AB_2684315"	"unprognostic (7.68e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.67e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.19e-9)"	"unprognostic (9.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.69e-2)"	25.0	29.2	32.3	18.0	36.5	23.6	22.8	29.8	44.2	21.7	21.1	17.1	20.3	22.3	25.6	33.6	23.4	20.3	18.9	37.9	30.5	27.1	31.2	39.0	17.7	21.4	25.5	27.6	26.1	18.9	29.0	18.9	22.1	31.5	25.6	21.9	18.4	19.1	24.9	43.7	22.3	23.8	26.9	21.2	24.1	20.3	33.0	18.7	20.8	25.4	31.8	23.2	24.5	23.5	13.6	10.5	14.5	14.0	14.3	18.9	10.2	11.0	13.1	13.2	11.2	18.1	17.5	20.2	14.4	17.3	21.6	10.3	11.4	11.5	17.7	11.6	15.4	9.3	17.2	21.1	14.8	25.2	4.2	17.6	13.0	6.4	24.1	21.8	19.7	18.2	18.6	17.2	12.5	11.9	19.0	14.9	7.2	14.9	6.0	18.2	12.0	14.1	27.5	20.1	10.1	19.5	16.4	24.3	21.0	26.0	11.7	18.1	11.6	17.0	25.9	15.6	13.6	10.0	15.4	15.3	12.9	8.1	9.2	12.0	14.8	10.1	23.8	13.5	17.1	10.7	13.0	11.5	14.5	11.9	14.0	15.4	13.6	16.1	13.3	10.5	10.4	16.0	15.7	12.1	14.3	12.0	7.4	18.9	10.2	32.3	36.5	29.8	44.2	30.5	27.1	25.5	27.6	31.5	18.7	47.6	31.0	65.5	60.6	112.8	37.1	86.5	28.1	80.3	42.1	38.4	17.7	68.7	76.3	62.0	53.0	41.0	64.6	0.0	54.2	58.1	44.1	43.1	53.1	50.8	51.1	35.0	49.8	31.3	41.3	44.4	46.3	47.7	69.2	64.1	46.0	56.2	58.4	56.1	55.5	78.9	37.8	51.8	68.0	155.1	97.9	105.3	144.2	46.5	47.8	68.8
DOLPP1	LSFR2	ENSG00000167130	"Dolichyldiphosphatase 1"	Q86YN1	9	129081100-129090438	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019179	Approved		Approved	"Vesicles,Intermediate filaments"		NA	NA			Vesicles	"Intermediate filaments"	"HPA019179: AB_1847827"	"unprognostic (1.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.59e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	6.4	12.8	10.0	6.8	10.6	7.7	6.8	11.7	19.3	8.3	17.1	17.7	8.6	28.6	6.0	7.4	18.8	6.6	9.2	4.1	10.1	10.7	9.4	21.8	6.7	6.6	13.2	10.6	7.7	10.5	10.4	6.9	11.6	12.5	10.0	14.2	6.1	10.3	5.8	5.2	10.3	27.7	6.3	15.2	8.5	11.8	12.2	11.0	9.4	6.3	8.5	9.1	7.8	8.0	8.8	12.5	9.8	8.3	7.9	21.7	7.2	4.1	16.0	15.7	14.4	5.3	4.5	18.2	10.3	6.0	19.6	11.0	20.6	13.9	8.1	9.1	6.4	15.0	30.3	16.1	8.6	8.3	9.4	9.9	10.6	10.8	15.7	9.4	11.0	13.2	4.9	12.1	12.8	10.2	4.5	8.7	15.1	17.5	8.1	5.5	21.0	12.5	11.4	13.5	30.9	13.0	14.8	12.7	14.5	7.1	6.7	18.0	11.8	13.0	11.8	4.3	9.6	21.7	7.3	7.1	16.9	8.1	15.9	13.9	10.1	19.4	12.3	7.5	2.2	11.1	4.4	6.8	9.8	8.9	8.1	21.7	8.8	10.9	10.8	8.5	6.0	11.1	10.5	1.4	7.9	8.3	12.5	10.1	7.2	10.0	10.6	11.7	19.3	10.1	10.7	13.2	10.6	12.5	11.0	6.0	4.6	3.7	2.9	2.1	3.2	1.6	5.1	0.0	2.3	1.8	5.9	16.9	1.7	5.9	0.5	2.4	26.6	0.0	8.4	11.4	3.3	2.7	5.7	17.0	6.5	3.2	3.5	6.2	3.8	0.4	2.0	2.3	5.0	4.6	9.0	9.1	5.4	13.3	3.9	3.8	3.4	0.0	3.1	4.5	8.7	3.4	13.7	3.8	12.2	3.4
DVL3	KIAA0208	ENSG00000161202	"Dishevelled segment polarity protein 3"	Q92997	3	184155388-184173610	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046486, HPA058265"	Approved		Approved	"Intermediate filaments,Midbody ring,Centrosome"		Yes	No			"Midbody ring, Centrosome"	"Intermediate filaments"	"CAB046486: AB_10610845, HPA058265: AB_2683658"	"unprognostic (2.20e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (8.61e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (4.77e-5)"	"prognostic unfavorable (1.53e-8)"	"unprognostic (1.87e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.95e-1)"	22.8	18.5	18.0	16.8	19.4	15.3	25.1	18.3	23.2	22.6	27.6	24.7	23.9	16.2	32.1	16.4	20.0	22.2	22.2	27.9	19.9	12.3	16.8	13.1	20.6	12.1	21.4	16.0	30.0	22.7	17.2	17.8	56.0	17.4	19.7	15.8	31.1	18.7	26.2	26.3	27.6	19.1	30.3	16.4	17.8	19.4	15.6	20.1	7.3	20.9	13.3	14.6	24.5	26.3	2.5	2.7	4.1	4.0	1.5	3.1	1.2	20.1	6.6	16.0	18.1	16.6	16.7	41.3	11.9	12.3	14.5	12.1	19.3	8.1	14.1	32.1	15.6	15.7	17.2	13.1	9.5	10.1	22.2	13.7	15.8	9.9	11.7	24.9	8.8	12.3	16.8	17.1	10.5	12.1	24.4	10.6	9.5	15.7	19.6	15.2	19.2	12.9	10.4	14.1	14.8	9.5	20.6	18.6	12.3	13.5	16.6	17.4	22.0	15.0	17.3	29.2	16.3	43.1	11.2	10.4	13.2	12.8	13.8	18.6	21.0	15.5	15.8	13.1	9.4	10.1	0.2	2.4	4.1	2.3	4.0	3.1	2.5	1.5	2.4	2.3	2.0	2.0	1.3	3.6	1.5	2.8	2.7	1.1	1.2	18.0	19.4	18.3	23.2	19.9	12.3	21.4	16.0	17.4	20.1	23.8	16.0	9.3	11.7	16.7	18.7	25.7	5.1	8.1	17.0	21.0	25.5	27.9	19.9	11.6	10.5	12.8	27.8	0.0	14.3	16.8	18.6	17.6	16.2	17.8	17.3	58.8	33.0	22.1	17.5	35.6	31.1	13.3	11.8	4.6	20.2	18.5	17.1	17.3	35.0	14.9	17.2	19.4	22.1	8.8	10.2	19.1	43.6	9.6	19.0	22.2
EIPR1	"EIPR-1, TSSC1"	ENSG00000032389	"EARP complex and GARP complex interacting protein 1"	Q53HC9	2	3188925-3377882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 43.9;Distal tubular cells: 43.1;Extravillous trophoblasts: 29.7;Hofbauer cells: 29.7;monocytes: 28.9;Proximal tubular cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031231, HPA031232, HPA031233, HPA031234"	Approved		Supported	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Nucleoplasm, Nucleoli"	"Intermediate filaments"	"HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: AB_2673803"	"unprognostic (2.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (3.67e-7)"	"unprognostic (1.94e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.83e-2)"	7.3	12.3	20.1	17.3	24.4	14.2	9.0	26.0	22.9	8.3	11.9	12.1	10.0	10.7	7.7	18.4	14.5	12.0	7.9	10.3	17.7	19.3	12.4	11.4	7.9	15.2	15.1	14.5	5.8	11.6	14.2	20.8	8.0	13.6	7.7	10.9	10.5	9.9	7.4	10.9	9.2	9.3	9.4	12.4	12.0	9.3	9.9	11.5	14.5	20.4	15.5	15.3	11.1	7.7	15.7	23.4	13.9	13.3	16.3	16.9	14.0	10.6	20.1	10.7	12.1	6.8	9.2	24.3	11.2	11.7	13.5	10.3	13.4	13.5	18.7	19.9	11.4	12.8	11.0	8.4	16.2	7.5	14.5	15.9	16.5	12.5	30.9	13.0	16.1	20.6	8.4	14.7	13.7	17.8	7.5	17.1	33.4	18.4	13.0	12.4	19.9	14.9	23.5	12.4	25.2	16.1	17.5	11.4	25.1	16.8	14.8	23.4	27.2	7.9	13.3	12.2	6.0	12.3	15.1	12.0	10.9	5.6	8.9	15.0	14.9	36.0	15.5	12.9	16.8	10.0	13.9	11.8	9.4	16.1	13.3	16.3	13.9	13.4	16.8	21.3	15.7	14.7	15.8	5.0	16.3	11.9	23.4	16.9	14.0	20.1	24.4	26.0	22.9	17.7	19.3	15.1	14.5	13.6	11.5	3.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	8.1	11.4	19.2	0.0	43.9	43.1	25.6	0.0	0.0	0.0	0.0	13.9	29.7	0.0	0.0	3.5	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	28.9	0.0	0.0	17.8	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0
EML4	"C2orf2, ELP120, ROPP120"	ENSG00000143924	"Echinoderm microtubule associated protein like 4"	Q9HC35	2	42169350-42332548	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 60.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036687, HPA036688, HPA065337"	Enhanced		Supported	"Intermediate filaments,Microtubules,Cytosol"		NA	NA		41000	Microtubules	"Intermediate filaments, Cytosol"	"HPA036687: AB_2675251, HPA036688: AB_10671968, HPA065337: AB_2685474"	"unprognostic (1.70e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	11.3	17.3	5.8	29.3	6.8	19.2	10.5	4.6	5.2	9.4	21.6	6.7	6.8	20.3	13.6	11.6	10.7	8.7	20.3	6.5	5.1	3.9	11.7	26.4	19.3	27.7	4.6	4.0	12.5	37.8	10.8	11.6	26.9	6.5	8.5	12.8	12.1	17.7	8.9	4.3	17.9	33.5	9.2	5.0	30.9	11.7	14.2	5.3	17.4	13.2	6.9	30.0	14.0	9.0	11.5	4.2	10.0	11.0	9.4	17.5	5.9	14.6	25.5	14.9	11.8	5.4	8.9	16.3	9.1	7.2	10.1	9.8	26.6	18.5	13.4	6.3	8.9	15.6	7.6	12.7	8.8	17.7	26.2	10.7	12.3	7.9	60.9	6.9	9.3	12.7	9.7	3.3	13.4	9.1	4.9	7.0	4.6	12.1	13.6	10.9	8.6	8.7	2.5	15.2	18.9	7.4	9.0	23.6	7.9	8.3	21.3	14.7	29.6	9.0	9.4	6.9	14.1	4.9	3.7	8.2	10.4	13.9	8.3	8.2	15.3	10.6	11.6	9.0	8.9	7.2	4.4	3.9	7.7	7.8	10.9	16.3	11.5	13.0	12.7	3.3	7.9	11.4	8.3	10.0	9.4	11.0	4.2	17.5	5.9	5.8	6.8	4.6	5.2	5.1	3.9	4.6	4.0	6.5	5.3	56.6	103.1	87.1	59.5	59.8	36.4	5.7	40.8	32.1	69.4	38.4	45.2	112.3	14.9	30.5	25.2	34.6	46.7	0.0	65.3	37.0	71.8	58.2	46.2	54.6	62.4	15.9	98.2	48.5	34.8	23.1	22.2	58.2	15.1	24.4	56.5	34.1	37.0	58.3	21.5	31.5	48.1	6.5	46.2	40.3	39.2	69.6	99.4	95.6	60.7	86.1
FAIM2	"KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2"	ENSG00000135472	"Fas apoptotic inhibitory molecule 2"	Q9BWQ8	12	49866896-49904217	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 138.5"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 136.4;Early spermatids: 135.6;Horizontal cells: 219.3"	"Cancer enriched"	"Detected in many"	8	"glioma: 21.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 1.7;T-reg: 6.2"	"Lineage enriched"	"Detected in single"	9	"T-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"HHSteC: 9.1;OE19: 11.7;SH-SY5Y: 4.9;U-87 MG: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018790, HPA048800"	Enhanced		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA018790: AB_1852822, HPA048800: AB_2680526"	"unprognostic (1.74e-1)"	"unprognostic (5.98e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.61e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-6)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.78e-4)"	3.9	27.2	35.6	4.1	57.5	1.4	2.5	42.4	138.5	3.2	4.7	29.1	0.2	2.7	4.2	6.4	3.9	5.8	7.5	7.4	38.8	51.0	2.0	1.5	2.5	3.5	35.9	33.7	2.6	2.8	14.7	7.8	1.5	65.6	8.8	3.5	3.9	3.0	7.1	2.0	1.8	4.0	8.7	36.9	2.5	2.6	12.1	20.5	0.0	1.7	0.0	3.1	4.7	2.0	0.0	0.0	0.0	0.4	0.6	6.2	0.2	0.0	0.3	0.4	0.5	2.0	1.3	0.1	0.5	2.6	0.5	0.3	0.3	0.0	0.0	0.1	3.6	0.2	0.2	1.2	0.0	0.3	0.0	0.0	2.0	0.0	0.0	9.1	0.1	0.0	0.8	0.2	1.9	0.0	0.0	0.0	0.2	1.1	0.3	0.5	0.0	0.1	0.0	0.0	11.7	0.0	0.0	0.1	0.0	0.0	0.0	3.2	4.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	28.4	0.0	0.2	0.0	0.1	0.0	1.7	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	6.2	0.2	35.6	57.5	42.4	99.5	38.8	51.0	35.9	33.7	65.6	20.5	0.0	0.0	0.0	0.1	0.2	136.4	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	135.6	0.0	0.0	0.0	0.2	0.0	1.4	0.6	26.4	0.0	0.4	219.3	0.0	0.0	0.0	31.4	4.6	0.0	0.0	0.0	2.0	34.2	0.1	0.0	4.9	0.1	14.5	0.0	0.9	1.2	2.1	0.3	0.1	0.0	0.2	0.1
FAM118A	"bK268H5.C22.4, C22orf8, FLJ20635"	ENSG00000100376	"Family with sequence similarity 118 member A"	Q9NWS6	22	45308968-45341955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 117.8;Syncytiotrophoblasts: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003902	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	Cytosol	"HPA003902: AB_1848368"	"unprognostic (6.22e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.02e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (9.76e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.16e-3)"	8.4	7.9	9.8	14.3	17.3	11.7	14.7	14.6	12.0	10.5	13.9	9.6	10.3	12.2	15.5	41.7	10.8	6.5	15.3	13.9	12.1	7.7	8.4	8.8	10.0	29.0	10.2	5.0	13.8	8.2	32.9	22.7	11.4	11.7	23.7	7.6	12.1	14.6	18.6	20.0	23.9	16.0	14.5	8.1	14.5	12.5	22.1	10.7	14.0	14.4	6.6	17.9	17.3	13.3	8.3	15.7	6.5	8.6	5.9	13.9	4.7	5.5	4.0	4.6	5.9	4.0	4.2	12.9	4.1	6.1	5.9	5.2	11.6	5.2	24.7	3.2	3.7	3.1	19.4	6.2	5.4	5.6	5.5	16.2	13.3	5.9	7.8	5.9	12.0	3.5	4.7	5.5	7.9	5.2	3.4	3.5	7.1	19.8	26.2	2.5	12.3	7.5	23.1	3.9	21.4	5.9	9.2	3.4	8.6	2.9	13.8	10.4	13.1	4.7	8.8	11.0	7.9	4.3	6.1	4.0	4.4	14.9	5.4	5.2	14.4	2.8	12.7	5.4	8.0	8.1	4.5	8.6	2.5	7.0	7.1	5.6	5.3	8.6	8.6	10.9	8.3	13.9	10.0	6.5	5.9	5.6	15.7	11.4	4.7	9.8	17.3	14.6	12.0	12.1	7.7	10.2	5.0	11.7	10.7	8.9	14.2	13.7	31.5	20.0	18.7	9.3	2.5	6.7	15.9	7.0	17.7	58.0	0.0	6.5	117.8	21.5	14.0	0.0	5.5	5.9	27.7	19.4	1.1	13.4	11.6	6.4	31.6	28.8	12.1	47.6	33.1	23.9	1.7	55.9	15.3	12.1	4.4	16.7	22.3	2.8	15.5	0.0	18.4	65.8	35.3	8.7	101.1	25.4	14.6	32.2
FAM131C	"C1orf117, FLJ36766"	ENSG00000185519	"Family with sequence similarity 131 member C"	Q96AQ9	1	16057769-16073632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 41.1"	"Cell type enhanced"	"Detected in some"	15	"Distal tubular cells: 16.6;Horizontal cells: 36.5;Muller glia cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 10.8;HEK 293: 7.0;PC-3: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031046	Uncertain		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Nucleoli, Intermediate filaments, Cytosol"		"HPA031046: AB_2673711"	"unprognostic (4.69e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.67e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (9.33e-6)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.44e-1)"	0.7	7.8	5.6	0.6	4.0	0.5	1.1	41.1	9.1	1.1	1.0	7.7	0.0	0.7	1.0	1.4	1.2	1.1	1.4	5.2	5.0	6.5	10.4	2.2	0.6	0.5	10.7	3.8	1.2	7.1	2.0	5.6	0.7	8.7	0.8	0.6	0.8	6.3	1.6	0.6	3.2	0.8	0.9	17.7	0.6	1.6	1.3	4.9	0.0	1.7	0.0	1.4	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.3	10.8	0.4	0.6	0.0	0.0	0.0	1.0	0.9	1.2	2.7	0.2	2.4	0.0	0.4	0.5	2.7	1.2	1.4	0.3	0.4	0.0	7.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.9	3.8	0.7	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.5	2.2	8.0	0.0	0.0	4.6	0.8	0.0	1.5	3.1	0.4	1.3	0.3	0.0	0.3	0.0	1.7	0.2	3.8	0.0	0.0	1.7	0.1	0.0	3.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	4.0	41.1	7.1	5.0	6.5	10.7	3.8	8.7	4.9	0.0	0.0	0.0	0.3	0.2	3.5	1.6	2.5	0.0	0.0	8.7	3.9	0.0	16.6	2.6	1.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.0	36.5	3.4	0.6	0.0	1.3	0.0	0.0	0.0	4.6	0.0	32.7	0.4	0.0	0.0	0.3	2.0	0.0	0.3	0.6	1.9	1.0	0.0	0.0	0.0	0.4
FAM174B	"LOC400451, MGC102891"	ENSG00000185442	"Family with sequence similarity 174 member B"	Q3ZCQ3	15	92617443-92809884	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 57.6"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 98.3;Mucus-secreting cells: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 4.5;granulocytes: 3.7;T-cells: 10.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.3;MCF7: 25.6;OE19: 21.5;RPMI-8226: 30.0;RT4: 63.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015306	Approved		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA015306: AB_2669182"	"unprognostic (3.00e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.50e-1)"	"prognostic favorable (9.03e-5)"	"unprognostic (4.68e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.23e-3)"	"unprognostic (7.67e-3)"	"unprognostic (5.05e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-2)"	6.1	3.5	5.9	3.3	6.3	0.7	17.9	3.9	8.6	10.9	6.2	2.9	21.5	3.6	5.1	4.9	5.2	14.6	6.4	4.2	7.4	8.3	3.3	4.0	16.3	5.5	6.5	6.2	10.2	57.6	2.5	15.9	4.6	6.7	19.4	9.2	7.7	47.7	10.8	16.3	4.9	5.0	4.6	4.9	3.2	17.3	9.7	3.6	4.2	28.9	3.9	4.8	24.4	15.3	0.4	4.5	3.7	0.9	0.7	10.9	0.7	0.0	3.6	2.3	0.7	0.0	0.0	0.3	1.3	6.3	0.0	0.0	21.3	2.4	0.3	6.1	0.1	1.7	0.1	4.0	0.1	0.0	0.1	1.8	0.2	0.4	0.2	0.4	0.3	0.9	0.3	0.1	0.0	0.0	0.1	3.0	2.0	0.3	15.8	3.5	25.6	0.7	0.0	11.5	21.5	0.0	2.4	6.6	30.0	1.5	63.4	1.4	1.1	1.8	12.2	3.9	7.0	9.8	2.2	0.0	0.0	0.5	0.1	2.9	0.5	4.7	0.7	0.0	0.2	1.5	1.1	0.8	0.9	0.2	0.9	0.4	0.4	2.5	0.0	0.6	0.3	2.8	3.3	3.7	0.7	0.0	4.5	10.9	0.7	5.9	6.3	3.9	8.6	7.4	8.3	6.5	6.2	6.7	3.6	98.3	20.3	0.0	14.7	2.1	5.3	4.1	10.2	14.7	18.2	7.0	7.9	1.1	6.6	4.4	19.8	5.8	2.3	0.0	12.4	15.9	4.1	29.2	18.4	5.8	4.2	11.1	40.5	30.7	4.3	39.0	5.5	1.8	11.8	0.0	61.2	3.5	17.4	0.0	1.8	1.1	2.7	0.0	5.3	1.0	3.4	2.6	0.6	2.1	4.7	23.7
FAM231C		ENSG00000268674	"Family with sequence similarity 231 member C"	"P0DMU3, P0DMU4, P0DMU5"	Unmapped	35407-35916	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 1.6;brain: 5.6;parathyroid gland: 3.2;testis: 1.4"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.1;U-698: 1.3"									"HPA043267, HPA043292, HPA077864"	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA043267: , HPA043292: , HPA077864: AB_2686862"																		0.0	0.3	0.1	0.0	0.1	0.1	0.0	5.6	0.3	0.1	0.3			0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0		0.2	0.1	3.2	0.0	0.1		0.1	0.0		0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.4			0.0		0.0	0.0	0.0	1.6	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXA13	"HOX1, HOX1J"	ENSG00000106031	"Homeobox A13"	P31271	7	27193503-27200106	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 48.5;prostate: 25.1"	"Group enriched"	"Detected in some"	15	"Basal glandular cells: 2.9;Enterocytes: 7.7;Fibroblasts: 3.5;Glandular cells: 4.8;Intestinal endocrine cells: 8.1;Mucus-secreting cells: 9.8;Paneth cells: 5.8;Undifferentiated cells: 9.7;Urothelial cells: 2.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 15.5;HEK 293: 21.6;PC-3: 10.7;RT4: 23.9;THP-1: 10.2;U-937: 11.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046098, HPA069061"			Supported	"Nucleoplasm,Mitotic chromosome,Intermediate filaments"		NA	NA			Nucleoplasm	"Mitotic chromosome, Intermediate filaments"	"HPA046098: AB_2679536, HPA069061: "	"unprognostic (7.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.04e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.30e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.42e-11)"	"unprognostic (2.58e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-2)"	0.6	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	48.5	6.9	0.0	7.1	0.0	5.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	16.5	0.0	25.1	8.6	0.0	0.1	17.9	1.2	0.4	0.1	15.7	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	12.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	1.4	0.1	0.0	0.0	7.6	8.3	3.0	1.9	1.5	0.1	0.0	0.9	3.5	0.4	0.0	15.5	0.0	2.5	0.0	21.6	1.0	4.1	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	4.9	0.0	6.6	10.7	1.5	0.4	0.0	0.0	23.9	0.4	0.0	1.9	0.0	0.1	1.2	0.0	10.2	0.0	0.3	2.7	0.1	0.1	0.0	0.0	0.0	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.7	0.0	0.0	0.1	3.5	4.8	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	9.7	2.8
INA	"NEF5, NF-66"	ENSG00000148798	"Internexin neuronal intermediate filament protein alpha"	Q16352	10	103277163-103290351	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 65.4"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 51.8;Cone photoreceptor cells: 21.6;Early spermatids: 34.2;Horizontal cells: 42.9;Late spermatids: 14.9;Rod photoreceptor cells: 32.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 18.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 21.1;SCLC-21H: 41.4;SH-SY5Y: 23.6;SiHa: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002059, HPA007572, HPA008057"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	Cytosol	"CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833"	"unprognostic (1.77e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	1.5	15.7	16.6	2.6	21.3	1.3	1.3	26.9	65.2	1.3	2.7	2.3	0.0	2.0	1.3	1.4	1.9	1.3	1.5	1.3	13.2	34.0	1.3	1.4	1.5	1.4	27.2	17.7	1.3	3.6	1.3	12.8	1.5	65.4	1.5	2.8	5.5	1.3	1.4	1.3	2.2	2.5	2.2	7.9	1.3	2.6	4.1	3.3	0.0	1.5	0.0	1.5	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	4.7	0.0	0.0	0.0	7.7	5.2	1.3	1.2	0.1	0.0	0.0	0.0	2.2	0.3	0.6	0.7	4.3	0.0	0.3	9.4	1.9	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	5.1	0.0	21.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	41.4	23.6	28.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	21.3	26.9	42.0	13.2	34.0	27.2	17.7	65.4	3.3	0.0	0.0	0.0	0.1	0.2	51.8	0.4	0.0	0.0	0.0	0.0	21.6	0.2	0.0	0.1	34.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	42.9	7.5	0.0	0.0	14.9	0.3	0.0	0.0	0.0	0.0	7.6	0.7	0.0	0.4	0.0	32.4	0.0	0.0	4.3	3.8	0.4	0.1	0.0	0.0	0.6
IQUB	FLJ35834	ENSG00000164675	"IQ motif and ubiquitin domain containing"	Q8NA54	7	123452400-123535077	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 20.8;testis: 35.5"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 91.0;Early spermatids: 206.9;Late spermatids: 121.6;Spermatocytes: 83.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.9;RPTEC TERT1: 7.2;T-47d: 2.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049626			Approved	"Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA			"Nuclear speckles, Intermediate filaments"	Cytosol	"HPA049626: AB_2732554"	"unprognostic (8.71e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.42e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.30e-2)"	0.6	1.0	1.3	0.3	2.9	0.3	0.9	3.0	3.5	1.2	0.5	1.8	3.2	0.4	1.4	6.9	1.8	5.7	1.6	0.6	2.6	1.2	8.5	0.4	3.2	0.3	0.7	1.2	2.7	0.7	2.7	20.8	0.5	6.4	0.9	0.4	0.3	0.7	4.3	0.6	0.5	0.5	0.6	1.0	0.4	0.6	35.5	2.8	0.0	5.6	0.0	0.3	0.7	0.6	0.8	0.0	0.0	0.3	0.5	0.7	0.0	0.3	0.0	1.3	0.6	0.6	0.6	0.1	0.0	0.1	0.0	0.3	0.0	0.8	0.8	0.0	0.4	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.7	0.3	0.2	0.3	0.7	0.0	0.2	1.9	0.2	0.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	7.2	1.6	1.1	0.4	0.0	0.0	0.1	1.1	2.5	0.0	0.0	0.5	0.3	0.5	0.2	0.5	0.1	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.7	0.3	0.4	0.2	0.2	0.2	0.0	0.8	0.7	0.2	0.0	0.5	0.1	0.0	0.3	0.0	1.3	2.9	3.0	3.5	2.6	1.2	0.7	1.2	6.4	2.8	6.0	0.3	0.0	0.5	0.5	2.7	1.0	0.0	91.0	15.9	17.4	3.9	0.3	1.7	0.9	206.9	0.4	0.0	0.0	0.4	0.2	0.5	0.6	1.1	0.0	0.1	3.2	1.7	0.6	0.0	121.6	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	2.8	4.3	8.8	6.5	0.9	83.1	7.1	0.1	0.6	0.0	0.0	0.3
ITFG1	"CDA08, LNKN-1, TIP"	ENSG00000129636	"Integrin alpha FG-GAP repeat containing 1"	Q8TB96	16	47154387-47464149	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015590, HPA019728"	Approved		Approved	"Intermediate filaments,Aggresome"	"Intracellular and membrane"	NA	NA		21000	"Intermediate filaments"	Aggresome	"HPA015590: AB_1846347, HPA019728: AB_1846348"	"unprognostic (6.53e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.62e-3)"	14.0	26.6	19.9	8.8	52.4	6.4	15.0	31.2	34.6	18.3	20.0	14.8	9.8	17.3	17.5	19.0	11.5	15.8	17.1	26.0	20.7	26.6	28.7	26.5	15.8	11.0	17.0	19.0	17.4	20.2	43.0	22.9	30.7	28.7	17.9	19.9	13.8	15.1	18.1	14.6	10.8	19.4	17.4	17.6	12.4	16.0	20.7	15.7	13.4	25.8	7.6	11.5	15.3	11.6	12.8	18.7	23.4	24.4	16.6	18.3	17.7	8.0	9.4	17.1	11.9	33.5	25.9	20.5	19.5	27.8	17.7	9.5	5.3	19.7	9.8	26.6	24.0	12.0	12.0	8.3	12.4	17.7	4.2	5.7	5.1	9.0	12.4	15.7	12.1	22.8	19.0	21.7	9.0	11.8	37.6	17.0	9.2	14.6	12.9	22.2	7.8	7.5	5.6	5.5	10.2	9.2	11.5	16.9	24.2	23.5	6.0	8.4	11.9	17.7	20.6	8.6	17.8	9.0	11.1	16.4	18.9	9.2	10.0	7.4	18.2	23.9	18.2	18.9	7.7	14.7	13.5	24.4	23.4	12.4	23.8	12.0	12.8	15.4	13.7	18.7	11.4	16.9	14.1	15.4	16.6	21.9	13.0	18.3	17.7	19.9	52.4	31.2	34.6	20.7	26.6	17.0	19.0	28.7	15.7	47.6	29.1	31.2	36.5	34.1	48.8	52.0	33.1	21.4	20.5	78.5	45.2	90.9	8.3	48.2	66.3	35.8	59.3	46.7	46.4	73.7	50.5	38.7	8.1	58.9	45.3	38.1	59.5	36.8	54.3	25.1	32.5	33.8	27.0	41.5	40.4	43.5	41.4	31.7	57.7	48.2	40.9	77.6	42.2	46.1	97.5	26.5	95.3	20.6	32.4	30.2
KATNAL2	"DKFZP667C165, MGC33211"	ENSG00000167216	"Katanin catalytic subunit A1 like 2"	Q8IYT4	18	46917492-47102243	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 30.3;testis: 33.2"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 46.8;Early spermatids: 59.9;Late spermatids: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040712, HPA042029"	Approved		Approved	"Nucleoplasm,Intermediate filaments"		No	No			"Nucleoplasm, Intermediate filaments"		"HPA040712: AB_2677092, HPA042029: AB_2677807"	"unprognostic (3.40e-1)"	"unprognostic (7.75e-2)"	"unprognostic (9.00e-3)"	"unprognostic (9.28e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.55e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.52e-6)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.24e-7)"	"unprognostic (1.64e-1)"	"unprognostic (7.14e-4)"	"unprognostic (1.06e-3)"	"unprognostic (1.61e-1)"	5.5	2.9	8.2	4.1	9.7	2.8	7.1	4.0	7.5	2.5	2.4	11.3	2.5	1.8	2.8	7.1	2.7	8.6	5.1	4.3	8.1	7.6	9.5	5.2	4.6	3.4	9.6	6.2	3.1	3.3	30.3	7.0	2.2	9.0	3.4	3.1	6.4	3.4	3.7	6.0	8.0	1.5	2.3	8.7	3.3	2.0	33.2	6.3	2.4	15.5	1.1	3.0	2.3	2.5	3.1	0.6	2.7	1.3	0.8	1.5	0.3	1.9	4.3	2.4	15.0	4.9	5.9	1.1	1.8	1.6	1.5	1.9	0.2	5.1	19.8	1.5	2.8	1.9	0.6	4.7	0.5	1.1	2.0	2.5	0.8	1.3	0.3	2.0	1.2	1.9	12.2	1.8	2.5	0.6	3.4	0.5	9.1	0.7	1.6	8.5	1.9	1.2	2.6	5.4	2.5	2.7	5.5	1.1	0.0	4.7	0.4	5.4	6.0	1.9	0.4	0.6	8.8	11.4	11.0	1.0	5.0	0.5	2.0	1.2	1.3	1.0	13.3	2.7	12.5	9.6	1.7	0.7	0.5	1.1	1.3	0.9	2.2	0.9	0.5	0.3	3.1	1.5	1.4	2.7	0.8	0.9	0.6	0.2	0.3	8.2	9.7	4.0	7.5	8.1	7.6	9.6	6.2	9.0	6.3	0.0	1.4	0.0	2.6	1.3	10.4	2.2	0.0	46.8	6.8	3.5	5.9	0.0	11.6	0.4	59.9	1.4	0.8	0.0	0.2	0.0	1.5	1.2	0.0	3.9	2.8	11.1	0.0	3.1	1.0	47.0	1.4	0.6	3.3	1.0	0.3	2.4	0.2	0.0	2.1	5.2	2.1	0.0	0.8	11.2	4.3	1.0	0.1	0.0	1.5	1.4
KBTBD11	"KIAA0711, KLHDC7C"	ENSG00000176595	"Kelch repeat and BTB domain containing 11"	O94819	8	1973878-2006936	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 33.4;Enterocytes: 28.4;Rod photoreceptor cells: 29.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.6;monocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.4;NB-4: 7.5;SCLC-21H: 9.1;THP-1: 14.7;U-937: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051159	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA051159: AB_2681367"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.76e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-2)"	3.2	6.8	17.6	2.6	17.7	8.7	1.8	16.3	22.4	4.5	8.2	10.9	0.0	10.9	1.6	1.7	1.7	3.8	3.8	2.1	16.1	10.8	13.9	6.7	2.3	3.1	13.2	16.7	1.9	3.2	5.1	2.0	0.8	11.4	5.0	6.6	3.1	2.1	2.9	1.8	1.0	12.7	1.7	12.4	6.4	1.9	1.6	9.3	4.7	2.4	0.0	2.0	1.4	0.7	0.0	0.4	4.6	1.4	0.0	0.6	0.4	1.5	1.0	4.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.9	0.4	0.1	0.4	0.1	0.0	2.1	0.0	0.0	10.4	1.2	0.0	0.0	0.0	1.0	4.5	0.2	0.2	0.0	0.0	0.0	0.7	0.0	4.0	0.0	0.0	2.1	0.8	4.6	7.5	1.0	1.6	0.0	1.3	0.0	0.0	2.2	0.3	9.1	4.6	0.0	0.0	0.1	0.4	0.1	14.7	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.1	20.9	0.8	0.7	1.4	4.6	0.0	0.6	0.2	0.0	0.2	0.1	0.4	0.0	0.6	0.3	0.9	0.0	0.3	0.0	0.5	0.4	17.6	17.7	16.3	21.9	16.1	10.8	13.2	16.7	11.4	9.3	0.0	7.2	0.5	0.4	0.9	21.8	4.5	10.2	2.7	0.0	12.2	33.4	0.0	21.6	1.6	0.6	4.1	28.4	0.0	3.3	0.1	1.1	2.7	0.0	10.6	3.3	19.1	5.8	4.9	9.5	0.0	4.6	2.1	1.7	3.6	13.6	6.4	7.4	10.1	9.9	22.4	29.5	0.0	1.0	0.4	3.6	0.6	0.2	0.0	14.9	0.7
KCTD9	"BTBD27, FLJ20038"	ENSG00000104756	"Potassium channel tetramerization domain containing 9"	Q7L273	8	25427847-25458476	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042468, HPA047902"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No			Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA042468: , HPA047902: AB_2680205"	"unprognostic (4.18e-2)"	"unprognostic (3.90e-2)"	"prognostic favorable (7.88e-4)"	"unprognostic (7.04e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.97e-3)"	14.4	5.8	7.4	17.3	7.7	11.5	14.6	17.7	10.1	15.7	14.1	5.4	16.8	12.4	15.6	12.2	18.2	11.3	12.8	48.4	5.9	5.2	9.6	6.6	10.3	6.9	7.4	5.3	12.4	8.3	7.3	11.2	7.4	14.6	11.8	14.8	9.4	14.6	18.4	19.0	15.0	10.9	16.7	10.8	8.6	10.6	11.2	6.6	11.8	8.7	11.7	8.7	19.1	14.8	2.2	3.2	3.7	2.9	0.9	3.8	1.5	18.1	12.9	14.1	4.9	18.4	24.5	11.6	27.6	24.9	18.2	18.5	9.2	13.4	11.9	11.8	27.5	25.7	12.3	12.3	13.0	22.0	6.1	7.3	13.9	12.6	8.5	22.4	4.8	10.4	18.8	15.8	16.5	13.8	11.1	15.3	12.0	14.6	9.4	20.6	4.8	18.7	8.4	6.9	14.1	6.9	7.3	16.4	4.4	18.5	10.4	3.6	4.7	21.2	9.4	14.3	13.3	7.2	5.6	16.9	20.1	11.7	38.5	14.9	2.7	4.9	15.7	14.1	8.6	14.4	2.6	1.7	3.7	3.4	2.5	3.8	2.2	3.6	3.6	1.1	1.2	2.2	3.6	1.8	0.9	2.9	3.2	3.5	1.5	7.4	7.7	17.7	10.1	5.9	5.2	7.4	5.3	14.6	6.6	29.8	11.5	4.5	33.0	66.1	13.0	55.7	5.1	16.0	22.7	26.2	23.6	8.1	11.6	15.4	3.8	15.4	29.0	0.0	23.8	14.2	32.6	43.6	19.7	8.3	8.1	3.2	9.8	12.3	8.1	2.1	28.4	15.1	28.7	7.2	12.4	7.8	24.5	22.1	52.3	8.4	18.3	6.5	26.5	24.6	30.7	47.8	9.4	15.2	16.5	40.5
KIAA1549		ENSG00000122778	KIAA1549	Q9HCM3	7	138831381-138981318	"Disease related genes, Predicted membrane proteins"			"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 27.5;seminal vesicle: 39.0"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.2;neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"PC-3: 20.4;SH-SY5Y: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019560	Uncertain		Approved	"Nuclear membrane,Intermediate filaments"		NA	NA			"Nuclear membrane"	"Intermediate filaments"	"HPA019560: AB_1852418"	"unprognostic (7.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (8.30e-2)"	"prognostic favorable (3.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.28e-2)"	2.1	3.2	3.3	0.6	4.4	0.6	2.9	1.2	8.3	2.7	1.8	1.6	27.5	1.5	3.7	4.1	1.4	4.9	2.5	1.9	3.1	2.0	8.0	1.5	4.7	0.3	1.6	3.8	2.6	12.9	6.5	3.6	4.6	3.7	3.1	1.5	2.0	4.4	39.0	1.4	2.6	1.8	2.9	3.3	1.2	3.0	2.9	1.2	3.1	2.2	0.1	0.4	3.8	4.4	0.3	0.1	1.5	0.1	0.3	0.2	0.0	5.1	9.7	8.6	15.0	0.1	0.0	5.0	5.2	4.7	3.0	3.9	9.0	3.1	0.0	3.2	7.9	9.3	1.0	5.3	1.5	3.7	2.4	3.3	2.4	10.4	2.3	1.3	3.7	3.5	1.3	2.4	1.1	1.6	2.9	5.0	3.4	1.9	0.1	3.4	4.8	2.6	3.6	8.1	3.7	20.4	7.2	4.4	0.0	1.5	3.1	11.4	19.5	2.8	5.2	2.3	5.2	4.3	2.3	3.2	3.1	3.2	0.0	4.9	0.7	0.0	0.2	4.1	1.5	7.2	1.2	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.5	0.3	0.1	0.1	0.0	0.0	3.3	4.4	1.2	8.3	3.1	2.0	1.6	3.8	3.7	1.2	0.0	2.1	0.0	2.1	0.5	13.5	2.2	0.0	9.4	3.4	7.0	53.0	2.1	0.0	2.3	0.3	4.5	0.1	0.0	2.8	1.9	2.1	3.0	16.1	0.5	0.4	3.2	10.4	1.8	1.0	0.0	1.4	0.2	1.7	0.0	2.0	7.7	4.7	0.6	2.5	6.9	26.7	6.5	1.6	0.0	7.7	0.6	1.3	1.0	1.5	1.4
KIAA1551	"C12orf35, FLJ10652, FLJ20696, GET, UTA2-1"	ENSG00000174718	KIAA1551	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;lymphoid tissue: 56.3"	"Cell type enhanced"	"Detected in many"	7	"Urothelial cells: 190.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 58.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.8"	"Cell line enhanced"	"Detected in all"		"SuSa: 44.6"					"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Intermediate filaments, Cytosol"	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	12.4	5.8	4.7	28.8	6.1	9.0	10.3	8.7	7.0	15.7	17.5	2.7	7.1	10.7	11.2	10.3	12.3	19.0	8.9	6.2	4.8	3.5	8.1	14.2	17.0	56.3	7.5	4.1	38.3	7.0	3.6	8.0	17.5	5.4	11.6	6.5	3.5	8.6	5.5	5.4	6.7	30.0	8.5	8.1	39.1	8.8	8.7	5.9	48.5	10.0	7.6	27.6	17.3	13.9	9.6	3.3	58.8	4.5	8.0	13.2	5.0	2.7	4.8	8.4	3.2	3.8	4.6	12.6	3.3	3.3	2.4	2.6	18.3	18.0	13.1	8.3	2.7	8.1	3.6	11.5	2.2	3.4	9.6	1.6	18.3	2.4	2.4	7.5	13.2	29.7	2.5	3.4	2.6	4.4	9.6	18.5	9.0	10.4	20.9	2.5	1.3	18.5	5.5	18.0	10.4	2.0	8.6	8.0	5.7	2.3	5.1	3.4	3.0	4.3	2.2	2.3	44.6	7.7	14.6	11.7	2.5	4.0	4.3	3.5	12.7	13.4	16.1	1.3	7.4	2.7	12.5	3.9	3.9	12.5	4.4	11.8	9.6	11.2	11.6	3.3	7.5	13.2	12.6	58.8	8.0	4.5	2.0	10.2	5.0	4.7	6.1	8.7	7.0	4.8	3.5	7.5	4.1	5.4	5.9	32.8	30.1	76.8	35.9	16.7	12.1	16.6	12.7	10.7	22.7	7.0	9.8	10.5	0.0	11.8	4.8	41.3	43.3	0.0	10.4	2.2	15.8	43.7	43.9	40.9	27.9	17.5	8.6	25.8	50.9	5.2	23.9	40.7	10.1	26.2	12.5	8.5	24.6	14.0	22.3	6.7	15.8	77.6	22.7	5.2	36.4	30.5	4.2	83.0	13.0	190.4
KIF3A	"FLA10, KLP-20"	ENSG00000131437	"Kinesin family member 3A"	Q9Y496	5	132692628-132737638	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.5"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 131.2;Cone photoreceptor cells: 117.8;Horizontal cells: 174.8;Spermatocytes: 129.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 27.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 27.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037085	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Nucleoplasm, Intermediate filaments, Cytosol"		"CAB037085: AB_477147"	"unprognostic (8.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.80e-1)"	"unprognostic (8.21e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.08e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.23e-1)"	3.4	9.9	19.6	5.0	21.0	2.5	6.6	23.8	54.5	6.2	3.6	8.1	3.2	3.5	6.5	7.1	4.5	8.7	5.3	7.0	28.0	22.9	7.6	2.5	5.7	4.8	18.7	25.5	6.9	4.0	15.8	18.5	4.3	37.7	6.6	3.8	3.8	3.8	6.6	3.5	5.1	3.0	5.7	15.0	3.8	4.9	23.9	11.1	3.5	6.9	0.1	4.7	5.3	3.5	3.4	0.7	27.1	1.1	2.4	4.3	1.1	7.0	8.8	7.8	14.1	5.2	5.2	6.2	5.9	4.6	5.6	7.9	8.5	5.7	19.3	8.2	6.8	16.8	4.6	6.1	11.7	11.7	5.7	7.1	2.8	4.4	3.2	5.2	3.6	7.6	4.0	6.0	8.1	9.1	7.6	7.0	12.4	2.9	11.2	6.8	5.1	22.7	2.7	3.8	2.6	3.3	6.4	6.2	2.3	5.6	6.0	24.2	7.6	8.9	2.9	8.9	13.2	8.9	1.1	7.3	7.0	12.3	5.1	7.1	8.1	11.8	11.1	8.6	2.9	7.7	27.1	0.4	1.1	3.9	0.8	4.1	3.4	4.0	3.6	0.7	2.1	3.9	4.3	0.3	2.4	1.1	0.7	3.0	1.1	19.6	21.0	23.8	32.3	28.0	22.9	18.7	25.5	37.7	11.1	50.6	33.1	5.4	13.8	12.0	70.6	23.3	7.6	131.2	38.7	36.6	117.8	13.0	24.9	16.7	49.7	8.5	0.9	0.0	11.3	9.8	12.6	8.0	12.8	2.4	5.5	174.8	19.0	9.2	3.3	16.3	15.3	5.0	40.5	6.4	3.4	51.3	11.4	2.3	23.0	7.3	94.7	12.9	10.8	129.4	94.9	13.9	8.2	16.0	1.7	6.0
KIF3C		ENSG00000084731	"Kinesin family member 3C"	O14782	2	25926596-25982749	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 72.9"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 15.5;Horizontal cells: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035755			Approved	"Nuclear membrane,Nuclear bodies,Intermediate filaments"		NA	NA			"Nuclear bodies, Intermediate filaments"	"Nuclear membrane"	"HPA035755: AB_10602242"	"unprognostic (3.95e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.96e-4)"	"unprognostic (1.53e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.90e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	3.0	7.3	22.8	2.9	21.2	2.2	2.6	22.7	72.9	3.6	2.4	3.8	0.0	2.1	3.9	2.6	3.0	3.3	4.1	3.0	21.6	18.9	2.0	1.6	2.6	2.0	17.5	20.3	7.3	2.3	4.5	4.8	2.8	22.8	3.3	2.6	1.9	1.9	4.6	2.4	2.3	2.7	4.8	6.2	2.2	2.0	3.0	5.2	0.5	2.5	0.0	2.0	3.5	1.5	0.1	0.3	2.4	0.2	0.7	2.0	1.3	13.0	19.8	10.5	8.1	6.2	7.2	8.5	6.8	3.4	4.1	4.7	3.5	2.0	0.0	5.6	6.2	12.9	1.4	8.0	4.1	2.8	2.1	3.8	4.7	1.5	7.1	3.6	1.2	4.1	5.2	1.2	12.9	2.6	15.9	13.5	3.8	1.6	1.7	4.3	0.9	3.3	1.6	10.8	0.3	5.8	5.3	5.2	0.8	9.4	3.2	12.9	29.0	2.7	1.2	14.2	9.1	0.4	1.6	10.7	7.2	7.4	3.2	6.6	0.4	2.3	1.5	16.3	6.4	6.1	0.0	0.2	0.0	0.4	0.0	1.1	0.0	1.6	1.5	0.3	0.1	0.5	0.6	2.4	0.7	0.0	0.2	2.0	1.3	22.8	21.2	22.7	40.0	21.6	18.9	17.5	20.3	22.8	5.2	0.0	0.0	0.0	1.2	0.5	15.5	3.1	2.5	1.4	1.2	0.0	5.9	0.3	0.0	7.7	2.5	3.9	0.0	0.0	1.2	3.3	1.3	0.9	6.9	0.0	2.8	39.7	2.9	9.8	2.7	3.6	1.7	1.1	3.3	2.8	0.2	6.4	8.3	0.0	4.2	0.7	5.9	6.5	2.3	0.2	1.1	0.3	1.0	2.2	0.1	0.5
KRT16	NEPPK	ENSG00000186832	"Keratin 16"	P08779	17	41609778-41615899	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"tongue: 503.5"	"Group enriched"	"Detected in some"	8	"Basal glandular cells: 391.0;Basal keratinocytes: 804.9;Suprabasal keratinocytes: 1178.6;Urothelial cells: 555.3"	"Group enriched"	"Detected in many"	7	"cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 137.6"	"Not detected"	"Not detected"							"CAB000136, HPA000539"	Approved		Approved	"Intermediate filaments"		NA	NA		2200000000	"Intermediate filaments"		"CAB000136: , HPA000539: "	"unprognostic (3.95e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (8.23e-2)"	"unprognostic (6.53e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.61e-2)"	1.6	0.2	0.2	0.2	0.2	0.0	2.1	0.2	0.2	32.4	0.2	0.2	0.2	0.0	1.1	0.2	112.4	0.1	0.6	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.6	0.2	0.7	0.0	0.3	15.5	9.9	0.4	41.4	0.2	0.2	0.2	0.2	0.1	0.6	0.2	3.0	0.2	503.5	26.4	0.6	50.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	4.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	137.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.1	0.0	0.0	15.6	0.1	1.0	0.0	0.0	9.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	391.0	804.9	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.2	2.5	20.6	95.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	60.8	0.0	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	1178.6	0.1	0.0	0.0	555.3
KRT2	"KRT2A, KRTE"	ENSG00000172867	"Keratin 2"	P35908	12	52644558-52652164	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 289.9"	"Cell type enriched"	"Detected in some"	15	"Suprabasal keratinocytes: 232.0"	"Group enriched"	"Detected in some"	35	"head and neck cancer: 4.7;melanoma: 23.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"naive CD4 T-cell: 4.4;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	45	"T-cells: 4.4"	"Group enriched"	"Detected in some"	4	"HEL: 6.3;HMC-1: 2.7;JURKAT: 2.4;OE19: 2.9"	"Group enriched"	"Detected in some"	6	"amygdala: 1.8;hippocampal formation: 2.9"	"Not detected"	"Not detected"			"HPA006299, CAB037321"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments,Cytosol"		NA	NA		14000000000	"Intermediate filaments, Cytosol"	"Golgi apparatus"	"CAB037321: , HPA006299: AB_1079180"	"unprognostic (1.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.69e-2)"		"unprognostic (1.84e-1)"	"unprognostic (3.59e-1)"		"unprognostic (2.12e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.56e-7)"	"unprognostic (6.43e-2)"	"unprognostic (5.98e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.46e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	9.5	0.1	0.1	18.3	0.1	0.1	0.1	0.0	2.0	0.1	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.4	289.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	6.8	0.1	19.2	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	4.4	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	15.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.2	0.6	0.8	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	232.0	0.1	0.0	0.1	0.0
KRT23	"CK23, DKFZP434G032, HAIK1, K23, MGC26158"	ENSG00000108244	"Keratin 23"	Q9C075	17	40922696-40937634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.3;salivary gland: 99.8;skin 1: 48.2"	"Cell type enhanced"	"Detected in many"	24	"Basal glandular cells: 835.0;Cytotrophoblasts: 634.9;Glandular cells: 639.4;Syncytiotrophoblasts: 3253.9;Urothelial cells: 1153.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	12	"neutrophil: 30.1"	"Lineage enriched"	"Detected in single"	70	"granulocytes: 30.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 21.1;Hep G2: 13.1;SuSa: 7.6;T-47d: 36.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA012050, HPA016959, CAB017091"	Approved		Approved	"Intermediate filaments,Cytosol"		NA	NA		170000	"Intermediate filaments"	Cytosol	"CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228"	"unprognostic (1.62e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.18e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (8.26e-4)"	0.3	0.0	0.2	0.5	0.2	0.5	10.0	0.3	0.3	9.8	0.2	0.2	2.1	0.0	1.1	1.2	2.5	1.5	4.5	0.2	0.2	0.0	0.3	0.6	1.1	0.6	0.2	0.2	0.6	1.2	0.0	0.9	128.3	0.2	6.9	0.0	0.3	99.8	2.8	0.3	48.2	0.2	0.3	0.2	1.0	0.0	9.1	0.2	2.0	0.3	11.7	9.5	2.3	3.2	0.0	0.0	30.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.3	0.0	0.0	0.6	0.0	21.1	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	7.6	36.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	2.2	0.0	835.0	4.0	0.0	0.3	20.4	21.4	10.3	3.5	0.0	634.9	1.7	211.1	47.4	0.7	0.0	0.0	0.7	68.7	0.5	639.4	0.0	0.0	56.0	0.0	6.8	0.0	0.0	5.4	0.6	0.7	5.0	7.2	0.0	11.8	19.4	0.0	0.7	0.0	0.2	0.0	0.4	29.7	0.7	7.0	3253.9	0.0	0.0	1153.1
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703750	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 4.0;Extravillous trophoblasts: 1.2;Leydig cells: 2.8;Syncytiotrophoblasts: 3.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"	"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 12.8"	"Region enriched"	"Detected in single"	18	"cerebellum: 1.1"	"Not detected"	"Not detected"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"		No	NA			"Intermediate filaments, Cytosol"		"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	9.2	4.1	0.0	0.0	0.0	0.7	9.3	62.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	48.6	0.0	0.1	3.1	0.0	1.2	0.8	0.1	0.1	0.2	3.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	1.4	68.9	0.6	3.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0
KRT35	"Ha-5, KRTHA5"	ENSG00000197079	"Keratin 35"	Q92764	17	41476689-41481140	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 33.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025750, HPA078713"	Enhanced		Approved	"Intermediate filaments"		NA	NA		270000000	"Intermediate filaments"		"HPA025750: , HPA078713: "																		1.8	0.0	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	33.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520687	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 463.1;skin 1: 338.1;tongue: 522.3"	"Cell type enhanced"	"Detected in some"	30	"Basal glandular cells: 909.3;Basal keratinocytes: 5214.3;Suprabasal keratinocytes: 1765.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3340.4"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.7"	"Cell type enriched"	"Detected in single"	197	"plasmacytoid DC: 19.6"	"Lineage enriched"	"Detected in single"	197	"dendritic cells: 19.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 120.8;HBEC3-KT: 216.3;hTCEpi: 494.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"		NA	NA		6500000000	"Intermediate filaments"		"CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034"	"prognostic favorable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	0.3	0.0	0.1	0.3	0.2	0.2	15.9	0.1	0.2	74.2	0.2	0.3	6.2	0.0	4.9	6.4	463.1	0.7	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	4.4	1.7	5.8	0.0	0.4	46.9	7.8	0.5	338.1	0.1	0.3	0.1	0.1	0.1	0.7	0.1	31.7	0.1	522.3	128.9	4.0	96.8	0.0	19.6	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	120.8	0.0	216.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	494.5	0.0	43.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.2	1.7	0.1	0.0	0.6	0.0	909.3	5214.3	0.0	0.6	0.0	30.8	153.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	28.8	53.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.4	271.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	66.8	0.0	0.0	1765.9	0.0	0.0	0.0	372.4
KRT6B	KRTL1	ENSG00000185479	"Keratin 6B"	P04259	12	52446651-52452126	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"esophagus: 135.3;tongue: 232.4"	"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 18.3;Ductal cells: 33.5;Suprabasal keratinocytes: 28.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 1424.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 57.1"									"CAB000130, HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"CAB000130: , HPA045697: AB_2679422, HPA061168: AB_2684440"	"prognostic favorable (9.44e-4)"	"unprognostic (3.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.77e-2)"		"unprognostic (9.63e-2)"		"unprognostic (3.29e-1)"	"prognostic unfavorable (9.52e-4)"	0.2	0.1	0.1	0.5	0.1	0.1	3.9	0.1	0.1	33.3	0.1	0.1	0.1	0.1	0.7	0.1	135.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	17.8	0.1	0.1	34.9	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1	232.4	15.4	0.1	26.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.1	0.4	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.8	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	1.5	0.0	0.0	0.0	1.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.5	0.0	0.0	0.0	4.8
KRT6C	KRT6E	ENSG00000170465	"Keratin 6C"	P48668	12	52468516-52473785	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 109.4;esophagus: 125.8;tongue: 244.2"	"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 3.1;Suprabasal keratinocytes: 2.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 564.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 46.0"									"HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (3.18e-2)"	"unprognostic (6.26e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-3)"		"unprognostic (6.97e-2)"		"prognostic unfavorable (1.23e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.24e-1)"		"unprognostic (2.84e-1)"			"unprognostic (4.50e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	109.4	0.2	0.0	0.0	0.2	1.1	0.2	125.8	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	16.3	0.2	0.2	2.7	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.1	0.2	244.2	6.7	0.2	40.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4
MARVELD3	MRVLDC3	ENSG00000140832	"MARVEL domain containing 3"	Q96A59	16	71626161-71642114	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.9;pancreas: 34.5"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 154.2;Paneth cells: 84.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 11.7;BEWO: 17.6;CACO-2: 13.0;CAPAN-2: 12.6;HaCaT: 11.9;MCF7: 22.2;RT4: 10.4;SK-BR-3: 10.5;T-47d: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043514, HPA045471"			Approved	"Vesicles,Intermediate filaments"		No	NA			Vesicles	"Intermediate filaments"	"HPA043514: AB_10959475, HPA045471: "	"unprognostic (1.18e-1)"	"unprognostic (3.92e-1)"	"unprognostic (9.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.16e-2)"	"prognostic favorable (6.80e-10)"	"unprognostic (2.63e-3)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.43e-1)"	0.4	0.3	0.4	12.5	0.3	0.0	5.0	0.7	1.2	2.0	35.7	0.3	5.2	17.3	1.3	8.6	4.1	2.1	15.4	0.5	0.5	0.4	14.2	4.3	3.3	0.5	0.3	0.1	1.0	34.5	5.4	1.2	5.3	2.4	6.5	10.5	2.4	10.4	4.3	0.3	3.0	52.9	0.7	0.4	0.4	2.1	1.2	0.1	1.3	8.3	2.3	4.6	3.0	3.4	1.5	1.4	4.1	0.8	1.5	0.8	0.2	11.7	0.4	0.2	0.5	0.0	0.1	17.6	0.0	0.0	0.0	0.0	13.0	12.6	0.1	1.3	0.0	0.0	11.9	1.1	5.7	0.0	0.0	6.8	0.0	0.1	3.4	0.0	0.1	0.1	0.5	7.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	22.2	0.1	0.2	2.0	7.4	0.1	0.0	0.0	4.7	0.2	10.4	2.1	0.1	0.2	10.5	0.0	1.5	14.9	0.2	0.0	0.0	0.2	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	4.1	0.8	0.8	0.7	0.5	0.4	0.8	0.8	0.6	0.3	1.5	0.7	0.7	4.0	1.5	0.5	1.4	0.7	0.2	0.4	0.3	0.7	0.5	0.5	0.4	0.3	0.1	2.4	0.1	8.9	5.9	0.0	25.0	7.0	5.9	0.4	38.2	20.1	12.5	8.7	0.0	31.8	1.7	23.0	4.2	0.0	154.2	0.0	29.6	0.7	1.0	32.3	0.0	5.0	2.5	0.0	59.0	0.6	1.2	2.2	0.3	1.0	0.0	1.0	62.0	0.8	24.0	84.2	0.7	20.2	19.7	0.0	1.0	7.7	4.3	3.1	4.0	1.3	44.3	38.8
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836557-22849027	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 216.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 96.4;HHSteC: 91.2;HSkMC: 92.7;hTERT-RPE1: 91.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		570000	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	60.9	10.5	2.4	16.6	4.7	0.2	64.2	2.2	3.2	56.3	35.0	8.2	12.7	12.0	53.1	24.1	47.0	21.9	39.6	17.5	3.4	1.8	16.8	9.0	29.8	16.9	5.8	2.9	39.3	11.2	34.4	4.7	73.5	16.4	39.1	11.3	27.1	24.4	16.7	20.4	37.0	22.9	28.5	20.7	22.5	18.2	26.3	4.6	5.4	22.3	14.6	16.7	52.5	53.9	0.1	0.7	0.0	0.7	0.0	0.0	0.1	7.8	0.1	2.4	0.1	96.4	61.3	44.3	24.7	49.8	7.5	13.4	2.3	29.4	0.1	13.8	26.0	2.3	20.0	0.0	25.7	9.6	0.1	0.1	3.6	0.1	0.5	91.2	0.0	0.1	92.7	15.5	31.2	26.8	91.6	45.3	0.1	0.0	0.2	17.6	0.1	0.0	8.8	1.4	1.7	4.3	0.3	8.5	0.0	6.8	13.5	0.0	0.0	16.1	0.0	53.5	10.8	0.1	7.9	40.0	60.9	5.2	17.7	28.1	0.1	0.1	0.1	37.1	0.0	35.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	4.7	2.2	3.2	3.4	1.8	5.8	2.9	16.4	4.6	11.9	4.8	3.7	19.4	30.2	0.0	3.6	53.5	2.7	3.4	7.0	0.0	83.6	10.0	61.2	0.4	13.5	16.8	0.0	24.9	216.8	65.7	13.9	3.5	2.9	79.3	0.0	7.5	41.1	18.3	0.7	66.7	26.5	35.4	34.3	32.5	17.1	102.2	28.5	51.6	13.0	0.8	38.8	34.8	0.9	0.7	29.9	102.6	1.0	17.1	28.7
NDOR1	"bA350O14.9, NR1"	ENSG00000188566	"NADPH dependent diflavin oxidoreductase 1"	Q9UHB4	9	137205685-137217009	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA024504	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA024504: AB_1854338"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.74e-3)"	9.6	11.4	10.6	18.4	17.4	29.2	10.0	15.0	16.2	9.4	10.4	18.7	7.4	19.1	11.4	10.5	11.2	11.0	10.4	7.4	11.6	7.7	12.1	9.4	11.6	20.5	18.6	8.6	10.2	14.7	9.7	12.2	9.2	13.5	13.0	6.8	12.5	17.3	16.1	6.5	18.5	16.5	8.7	14.2	19.9	13.9	22.2	14.2	20.6	14.4	4.9	15.8	9.7	9.4	2.7	3.7	6.6	4.8	1.6	4.0	3.0	7.2	10.9	7.5	11.4	3.2	3.2	22.5	10.6	4.9	10.4	7.2	10.9	8.6	10.1	8.4	4.1	8.3	27.1	5.4	7.5	2.1	13.0	8.4	9.0	26.2	5.8	5.3	10.1	19.3	4.3	5.3	11.6	4.3	2.8	4.8	13.7	14.5	10.8	3.7	13.0	10.4	17.9	11.9	6.7	13.6	19.2	8.8	14.4	3.3	6.3	9.4	9.3	8.8	8.9	5.5	3.4	14.4	11.7	6.2	19.1	12.5	22.0	11.8	6.7	13.2	10.5	8.3	9.2	10.8	1.7	4.4	6.3	3.2	4.8	2.7	1.3	2.8	2.7	3.7	2.7	1.6	1.4	6.6	1.6	3.8	2.4	4.0	3.0	10.6	17.4	15.0	16.2	11.6	7.7	18.6	8.6	13.5	14.2	0.0	1.6	0.8	0.6	0.5	0.2	1.1	0.0	0.0	2.3	3.5	0.0	4.2	1.7	0.9	0.6	1.5	2.2	0.0	1.0	2.8	0.6	0.5	1.1	0.6	2.3	0.0	2.4	1.8	3.7	0.8	0.6	1.6	1.7	4.6	1.4	0.1	1.5	0.8	0.4	1.1	1.0	0.0	0.8	1.9	1.1	0.3	3.1	0.0	1.7	0.7
NEFL	"CMT1F, CMT2E, NF68, NFL, PPP1R110"	ENSG00000277586	"Neurofilament light"	P07196	8	24950955-24957110	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.1"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 32.2;Distal tubular cells: 87.9;Horizontal cells: 28.6;Intestinal endocrine cells: 32.1;Muller glia cells: 29.9;Rod photoreceptor cells: 73.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.0"					"Cell type enriched"	"Detected in some"	5	"memory CD4 T-cell: 13.7"	"Lineage enriched"	"Detected in single"	138	"T-cells: 13.7"	"Group enriched"	"Detected in some"	5	"HEK 293: 114.9;PC-3: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014850, HPA015021"	Enhanced	Supported	Approved	"Nucleoplasm,Intermediate filaments,Midbody"		NA	NA			"Nucleoplasm, Intermediate filaments"	Midbody	"HPA014850: AB_1854397, HPA015021: AB_2669135"	"unprognostic (7.63e-2)"	"unprognostic (1.36e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (5.76e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.17e-3)"	0.7	12.0	10.3	1.4	20.1	0.6	0.6	2.3	92.1	1.8	1.8	3.0	0.0	1.0	0.7	0.8	3.8	0.7	0.6	0.6	14.1		3.5	0.6	0.6	0.7	0.0	23.8	0.7	0.7	0.6	0.0	0.6	95.1	1.6	1.5	5.0	0.6	9.5	0.6	0.7	1.7	1.2	18.0	0.7	1.1	1.6	2.1	0.0	1.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	13.7	2.1	0.0	0.1	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.1	0.0	0.0	114.9	0.0	0.0	0.0	5.1	0.0	0.1	1.9	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.9	0.0	30.8	0.0	0.0	0.0	7.1	1.0	6.4	6.5	2.6	0.0	0.4	0.5	0.0	0.0	0.0	0.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.7	1.5	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.2	2.1											0.0	0.0	0.0	0.0	0.0	32.2	0.4	0.0	0.0	0.0	0.0	7.9	0.0	87.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	8.9	0.0	73.4	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0
OTUD3	"DUBA4, KIAA0459"	ENSG00000169914	"OTU deubiquitinase 3"	Q5T2D3	1	19882513-19912945	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028543, HPA028544"	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA028543: AB_10599302, HPA028544: AB_10602277"	"unprognostic (6.45e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.15e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-2)"	6.5	11.0	15.0	6.9	19.2	11.4	10.0	19.3	23.2	10.6	8.9	6.6	6.4	10.2	14.2	13.0	6.1	8.2	7.2	5.2	12.6	7.3	7.1	4.8	8.5	7.0	9.9	12.5	11.2	7.2	9.3	20.2	5.4	9.0	9.8	8.3	6.9	6.2	9.2	9.2	13.0	9.6	11.9	8.1	7.7	7.3	28.4	9.7	6.0	6.9	2.9	6.3	7.0	7.6	1.7	0.6	0.8	0.4	0.6	2.2	0.3	5.1	1.9	8.7	10.4	3.8	3.3	8.6	5.5	3.2	2.8	2.8	9.1	4.9	8.1	4.5	12.1	2.0	5.0	8.1	3.2	5.5	5.3	10.8	7.8	10.4	6.3	2.1	5.7	7.2	2.7	3.2	4.4	5.7	6.0	3.7	8.3	5.5	3.5	4.8	2.8	4.3	5.7	4.1	4.1	5.1	10.1	22.3	3.0	4.7	5.6	7.7	5.5	3.9	3.2	4.2	8.9	4.8	4.2	4.5	6.8	8.7	7.5	4.7	4.0	3.4	5.0	4.8	7.6	3.1	0.8	0.4	0.1	1.5	0.3	1.4	1.7	1.7	1.4	0.3	1.3	2.2	1.8	0.7	0.6	0.1	0.6	0.9	0.3	15.0	19.2	19.3	23.2	12.6	7.3	9.9	12.5	9.0	9.7	14.9	6.9	3.0	5.2	12.6	13.5	3.6	0.0	10.7	1.2	8.7	15.7	2.3	0.0	4.5	9.9	4.5	3.8	0.0	4.0	4.7	4.2	8.8	1.1	2.1	1.6	25.4	11.5	9.2	1.6	11.5	5.2	3.3	5.0	2.8	6.7	10.2	3.9	5.9	5.6	3.4	16.0	6.5	3.5	19.1	21.2	7.8	2.1	4.4	5.9	3.0
PAFAH1B3		ENSG00000079462	"Platelet activating factor acetylhydrolase 1b catalytic subunit 3"	Q15102	19	42297033-42303546	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatogonia: 212.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035639	Uncertain		Approved	"Intermediate filaments"		NA	NA		370000	"Intermediate filaments"		"HPA035639: AB_10670163"	"unprognostic (3.19e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.80e-3)"	4.5	12.8	23.8	10.4	23.2	20.7	12.2	36.4	24.9	17.2	14.6	7.8	8.0	10.9	10.1	11.9	15.5	13.5	9.6	4.6	15.4	25.7	11.7	5.6	5.8	13.6	13.9	13.1	15.4	11.9	8.3	11.8	5.8	12.4	10.3	10.7	11.2	9.8	6.1	10.8	10.6	11.2	6.6	11.7	9.5	11.3	16.3	11.3	37.4	7.8	13.8	15.4	14.6	10.9	19.6	24.6	8.7	13.6	7.8	27.4	10.5	29.3	53.8	33.6	35.9	0.7	1.8	10.4	7.4	10.2	24.3	25.2	17.9	24.7	18.1	9.7	8.9	16.9	10.0	15.2	19.4	10.1	27.4	20.8	21.9	14.4	24.0	5.2	13.9	24.4	5.3	9.0	14.9	7.0	13.5	10.8	39.7	15.4	21.6	17.7	42.9	31.0	10.9	18.6	34.8	0.0	23.0	12.9	16.2	19.7	31.0	38.7	30.3	11.8	23.4	12.3	11.1	29.2	15.9	5.8	20.2	27.4	1.8	19.9	10.3	21.3	15.4	11.3	22.5	17.7	8.7	13.6	7.2	12.1	10.7	16.1	19.6	17.3	13.9	24.6	18.4	23.0	16.0	1.8	7.8	5.4	13.6	27.4	10.5	23.8	23.2	36.4	24.9	15.4	25.7	13.9	13.1	12.4	11.3	14.9	9.1	22.3	37.0	25.0	24.5	1.2	28.1	30.8	15.9	31.4	13.7	30.1	68.0	88.9	12.7	17.1	21.2	23.3	48.0	33.8	21.6	29.7	27.6	7.2	52.3	11.1	56.6	9.2	23.0	16.4	12.7	23.2	43.9	10.8	47.4	24.0	78.6	24.6	8.5	40.4	17.2	0.0	6.2	4.3	212.2	15.6	11.3	17.5	63.6	43.4
PELI1		ENSG00000197329	"Pellino E3 ubiquitin protein ligase 1"	Q96FA3	2	64092652-64144454	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.7"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 199.1;Suprabasal keratinocytes: 190.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 33.9"	"Group enriched"	"Detected in all"	4	"granulocytes: 33.9;monocytes: 9.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.8;U-698: 54.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.33e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-3)"	"unprognostic (5.99e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (5.67e-6)"	"unprognostic (6.72e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.03e-1)"	15.7	5.1	10.0	15.1	20.5	105.7	22.3	15.1	8.9	9.9	14.5	11.0	3.3	9.9	14.5	7.1	26.4	8.0	14.9	11.6	11.3	6.8	6.7	8.6	20.1	16.8	15.6	5.2	4.8	6.2	11.0	14.8	13.7	10.8	7.6	11.8	6.0	12.3	8.5	4.5	17.5	17.3	8.4	15.0	17.8	10.2	7.8	12.8	19.9	6.3	10.2	19.3	14.1	14.8	3.9	2.3	33.9	9.2	1.3	5.0	2.5	1.3	1.0	14.0	9.3	1.6	1.2	3.2	1.8	2.0	1.6	2.6	21.8	1.5	17.9	4.4	0.6	0.6	2.1	4.2	3.9	3.3	4.4	3.3	1.6	0.7	3.5	4.9	1.7	3.2	1.6	3.1	2.4	8.4	1.7	9.2	6.9	1.0	4.5	1.4	0.1	3.8	2.5	9.1	4.1	0.6	4.8	4.8	10.2	6.7	4.0	6.4	9.0	1.3	2.1	4.8	4.5	1.1	1.2	6.5	1.5	2.2	1.5	2.6	10.4	1.0	54.2	0.8	1.6	4.1	5.1	6.5	6.3	0.4	6.1	0.7	3.9	2.2	0.9	2.3	2.4	2.7	1.1	33.9	1.3	9.2	0.2	5.0	2.5	10.0	20.5	15.1	8.8	11.3	6.8	15.6	5.2	10.8	12.8	26.8	45.1	22.4	65.1	199.1	0.9	5.1	10.2	30.8	55.7	5.2	0.0	1.4	1.7	4.5	8.5	42.7	37.0	0.0	23.1	6.5	25.9	43.3	14.0	6.8	19.1	3.2	24.6	36.2	52.6	7.8	1.4	57.1	106.3	13.6	22.2	4.5	18.2	28.1	1.8	7.7	1.8	0.0	48.4	6.1	7.8	190.1	3.3	11.5	27.3	104.0
PELI2		ENSG00000139946	"Pellino E3 ubiquitin protein ligase family member 2"	Q9HAT8	14	56117814-56301526	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 21.4"	"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 19.3;JURKAT: 24.9;MOLT-4: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (3.64e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	12.3	3.3	5.2	5.6	4.6	16.5	8.7	21.4	6.5	7.5	9.4	5.4	9.7	11.1	9.3	7.1	4.7	5.9	11.5	3.4	4.6	4.5	9.7	3.1	7.3	4.8	5.2	3.9	16.0	38.9	1.7	5.5	3.3	4.4	8.2	4.2	9.2	7.6	12.4	3.8	6.5	12.6	17.7	5.8	6.6	14.1	10.0	4.2	38.2	4.9	3.4	2.6	13.3	14.9	0.9	2.0	9.0	3.0	0.5	0.8	1.1	0.0	1.8	5.1	0.0	2.8	4.2	0.1	0.7	2.4	0.5	0.0	0.1	0.4	0.1	2.4	1.4	0.0	0.5	3.9	0.0	0.2	1.2	1.4	4.4	7.9	0.0	2.4	0.6	19.3	2.7	0.2	0.0	0.0	2.8	0.9	24.9	3.2	0.0	0.5	0.0	21.6	0.2	8.3	0.0	0.7	10.6	0.3	0.9	2.1	8.7	10.2	0.0	0.4	0.0	5.7	3.3	0.0	3.5	0.3	1.5	2.6	0.4	2.5	0.4	0.0	0.5	2.7	3.0	1.5	1.4	3.0	3.5	0.5	1.6	0.8	0.2	0.6	0.3	2.0	0.9	0.4	0.3	9.0	0.5	1.2	0.5	0.0	1.1	5.2	4.6	21.4	4.4	4.6	4.5	5.2	3.9	4.4	4.2	0.0	7.7	2.7	11.0	12.7	30.0	1.9	7.6	14.7	10.3	12.2	27.5	0.0	3.3	4.4	2.3	10.9	8.4	0.0	12.2	0.1	5.6	7.0	5.7	0.8	1.1	20.6	6.9	11.1	16.5	4.1	15.8	11.1	16.9	2.8	7.4	10.0	8.6	3.7	17.0	8.8	18.5	12.9	22.1	1.4	27.2	15.9	0.1	3.5	3.0	9.7
PFDN5	"MM-1, PFD5"	ENSG00000123349	"Prefoldin subunit 5"	Q99471	12	53295291-53299450	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008587	Approved		Supported	"Intermediate filaments,Cytosol"		NA	NA		110000	"Intermediate filaments, Cytosol"		"HPA008587: AB_1079597"	"unprognostic (3.56e-3)"	"unprognostic (2.31e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (5.45e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.34e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.01e-3)"	75.9	73.7	105.0	82.3	85.4	119.3	142.4	53.8	66.7	97.0	77.1	56.3	102.5	39.7	94.3	156.8	80.3	94.6	91.0	77.0	82.7	76.7	81.8	83.5	64.9	117.2	94.3	69.2	134.5	155.8	49.6	81.2	67.3	63.3	96.1	65.4	60.1	116.4	99.9	87.0	71.6	54.1	108.1	91.0	83.8	64.7	60.5	64.9	60.5	128.1	108.9	101.1	91.8	144.9	163.9	98.0	63.7	127.8	69.4	158.4	329.0	34.6	53.5	51.8	46.6	100.5	139.9	37.8	86.8	118.2	80.9	54.7	48.8	53.4	46.9	52.5	93.3	31.5	31.9	45.0	62.2	78.4	44.3	63.0	42.7	66.1	67.0	64.6	69.4	46.7	133.3	91.4	57.2	44.7	142.1	71.9	57.5	49.8	63.3	80.3	122.5	48.6	103.5	48.8	38.2	82.7	39.6	56.2	55.4	92.3	51.3	43.8	50.0	55.8	49.3	63.0	55.5	64.1	88.7	62.9	45.8	34.9	21.6	38.8	47.5	50.6	69.0	50.2	55.5	41.8	63.7	127.8	46.5	80.9	97.0	110.9	163.9	123.2	97.6	98.0	156.8	158.4	125.9	38.3	69.4	100.2	91.0	95.8	329.0	105.0	85.4	53.8	66.7	82.7	76.7	94.3	69.2	63.3	64.9	244.2	498.3	821.4	978.4	1337.0	168.6	512.1	654.7	603.6	410.6	537.3	96.2	782.3	1197.0	474.2	740.9	714.2	762.1	327.1	835.6	808.8	895.0	782.4	633.6	473.3	1556.7	68.3	634.1	613.9	1908.4	2168.6	878.5	1189.4	1459.3	1100.1	742.2	240.0	653.0	927.0	616.0	1515.7	241.4	543.3	956.8	450.5	191.9	1334.3	732.5	827.4	772.2	931.8
PGD		ENSG00000142657	"Phosphogluconate dehydrogenase"	P52209	1	10398592-10420144	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Gluconate utilization, Pentose shunt"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 115.1;esophagus: 123.8"	"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 204.0;monocytes: 212.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 98.6;classical monocyte: 32.0;eosinophil: 115.1;neutrophil: 38.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 115.1;monocytes: 32.0"	"Cell line enhanced"	"Detected in all"		"A549: 181.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031314, HPA031315"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		No	No		59000000	"Intermediate filaments, Cytosol"		"HPA031314: AB_10610278, HPA031315: AB_2673825"	"unprognostic (4.65e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	29.8	12.7	10.9	14.2	11.8	85.5	23.7	8.0	19.1	16.0	14.1	13.8	8.1	22.9	6.3	12.5	123.8	8.4	24.9	14.3	10.3	12.1	15.4	23.2	25.6	34.9	12.4	11.4	14.3	8.3	16.2	10.8	17.0	19.3	7.9	12.9	19.7	31.8	6.8	8.5	10.6	25.3	9.5	12.6	27.6	13.4	27.0	7.4	16.8	21.2	68.8	49.9	14.8	26.1	3.9	15.9	115.1	32.0	2.0	3.0	19.0	23.1	181.8	45.3	48.7	69.0	42.7	9.8	15.7	27.8	21.8	29.8	26.6	26.7	22.8	19.4	16.1	29.9	19.7	33.1	28.1	14.7	15.7	28.9	30.8	32.7	55.9	21.0	50.8	34.2	30.4	14.1	34.4	8.5	27.8	51.4	32.0	41.0	20.2	27.8	26.3	41.9	25.5	27.2	31.8	16.0	32.5	41.6	41.9	30.4	12.5	24.4	21.3	13.4	21.3	18.5	31.2	23.5	43.6	48.1	11.5	20.4	13.7	17.3	15.3	27.9	40.8	25.1	55.2	10.3	98.6	32.0	115.1	2.6	15.3	3.0	3.9	2.5	2.4	15.9	2.3	2.4	2.6	38.4	2.0	10.9	11.4	2.4	19.0	10.9	11.8	8.0	19.1	10.3	12.1	12.4	11.4	19.3	7.4	17.9	31.2	16.0	28.9	11.6	7.9	9.5	50.9	17.4	23.9	19.2	17.7	114.8	44.7	45.3	7.1	17.5	32.9	0.0	35.1	31.4	28.8	33.1	24.4	48.2	117.8	1.6	22.4	16.0	204.0	9.8	15.8	88.3	16.9	212.8	23.7	12.9	39.9	25.9	9.9	40.3	16.4	19.4	9.8	33.4	37.9	14.4	68.0	16.0	44.1	66.7
PGM2	FLJ10983	ENSG00000169299	"Phosphoglucomutase 2"	Q96G03	4	37826633-37862937	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 345.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040676	Uncertain		Approved	"Intermediate filaments"		NA	NA		1900000	"Intermediate filaments"		"HPA040676: AB_2677076"	"unprognostic (3.11e-2)"	"unprognostic (1.01e-2)"	"prognostic favorable (2.14e-5)"	"unprognostic (2.29e-1)"	"unprognostic (3.94e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.32e-2)"	"unprognostic (7.02e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.02e-1)"	11.2	10.8	7.7	11.6	5.9	7.5	13.5	9.8	5.7	14.7	10.3	4.2	6.5	6.1	15.0	7.6	41.3	7.0	11.0	8.3	7.1	4.0	11.1	13.3	7.5	13.2	4.4	5.7	10.0	9.0	9.5	6.4	27.9	10.4	11.1	8.4	6.8	11.0	5.0	2.4	17.7	8.6	12.2	6.9	13.4	9.0	9.0	3.9	17.3	8.8	31.7	22.9	13.6	18.9	4.5	15.3	30.8	13.1	13.2	7.0	7.2	11.7	4.1	6.3	6.7	4.7	5.3	8.3	14.2	8.4	11.7	12.0	7.2	8.6	15.5	7.1	7.7	15.6	6.1	15.3	13.3	29.8	9.9	8.8	17.0	6.9	5.1	10.3	17.8	11.9	7.7	16.1	9.5	8.6	7.3	18.6	13.7	22.1	2.8	10.2	6.2	20.3	21.1	7.3	8.5	6.4	15.5	10.0	6.4	7.2	22.7	13.3	4.5	7.1	10.5	4.9	9.1	9.1	19.2	16.2	8.8	10.8	11.8	28.8	6.3	16.4	17.6	4.6	23.4	14.6	8.0	13.1	30.8	4.9	10.5	5.8	4.5	4.1	5.6	15.3	2.8	4.0	5.0	16.3	13.2	8.0	3.4	7.0	7.2	7.7	5.9	9.8	5.7	7.1	4.0	4.4	5.7	10.4	3.9	0.0	8.0	10.3	13.2	13.1	5.8	4.5	7.6	5.3	4.5	3.5	0.0	26.6	5.0	13.0	0.8	25.5	7.9	0.0	10.4	30.7	6.7	18.4	12.7	7.3	33.4	6.4	6.9	44.8	19.6	0.9	7.8	24.9	5.0	52.3	9.0	345.3	11.4	3.5	9.2	7.4	13.5	12.9	23.7	0.7	0.5	28.1	66.7	12.9	12.3	17.9
PHACTR4	"FLJ13171, PPP1R124"	ENSG00000204138	"Phosphatase and actin regulator 4"	Q8IZ21	1	28369582-28500369	"Predicted intracellular proteins"	Neurogenesis	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028985	Approved		Approved	"Plasma membrane,Intermediate filaments,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA028985: AB_10602142"	"unprognostic (1.55e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.27e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (9.65e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.26e-2)"	11.0	12.3	10.0	17.2	17.4	11.5	11.6	18.7	15.2	17.2	14.2	16.5	11.7	9.9	22.7	12.1	37.0	15.1	12.6	10.7	11.4	7.9	16.4	18.7	13.8	10.4	15.3	8.9	15.3	15.4	22.3	18.1	11.6	12.1	13.7	15.8	15.4	18.1	10.3	14.9	19.1	15.4	15.7	13.6	14.4	12.1	15.7	18.5	17.8	15.2	18.1	30.0	12.1	20.6	5.3	5.6	4.0	6.3	4.8	7.7	3.4	12.4	8.6	19.3	13.9	4.9	5.5	2.9	9.0	9.2	19.7	20.5	8.2	14.2	12.0	8.2	10.7	12.4	8.9	13.3	9.0	17.7	9.0	7.4	25.0	14.7	12.7	7.4	14.9	28.9	4.9	8.4	12.6	22.3	7.3	25.9	9.3	12.6	8.3	12.5	3.9	10.5	3.7	14.6	6.8	5.9	11.1	18.4	8.9	10.2	11.3	10.2	12.8	20.1	8.3	10.4	8.0	11.2	5.5	16.8	9.6	18.0	6.7	17.3	6.4	9.1	10.1	9.3	12.6	10.1	3.4	4.6	4.0	7.7	4.1	6.8	3.3	5.9	7.2	4.5	5.3	4.0	5.4	3.5	4.8	6.3	5.6	2.7	3.4	10.0	17.4	18.7	15.2	11.4	7.9	15.3	8.9	12.1	18.5	65.5	49.1	30.2	22.5	34.3	33.3	35.0	28.1	81.7	67.1	22.7	19.6	15.0	14.9	29.8	4.7	40.9	48.1	23.3	31.5	14.3	20.1	21.0	45.2	50.0	20.2	22.3	47.4	41.1	23.6	5.9	17.8	29.3	16.9	19.0	49.8	18.4	39.7	31.6	28.0	40.8	37.3	38.8	26.8	48.3	31.1	47.3	12.7	29.4	44.9	29.8
PTPN18	BDP1	ENSG00000072135	"Protein tyrosine phosphatase, non-receptor type 18"	Q99952	2	130356007-130375409	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012174, HPA053367"	Uncertain		Approved	"Intermediate filaments"		NA	NA		550000	"Intermediate filaments"		"CAB012174: AB_2173224, HPA053367: AB_2732579"	"unprognostic (3.11e-3)"	"unprognostic (2.89e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.81e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.85e-3)"	12.8	7.1	11.0	16.7	13.5	18.9	22.3	26.8	13.7	15.3	22.8	6.6	25.7	16.6	9.3	11.0	11.3	13.3	21.3	7.5	9.8	8.5	13.9	19.2	16.9	29.2	8.4	9.5	7.8	28.9	6.4	11.0	9.4	6.9	17.8	19.3	7.9	18.5	24.0	11.0	6.9	28.8	10.5	9.1	37.7	16.0	3.3	9.1	1.6	13.0	7.1	35.5	11.0	10.7	7.6	7.4	6.2	17.1	2.8	6.6	10.2	5.8	3.9	1.6	7.9	9.9	6.8	16.4	3.0	2.7	3.9	4.4	7.8	9.0	21.9	3.0	7.3	1.8	6.7	6.9	6.8	3.8	9.9	3.8	7.9	4.7	9.2	5.1	7.7	21.5	8.0	5.6	4.3	5.9	0.8	7.4	4.9	7.4	16.7	7.4	11.4	1.4	13.4	1.6	12.6	4.3	13.3	4.6	29.6	7.7	3.6	10.1	2.6	5.3	19.0	8.7	1.6	6.6	11.4	6.9	5.6	6.3	3.0	2.8	2.6	0.7	21.1	8.5	7.0	6.0	6.2	7.8	6.1	6.6	10.8	4.1	7.6	4.4	6.3	6.7	4.5	2.7	5.4	4.9	2.8	17.1	7.4	5.6	10.2	11.0	13.5	26.8	13.7	9.8	8.5	8.4	9.5	6.9	9.1	26.8	22.9	49.5	26.1	5.8	13.5	8.1	20.4	18.7	12.5	34.9	3.9	12.1	46.4	16.6	0.7	21.5	49.1	0.0	39.9	25.3	13.3	43.8	35.7	18.1	76.6	9.5	46.7	17.2	79.3	0.9	17.5	52.8	32.1	16.2	50.4	12.4	23.4	56.1	10.6	25.1	10.0	19.4	19.8	3.0	4.1	5.1	9.6	39.8	38.3	27.6
PTPRE	PTPE	ENSG00000132334	"Protein tyrosine phosphatase, receptor type E"	P23469	10	127907061-128085855	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 91.0"	"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 141.1;Macrophages: 249.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 91.0;plasmacytoid DC: 65.7"	"Group enriched"	"Detected in all"	11	"dendritic cells: 65.7;granulocytes: 91.0;monocytes: 25.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 18.8;HUVEC TERT2: 19.8;NB-4: 14.9;TIME: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015870, HPA021872"	Supported		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA015870: AB_1855759, HPA021872: AB_1855760"	"unprognostic (5.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.59e-2)"	16.8	18.5	12.5	24.0	12.5	39.5	11.0	7.4	15.3	4.8	9.2	14.5	1.6	9.6	5.1	8.1	8.8	6.2	10.7	12.3	15.0	12.2	4.4	4.8	22.5	20.0	12.5	6.5	4.3	3.1	3.4	6.5	8.0	9.8	4.5	9.8	4.8	7.0	3.1	1.9	4.9	12.7	7.7	14.3	26.4	7.7	4.3	10.9	11.4	6.6	6.1	12.2	10.0	5.0	1.2	65.7	91.0	25.5	4.0	5.4	4.9	1.9	0.4	0.2	0.0	1.2	0.2	3.6	0.0	0.0	0.8	1.7	0.8	12.0	1.5	1.3	1.0	2.6	1.1	1.0	5.7	0.3	1.8	0.9	0.1	0.7	0.0	2.0	7.4	5.6	0.4	3.3	2.9	5.9	18.8	19.8	4.9	0.0	0.9	1.2	1.8	2.2	14.9	0.1	2.1	0.7	8.8	1.2	2.9	3.3	8.5	0.0	1.2	3.4	0.6	0.1	0.9	0.3	9.4	37.4	0.8	0.8	3.7	4.1	0.4	0.6	2.1	5.5	5.8	0.0	17.4	25.5	19.3	5.4	9.0	3.2	0.9	2.4	3.6	13.3	1.2	1.7	2.9	91.0	4.0	6.8	65.7	3.5	4.9	12.5	12.5	7.4	12.7	15.0	12.2	12.5	6.5	9.8	10.9	77.4	67.6	24.7	47.2	52.9	2.6	15.1	5.1	9.4	33.0	3.5	0.0	33.6	0.0	4.3	1.6	49.4	12.3	0.0	4.0	40.5	9.9	8.3	30.1	1.3	53.6	0.0	6.4	46.1	141.1	1.7	0.6	249.1	23.6	4.6	14.4	0.0	28.7	11.5	0.4	1.9	0.8	0.0	8.1	0.5	1.4	56.6	14.2	52.4	10.2	34.4
QTRT2	"FLJ12960, QTRTD1"	ENSG00000151576	"Queuine tRNA-ribosyltransferase accessory subunit 2"	Q9H974	3	114005833-114088422	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 16.9;Club cells: 19.4;granulocytes: 14.0;monocytes: 14.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036827, HPA036828"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA036827: AB_2675336, HPA036828: AB_10696788"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.41e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.48e-3)"	"prognostic unfavorable (6.95e-4)"	"unprognostic (1.44e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-3)"	17.1	13.9	8.7	12.4	10.4	13.3	14.1	6.4	10.3	11.0	11.2	14.9	7.9	10.4	16.1	9.2	13.7	13.1	13.6	7.5	6.7	6.7	15.8	15.7	12.2	14.9	11.0	7.6	12.6	15.3	10.7	16.9	11.6	9.4	11.2	12.5	17.7	11.8	9.8	7.5	12.4	12.9	10.8	11.3	19.9	10.7	14.1	10.0	17.3	13.2	10.9	21.6	11.6	10.9	13.9	15.8	5.3	12.9	6.4	6.6	5.0	13.4	14.0	11.7	12.9	5.2	6.4	11.1	7.1	4.5	12.1	11.2	13.3	9.8	25.1	10.4	6.5	14.5	13.5	22.7	10.7	16.0	4.7	10.2	11.3	8.4	9.4	7.4	20.4	10.6	5.0	9.7	11.0	15.7	4.9	12.5	11.7	11.8	9.0	6.8	10.7	17.1	8.0	22.4	19.2	15.4	15.5	8.2	13.5	9.5	9.3	16.0	7.6	10.3	10.2	13.0	10.2	11.3	10.4	8.2	10.6	11.6	4.1	13.7	6.4	9.2	35.1	9.3	15.2	21.3	0.3	12.4	2.9	5.6	12.9	5.3	13.9	4.8	5.5	15.8	9.5	6.6	5.3	5.3	6.4	9.1	6.6	5.9	5.0	8.7	10.4	6.4	10.3	6.7	6.7	11.0	7.6	9.4	10.0	17.9	16.9	0.0	0.0	0.0	0.0	0.0	0.0	8.1	19.4	3.5	0.0	9.4	1.7	13.8	0.0	0.0	0.0	0.0	10.8	8.6	0.0	0.0	14.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	14.4	0.0	0.0	12.5	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
RAB3IP	"FLJ22548, RABIN3, RABIN8"	ENSG00000127328	"RAB3A interacting protein"	Q96QF0	12	69738681-69823204	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Bipolar cells: 217.9;Early spermatids: 250.3;Late spermatids: 317.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 52.8"					"Low region specificity"	"Detected in all"			HPA039794	Uncertain		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA039794: AB_10960557"	"unprognostic (4.38e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.68e-13)"	"unprognostic (6.17e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.37e-1)"	3.4	10.2	15.9	6.2	17.2	13.7	12.3	49.7	17.9	5.2	12.9	14.0	8.2	11.9	3.5	28.5	6.0	9.3	9.6	11.2	15.8	11.3	29.9	10.2	9.1	7.7	15.0	11.2	3.2	15.0	15.9	24.4	7.3	25.9	13.2	14.1	22.4	9.9	12.0	7.7	8.6	13.4	3.1	14.9	5.6	11.1	42.6	12.1	8.7	9.6	2.6	9.1	5.5	7.6	10.2	5.9	7.4	5.7	7.6	12.4	5.0	14.9	8.1	4.7	8.1	2.4	1.1	14.7	1.5	3.4	5.9	8.2	23.7	6.8	11.9	4.9	0.8	7.8	11.5	4.6	8.0	10.4	17.2	8.7	8.4	3.1	11.2	2.3	9.4	5.4	2.5	8.3	5.4	18.8	6.1	8.6	14.7	4.0	10.7	3.4	16.2	9.3	4.4	12.7	15.7	9.0	11.4	7.4	12.4	19.6	18.7	19.0	3.5	5.5	9.6	2.2	21.3	17.1	3.9	2.4	2.5	6.7	1.0	6.6	4.9	19.5	52.8	5.9	6.2	4.0	1.9	5.7	7.3	4.8	2.0	9.5	10.2	8.5	7.7	5.9	9.1	10.8	10.3	7.4	7.6	2.3	5.5	12.4	5.0	15.9	17.2	49.7	15.5	15.8	11.3	15.0	11.2	25.9	12.1	56.6	41.9	9.8	44.6	20.9	217.9	43.6	81.5	42.8	54.6	48.8	104.1	18.8	31.5	58.7	250.3	9.0	33.9	23.3	27.6	7.0	6.9	68.5	2.3	15.6	3.1	27.0	39.2	4.3	1.8	317.8	4.0	6.1	5.0	18.0	32.4	97.7	42.5	31.6	3.5	65.3	93.1	6.5	4.9	48.1	25.3	26.1	7.1	7.9	41.7	65.8
RBM23	"CAPERbeta, FLJ10482, RNPC4"	ENSG00000100461	"RNA binding motif protein 23"	Q86U06	14	22893206-22919184	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA004144	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Intermediate filaments"	Nucleoplasm	"HPA004144: AB_1079747"	"unprognostic (5.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-1)"	"prognostic favorable (8.06e-9)"	"unprognostic (4.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.81e-1)"	18.7	26.9	22.0	22.1	29.3	28.1	24.8	33.7	35.7	28.6	22.5	26.9	25.9	18.3	35.0	24.7	25.9	36.9	24.2	20.3	19.9	24.2	27.8	27.0	25.2	25.0	19.7	23.7	40.8	23.2	56.6	37.5	43.9	23.9	27.2	25.7	35.4	25.3	25.8	18.0	22.3	24.8	28.2	22.6	32.7	25.3	23.5	26.7	44.0	42.4	19.7	31.2	24.8	34.9	14.0	17.8	49.9	17.2	20.5	14.3	9.8	20.1	31.9	32.6	17.0	17.9	15.4	13.6	22.1	30.4	43.1	33.9	14.4	24.8	33.8	17.5	20.5	20.7	28.7	36.5	18.6	35.2	26.5	30.1	15.9	24.9	1.1	28.2	30.5	26.2	19.7	25.8	24.8	16.5	24.1	24.0	17.0	20.0	22.0	21.1	25.7	33.3	13.7	14.5	30.8	30.0	28.8	27.0	20.5	16.8	28.6	22.5	25.2	33.2	25.8	14.0	22.4	19.0	18.1	22.2	7.5	12.8	17.9	20.4	20.9	26.7	31.9	12.5	17.6	26.7	11.3	17.2	17.6	14.3	13.3	9.8	10.8	10.2	12.3	17.8	14.0	12.5	10.9	49.9	20.5	16.4	9.3	10.4	9.8	22.0	29.3	33.7	35.7	19.9	24.2	19.7	23.7	23.9	26.7	41.7	38.7	72.9	41.5	16.4	60.7	21.2	58.6	76.3	47.8	31.4	110.0	43.5	38.1	32.4	6.9	35.1	49.3	46.7	29.6	40.1	28.0	24.3	68.2	30.6	27.8	47.7	62.8	44.8	37.7	8.2	32.8	36.7	15.1	54.1	33.4	44.2	29.7	35.3	26.5	21.4	123.6	32.3	32.8	39.7	58.7	18.3	84.8	83.0	31.8	22.7
RGS14		ENSG00000169220	"Regulator of G protein signaling 14"	O43566	5	177357837-177372601	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.9;brain: 76.1"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 61.1;Proximal tubular cells: 68.0;Suprabasal keratinocytes: 100.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 76.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 40.7;HMC-1: 36.4;NB-4: 16.0;RPMI-8226: 21.0"	"Group enriched"	"Detected in many"	11	"amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5"	"Low region specificity"	"Detected in all"			"HPA046847, HPA061819"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments"		No	No			Nucleoplasm	"Vesicles, Plasma membrane, Intermediate filaments"	"HPA046847: AB_2679836, HPA061819: "	"unprognostic (6.05e-3)"	"unprognostic (1.65e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.95e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-2)"	1.9	1.5	7.7	12.5	76.1	17.5	1.3	0.4	8.8	1.7	2.6	1.9	0.6	5.1	1.3	1.4	3.2	6.6	3.4	0.7	17.1	1.9	2.1	6.9	4.3	15.5	2.5	3.6	0.8	1.5	0.1	0.9	1.0	0.8	1.2	0.5	0.7	5.2	1.8	1.6	3.5	5.7	1.2	0.7	12.8	3.7	0.7	4.4	24.2	4.3	1.7	12.9	4.9	1.6	9.2	12.2	43.9	12.3	6.5	20.7	12.4	1.9	0.4	0.7	0.4	0.0	0.0	1.2	0.0	0.0	0.1	0.2	1.2	3.8	4.8	2.7	0.0	0.4	3.9	0.0	1.2	0.0	40.7	0.1	7.5	0.1	1.5	0.2	5.8	36.4	0.6	0.3	0.2	0.2	0.0	0.2	5.5	1.3	9.8	0.0	0.1	7.8	16.0	0.6	1.9	1.0	3.6	0.0	21.0	0.4	0.1	0.1	0.7	0.0	0.1	3.0	0.0	1.3	9.2	0.3	0.0	0.7	0.0	3.5	5.2	2.5	2.1	0.6	11.0	0.9	18.6	12.3	43.9	20.5	11.4	20.7	9.2	19.1	18.7	12.2	8.0	16.0	14.3	43.0	6.5	11.6	5.4	18.2	12.4	7.7	76.1	0.4	8.8	17.1	1.9	2.5	3.6	0.8	4.4	6.0	4.1	20.7	25.0	61.1	0.4	1.6	40.8	14.7	4.5	10.4	2.0	3.2	26.6	10.5	0.5	6.0	7.5	0.0	14.4	8.2	5.3	12.3	24.3	55.7	21.0	0.0	4.6	7.4	13.7	0.8	2.6	16.9	20.3	0.0	5.3	8.0	12.8	14.4	2.1	68.0	1.9	0.0	5.1	0.0	15.1	100.6	2.7	40.0	3.3	13.7
RGS4	SCZD9	ENSG00000117152	"Regulator of G protein signaling 4"	P49798	1	163068775-163076802	"Disease related genes, Predicted intracellular proteins"		"Signal transduction inhibitor"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 88.0"	"Cell type enhanced"	"Detected in some"	25	"Early spermatids: 10.1;Intestinal endocrine cells: 49.4;Muller glia cells: 14.1;Smooth muscle cells: 10.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 91.6;LHCN-M2: 36.1;SH-SY5Y: 71.9;TIME: 146.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030802			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA030802: AB_10602295"	"unprognostic (1.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.02e-2)"	"unprognostic (6.84e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (8.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.97e-4)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.30e-2)"	2.9	20.9	9.1	2.1	45.3	0.5	1.4	1.1	88.0	4.0	1.7	1.0	0.0	2.9	4.8	1.4	6.3	4.9	11.2	4.7	13.9	10.1	1.5	2.6	2.1	2.3	12.1	36.2	1.1	2.7	1.2	6.2	1.3	16.0	3.3	1.8	1.0	0.9	3.9	0.7	0.6	1.6	3.0	1.9	1.5	3.7	2.1	2.1	0.0	1.5	0.2	0.7	2.8	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	3.5	18.5	0.0	12.5	13.6	1.8	4.8	0.0	0.0	0.0	5.5	8.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.0	0.0	19.7	2.4	91.6	19.1	0.0	0.0	0.0	36.1	0.0	0.0	0.0	1.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	71.9	0.0	0.0	0.0	0.7	0.0	0.0	146.6	14.9	0.7	2.9	20.7	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.1	45.3	1.1	78.8	13.9	10.1	12.1	36.2	16.0	2.1	0.0	0.0	0.0	0.8	0.2	0.2	0.5	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	10.1	0.5	0.0	0.0	0.2	0.0	1.7	0.5	0.0	0.0	0.4	0.0	49.4	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	14.1	4.1	0.0	0.0	0.0	1.6	0.0	10.3	0.0	0.2	0.3	0.1	0.0	0.0	0.1
RWDD4	"FAM28A, MGC10198, RWDD4A"	ENSG00000182552	"RWD domain containing 4"	Q6NW29	4	183639635-183659225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036501, HPA036502"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA036501: AB_2675159, HPA036502: AB_10670800"	"unprognostic (1.30e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.98e-1)"	"prognostic favorable (1.01e-6)"	"unprognostic (6.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (4.65e-2)"	11.0	37.4	8.3	9.3	8.2	8.5	14.8	10.0	7.5	10.0	11.6	8.1	10.6	7.6	9.7	12.1	16.0	9.7	11.6	15.7	7.8	9.1	17.6	13.3	10.3	9.9	8.4	6.1	28.6	17.9	7.1	28.4	10.3	8.1	12.2	8.5	8.9	25.6	13.6	30.7	8.2	11.2	10.4	8.4	11.4	9.5	12.3	7.7	10.6	17.1	17.7	10.5	13.2	13.7	7.4	8.5	11.8	9.7	11.4	9.9	6.4	13.3	7.8	12.0	14.7	19.3	20.5	9.1	16.9	13.5	21.4	13.6	5.0	17.6	20.2	4.0	13.8	10.3	6.3	16.6	15.8	22.6	13.4	7.4	14.6	9.2	12.8	13.7	22.4	11.1	13.3	16.5	11.7	13.1	16.6	16.0	15.9	13.9	26.4	22.3	5.6	22.9	18.9	8.0	5.1	10.2	16.0	9.3	12.8	20.9	6.5	11.5	16.2	15.9	18.7	14.6	9.6	9.4	13.6	11.6	9.0	4.4	9.6	13.0	8.9	6.6	6.9	16.9	16.6	12.7	6.0	6.1	11.8	8.6	8.2	8.4	7.4	7.8	8.1	8.0	5.2	7.4	7.7	5.3	11.4	9.7	8.5	9.9	6.4	8.3	8.2	10.0	7.5	7.8	9.1	8.4	6.1	8.1	7.7	20.8	15.0	21.6	28.9	29.9	17.0	9.4	28.1	29.4	20.5	17.4	5.9	22.5	63.0	27.5	5.6	26.2	14.0	0.0	67.9	34.3	27.8	53.7	35.7	29.7	32.4	9.5	20.8	19.0	31.4	7.3	68.4	22.4	54.0	30.7	25.4	27.0	45.6	10.5	66.4	98.2	21.6	19.4	33.3	39.5	54.4	31.0	22.7	26.1	24.3	39.9
SBF2	"CMT4B2, DENND7B, KIAA1766, MTMR13"	ENSG00000133812	"SET binding factor 2"	Q86WG5	11	9778667-10294207	"Disease related genes, Predicted intracellular proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050933	Uncertain		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA050933: AB_2681280"	"unprognostic (2.26e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.36e-2)"	"unprognostic (5.55e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.43e-1)"	"prognostic favorable (3.66e-5)"	"unprognostic (3.72e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.11e-2)"	26.2	12.7	19.8	8.9	22.5	6.1	17.9	26.7	17.4	23.6	15.6	18.4	13.2	9.8	19.1	14.2	16.9	15.3	14.9	13.7	16.3	12.3	20.8	13.8	13.8	8.7	14.6	12.0	26.8	8.0	33.9	23.2	20.5	13.7	16.8	15.3	15.6	14.7	17.7	8.8	13.2	11.1	22.0	16.1	12.4	13.3	15.3	19.1	7.8	24.0	9.1	9.2	20.2	25.5	0.6	1.0	3.9	3.9	0.9	0.6	0.5	6.7	6.1	9.6	6.8	12.9	17.2	49.3	5.3	9.6	6.3	8.9	4.0	8.3	2.6	2.8	9.3	9.2	4.5	5.7	4.3	11.0	2.7	4.1	1.0	4.4	5.4	5.2	2.4	3.6	8.7	5.8	3.3	12.3	9.6	10.2	5.6	2.2	2.5	7.4	2.0	3.5	0.7	4.1	6.1	6.1	3.3	6.7	3.4	5.6	6.1	3.2	7.1	7.3	10.2	4.5	5.2	3.0	1.7	11.1	11.3	5.6	11.2	4.3	0.9	1.9	3.7	8.4	1.2	7.9	0.0	1.9	0.1	0.2	1.8	0.6	0.3	0.2	0.4	1.0	0.6	0.3	0.1	3.9	0.9	3.9	0.4	0.2	0.5	19.8	22.5	26.7	17.4	16.3	12.3	14.6	12.0	13.7	19.1	41.7	103.3	8.8	32.8	22.7	31.5	23.8	15.3	38.8	31.8	15.7	70.7	11.6	3.3	11.0	12.7	38.3	13.8	0.0	7.5	10.5	31.5	47.0	19.8	14.7	16.3	35.0	42.1	51.0	51.2	6.2	47.2	31.9	28.7	15.4	17.1	13.0	10.9	21.8	25.5	9.8	76.6	25.8	28.8	16.8	16.8	26.8	11.6	34.6	17.2	43.4
SCN3B	HSA243396	ENSG00000166257	"Sodium voltage-gated channel beta subunit 3"	Q9NY72	11	123629187-123655244	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 70.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 15.3;Early spermatids: 12.8;Horizontal cells: 19.1;Late spermatids: 24.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 9.6;RH-30: 4.3;SCLC-21H: 9.5;SH-SY5Y: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041707			Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	Cytosol	"HPA041707: AB_2732493"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.13e-4)"	"unprognostic (3.93e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.29e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.34e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.16e-4)"	"unprognostic (4.01e-1)"	"unprognostic (1.89e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.43e-2)"	2.2	8.5	17.7	1.5	23.5	1.3	2.0	2.8	70.3	1.6	1.5	1.2	0.0	1.6	1.5	1.5	1.5	1.8	1.4	1.9	26.2	13.2	1.6	1.0	1.4	1.2	5.2	18.8	1.7	1.9	3.9	12.6	1.1	3.8	1.8	1.6	3.7	1.2	1.4	5.8	1.7	1.5	2.1	1.5	1.3	1.4	2.2	1.2	0.0	3.7	0.0	1.2	1.1	0.4	1.2	1.3	2.7	0.6	1.1	0.8	0.1	0.0	0.2	0.3	0.2	0.1	0.1	0.3	0.2	0.3	0.0	0.0	3.0	0.1	0.3	1.5	0.4	3.1	0.2	1.0	0.1	0.2	0.1	0.6	0.0	0.5	0.3	0.1	0.0	0.6	0.4	9.6	0.1	0.1	0.0	0.3	0.3	0.4	0.5	0.0	0.1	0.1	0.2	0.8	0.3	0.1	0.2	4.3	0.0	0.0	0.2	9.5	7.2	0.6	0.1	0.0	1.0	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.6	0.6	0.5	0.6	0.4	0.4	0.7	0.7	0.7	0.3	1.2	0.5	0.8	2.7	1.1	0.5	1.3	0.4	0.1	17.7	23.5	2.8	39.5	26.2	13.2	5.2	18.8	3.8	1.2	0.0	0.3	0.0	0.8	5.0	15.3	1.4	0.0	0.0	0.0	1.8	5.9	0.1	0.0	0.3	12.8	8.7	0.0	0.0	0.9	0.1	1.1	1.0	0.0	0.0	0.2	19.1	4.1	0.6	0.0	24.3	0.0	0.5	0.0	0.0	0.0	8.3	0.4	0.0	0.4	0.1	5.9	6.5	0.7	0.3	1.5	4.8	0.0	0.0	0.0	0.4
SEC62	"Dtrp1, HTP1, TLOC1"	ENSG00000008952	"SEC62 homolog, preprotein translocation factor"	Q99442	3	169966635-169998373	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014059, HPA061450"	Approved		Approved	"Endoplasmic reticulum,Intermediate filaments"		NA	NA			"Endoplasmic reticulum"	"Intermediate filaments"	"HPA014059: AB_1858029, HPA061450: AB_2684524"	"unprognostic (8.15e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.13e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-1)"	33.2	30.8	43.1	18.8	46.0	27.3	22.5	30.3	51.7	28.7	26.6	19.7	33.1	19.6	26.1	47.7	25.5	18.7	20.2	21.0	41.7	40.7	41.7	65.7	25.7	19.5	53.2	25.9	31.9	39.5	37.3	34.7	37.8	53.9	34.0	19.9	10.5	39.7	30.8	22.1	11.2	24.4	32.5	55.1	35.3	30.1	16.3	40.2	17.6	42.3	12.2	21.8	43.7	28.3	38.5	14.9	25.0	15.5	12.7	23.6	11.0	34.3	24.2	19.1	16.8	57.2	30.3	12.0	44.1	32.5	20.6	21.5	25.8	36.3	38.7	49.3	31.5	34.4	32.9	23.4	21.3	32.4	30.2	22.7	26.8	15.1	25.9	41.6	27.1	17.6	30.2	20.5	22.6	22.1	28.3	20.3	12.0	16.4	37.5	24.4	28.7	14.2	14.4	19.5	27.6	15.9	19.1	27.6	52.1	29.5	22.1	19.6	18.5	36.1	39.7	30.1	19.2	59.4	25.0	27.0	29.3	13.3	24.4	35.5	43.5	32.6	60.5	30.7	21.2	27.3	6.4	14.1	25.0	19.4	15.5	22.2	33.2	18.4	19.4	13.0	38.5	23.6	20.9	22.2	12.7	11.6	14.9	16.0	11.0	43.1	46.0	30.3	51.7	41.7	40.7	53.2	25.9	53.9	40.2	220.3	262.7	342.9	200.0	226.0	367.3	496.5	300.7	294.5	280.9	645.6	261.1	203.3	165.8	224.9	14.0	313.8	139.0	771.0	299.5	183.3	350.0	241.8	280.2	977.5	192.3	427.5	250.7	386.1	211.1	22.8	518.6	248.1	264.9	296.6	208.7	387.4	260.2	190.0	409.4	320.7	346.7	291.1	249.2	173.4	114.7	150.7	363.1	201.5	162.6	151.0
SEMA6A	"HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ"	ENSG00000092421	"Semaphorin 6A"	Q9H2E6	5	116443616-116574934	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.2"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 93.0;Horizontal cells: 130.3;Ito cells: 160.2;Syncytiotrophoblasts: 291.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 12.9;HAP1: 15.1;NTERA-2: 33.8;SuSa: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031264, HPA031265, HPA031267"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Intermediate filaments"		NA	NA		180000	Nucleoplasm	"Nuclear bodies, Intermediate filaments"	"HPA031264: , HPA031265: AB_10610423, HPA031267: "	"unprognostic (3.79e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.39e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-3)"	"unprognostic (7.32e-3)"	12.7	37.4	12.6	4.9	34.7	3.6	10.6	18.7	26.5	6.9	19.6	31.2	0.8	19.2	6.1	3.4	3.9	6.2	12.8	5.0	17.2	12.9	6.1	6.0	17.8	4.5	35.9	13.9	13.1	10.3	2.2	4.4	30.2	32.2	6.6	17.5	2.6	15.1	3.2	7.6	5.6	24.0	6.3	48.2	8.2	5.4	6.6	31.4	0.5	6.7	1.6	2.7	4.6	5.9	1.6	0.7	0.1	0.4	0.0	1.3	0.0	0.1	0.0	10.9	12.9	0.0	0.0	11.3	0.2	0.1	0.0	0.0	0.6	0.4	0.4	0.5	0.1	0.2	0.1	15.1	0.0	0.0	0.4	2.2	0.2	0.2	3.6	0.1	0.1	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	1.1	33.8	0.0	0.1	1.9	7.1	0.5	5.6	9.7	3.0	1.1	0.0	0.2	5.8	68.7	4.2	0.7	0.2	1.0	0.9	0.1	0.4	0.2	0.1	0.2	0.1	0.5	4.0	0.0	0.4	0.0	1.2	0.0	0.1	1.6	1.3	0.0	0.3	1.2	0.4	0.5	0.1	0.0	0.2	0.7	0.1	0.0	12.6	34.7	18.7	24.0	17.2	12.9	35.9	13.9	32.2	31.4	0.0	1.1	0.8	0.7	5.8	8.1	6.7	48.4	0.0	0.0	14.0	2.0	93.0	0.0	26.5	9.7	56.5	45.5	0.0	1.1	3.7	16.0	1.5	0.0	0.6	10.8	130.3	26.9	160.2	15.5	1.4	6.1	1.3	23.6	0.0	31.1	5.1	2.5	42.1	1.8	3.7	3.2	0.0	6.2	0.5	1.4	3.6	291.1	1.3	32.4	0.5
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780592-153789120	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 102.5"	"Group enriched"	"Detected in some"	15	"Basal keratinocytes: 102.6;Fibroblasts: 163.9;Melanocytes: 113.1;Smooth muscle cells: 47.4;Suprabasal keratinocytes: 92.6"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 53.5;ASC diff: 20.3;HSkMC: 33.5;NTERA-2: 74.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"	NA	NA			"Intermediate filaments"		"HPA002652: AB_2732394"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.39e-4)"	42.9	4.0	3.4	17.6	1.7	0.2	70.0	1.3	8.0	10.9	20.6	11.3	18.2	4.4	6.4	64.4	51.5	18.5	74.9	42.2	8.5	1.2	1.9	0.2	21.3	2.6	2.8	5.6	7.9	22.5	1.6	23.2	0.3	4.6	33.4	10.8	8.4	23.9	19.5	2.5	26.1	13.7	72.3	5.4	0.3	11.4	13.2	5.0	0.3	29.1	29.4	6.8	102.5	37.4	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	53.5	0.0	20.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.4	1.7	1.3	5.7	8.5	1.2	2.8	5.6	4.6	5.0	3.0	1.1	0.0	0.6	102.6	0.0	0.3	0.0	5.3	3.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	163.9	0.3	1.1	0.0	3.3	0.0	0.0	0.0	0.0	0.2	3.7	2.2	113.1	1.0	0.0	0.0	0.2	0.0	6.7	0.0	0.0	0.0	47.4	0.0	0.2	92.6	0.1	0.0	0.0	1.0
SH3RF1	"KIAA1494, POSH, RNF142, SH3MD2"	ENSG00000154447	"SH3 domain containing ring finger 1"	Q7Z6J0	4	169094256-169271105	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.9;myeloid DC: 3.4;non-classical monocyte: 8.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 3.4;monocytes: 8.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074783	Approved		Supported	"Vesicles,Intermediate filaments"		No	No			Vesicles	"Intermediate filaments"	"HPA074783: AB_2732268"	"unprognostic (4.14e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (9.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.88e-2)"	"prognostic favorable (5.51e-8)"	"unprognostic (4.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.77e-1)"	15.2	4.8	13.8	7.2	11.8	3.7	11.1	2.5	12.7	7.5	17.2	15.9	10.8	15.7	6.8	7.2	7.1	6.9	19.7	7.8	17.8	9.3	14.6	9.6	11.3	3.7	13.0	10.9	11.9	12.0	5.2	7.8	8.6	10.3	17.2	16.0	10.7	20.9	10.7	16.2	6.8	17.2	8.8	11.7	4.5	27.6	7.0	11.3	0.9	23.1	7.6	5.5	9.4	6.3	0.4	3.4	0.0	8.5	0.3	0.0	0.7	7.3	6.1	5.6	16.1	6.0	7.6	7.2	20.5	9.9	15.2	7.1	6.1	8.9	0.0	1.0	21.2	4.1	4.9	4.5	8.0	16.9	0.0	2.6	4.3	14.0	3.2	13.7	1.5	0.1	4.5	4.4	13.0	10.4	19.4	9.4	1.6	0.0	0.0	14.1	3.0	1.5	1.4	2.8	9.5	5.3	2.2	1.8	0.3	7.0	5.8	4.2	5.1	5.1	8.0	2.0	2.5	2.6	0.6	8.4	7.2	5.6	12.0	7.2	0.5	0.0	0.0	8.2	1.5	8.6	0.0	1.4	0.0	0.0	5.9	0.0	0.4	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.3	8.5	0.2	0.0	0.7	13.8	11.8	2.5	12.7	17.8	9.3	13.0	10.9	10.3	11.3	59.6	33.6	6.2	32.4	30.5	2.1	5.2	45.9	34.8	45.5	26.2	0.0	9.8	10.0	35.2	4.4	11.2	52.9	0.0	55.1	19.0	14.9	71.6	10.3	7.6	6.5	0.0	30.1	8.6	6.5	3.1	11.2	7.5	3.3	1.8	26.8	11.3	54.5	27.9	11.3	13.3	0.9	64.7	42.1	2.3	7.5	11.0	11.0	0.0	28.8	55.9
SIK2	"DKFZp434K1115, KIAA0781, LOH11CR1I, QIK, SNF1LK2"	ENSG00000170145	"Salt inducible kinase 2"	Q9H0K1	11	111602391-111730853	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 62.8;Rod photoreceptor cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016026, HPA071049"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles,Intermediate filaments,Cytosol"		NA	NA			"Nucleoplasm, Vesicles"	"Nuclear speckles, Intermediate filaments, Cytosol"	"HPA016026: AB_1857321, HPA071049: "	"unprognostic (2.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.81e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.72e-3)"	"unprognostic (9.27e-2)"	"prognostic favorable (1.17e-9)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.82e-3)"	"unprognostic (2.13e-2)"	32.8	10.7	10.1	6.6	17.2	4.0	22.5	10.6	17.3	10.0	9.9	15.1	5.2	7.7	9.5	7.0	7.9	9.7	12.7	14.5	10.5	10.3	14.6	24.4	13.6	5.4	9.7	9.9	16.4	37.8	22.0	28.6	7.5	11.9	8.4	8.3	14.9	15.4	8.6	35.1	8.7	7.7	8.7	9.6	5.8	19.6	4.2	13.0	4.4	11.1	7.9	5.8	8.6	10.0	2.2	2.7	2.8	3.6	2.2	3.5	2.1	5.9	4.0	7.0	7.5	34.8	10.3	4.1	5.2	7.5	4.0	4.6	13.4	6.4	4.7	7.3	6.1	4.7	8.4	5.4	3.9	5.2	3.5	2.3	5.1	3.5	6.6	7.5	4.9	3.3	10.0	5.8	5.8	7.6	8.0	4.7	4.7	4.7	6.9	6.2	2.8	5.1	4.5	2.4	5.0	3.9	6.9	7.4	5.6	8.9	5.4	3.3	7.7	7.7	3.1	3.1	6.6	7.7	4.0	6.5	8.8	5.3	5.6	7.1	2.0	1.5	9.9	2.8	7.0	5.9	1.1	3.3	2.8	3.5	3.6	1.9	2.0	2.5	2.5	2.7	2.2	1.4	2.0	1.4	2.2	2.9	1.5	2.4	2.1	10.1	17.2	10.6	16.4	10.5	10.3	9.7	9.9	11.9	13.0	17.9	32.3	9.1	6.7	13.1	14.4	16.6	22.9	13.4	11.4	15.7	62.8	3.5	5.0	7.1	12.4	18.0	9.5	46.7	6.7	4.1	14.4	5.8	9.2	34.2	4.8	30.2	17.3	9.8	12.4	9.7	10.6	8.6	18.6	2.8	10.2	13.3	9.2	8.6	13.8	20.7	60.3	0.0	13.7	3.2	5.9	10.5	4.3	7.4	9.9	6.5
SLC10A3	"DXS253E, P3"	ENSG00000126903	"Solute carrier family 10 member 3"	P09131	X	154487306-154490690	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	9	"basophil: 51.2"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 51.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021656	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA021656: AB_1856955"	"unprognostic (1.60e-1)"	"prognostic favorable (4.53e-4)"	"prognostic unfavorable (4.15e-5)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (9.97e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.28e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (3.42e-1)"	"unprognostic (2.52e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.99e-2)"	14.5	14.6	3.6	11.6	5.1	22.5	13.4	5.0	8.1	21.5	15.3	8.1	16.3	10.6	25.0	36.1	22.8	15.4	21.1	19.5	6.0	4.6	17.7	6.7	16.3	14.0	5.8	6.2	32.3	25.7	6.1	12.7	40.1	7.6	23.7	6.4	12.4	11.7	13.3	13.7	26.2	13.6	20.1	5.3	13.1	12.6	11.6	4.7	12.6	15.7	23.3	18.6	23.3	18.3	1.6	2.7	51.2	1.7	2.2	3.8	1.8	24.9	10.7	2.9	14.6	10.1	11.0	19.0	18.6	11.4	12.6	12.7	9.5	12.1	19.0	35.4	17.8	16.8	21.5	9.4	9.5	3.4	12.3	4.4	5.9	14.1	7.5	18.6	7.0	9.6	13.7	10.9	11.7	6.3	11.3	8.6	3.3	6.6	18.7	8.2	33.1	3.8	6.3	2.2	12.2	20.8	6.1	7.7	14.4	9.5	9.3	2.6	4.7	11.7	21.3	4.9	3.5	6.8	5.6	11.3	15.0	9.4	34.8	23.5	13.4	12.9	19.6	16.0	14.7	7.7	51.2	1.3	5.6	3.8	1.7	2.9	1.6	2.6	2.8	1.1	1.6	1.9	1.8	1.7	2.2	1.5	2.7	1.8	1.8	3.6	5.1	5.0	8.1	6.0	4.6	5.8	6.2	7.6	4.7	3.0	6.5	11.7	23.8	20.0	2.0	3.6	7.6	4.0	3.4	17.4	5.9	42.9	6.6	15.3	2.4	14.3	14.4	0.0	17.0	52.6	23.3	12.1	12.7	1.6	17.2	3.2	9.8	18.4	7.8	1.0	25.0	10.5	3.3	16.2	14.0	2.3	15.9	15.3	12.4	7.7	1.6	6.5	22.6	1.2	2.7	24.3	86.2	17.5	10.6	24.7
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 70.9"	"Cell type enhanced"	"Detected in some"	9	"Leydig cells: 4.0;Melanocytes: 5.0;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.1;RT4: 4.5;SiHa: 6.5;T-47d: 7.8;U-266/70: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075017	Enhanced		Approved	"Intermediate filaments,Focal adhesion sites"		No	NA			"Focal adhesion sites"	"Intermediate filaments"	"HPA075017: AB_2732276"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	1.6	2.6	1.9	0.8	5.1	1.2	0.8	0.8	3.3	0.8	0.8	0.8	0.8	0.5	1.3	0.8	1.1	1.2	2.7	2.9	2.7	2.9	0.8	0.8	0.8	0.9	2.8	0.8	0.8	2.1	0.0	2.6	0.8	1.3	4.0	0.0	70.9	10.0	0.8	1.9	4.2	0.8	0.8	3.7	1.8	2.3	2.0	0.8	0.8	0.9	0.8	0.8	1.6	0.8	0.0	0.0	0.0	0.0	0.5	0.6	0.0	1.4	0.7	1.2	0.2	0.0	0.0	6.1	0.5	0.0	0.0	0.0	1.3	3.5	0.4	1.7	0.0	0.1	0.8	0.0	0.0	0.0	0.0	1.9	0.3	1.0	0.1	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	1.6	0.0	4.0	0.0	0.0	1.4	0.1	0.1	2.0	0.0	0.0	0.0	4.5	2.0	0.3	6.5	0.3	1.0	0.6	7.8	0.2	0.0	0.0	3.6	0.3	0.0	11.5	1.6	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	5.1	0.8	1.2	2.7	2.9	2.8	0.8	1.3	0.8	0.0	0.0	0.0	0.5	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.8	0.0	0.0	1.3	0.3	1.6	4.0	0.0	5.0	0.0	0.0	0.9	0.2	0.0	2.1	0.0	0.5	0.0	0.9	0.9	4.1	0.6	0.0	0.0	0.0	0.1
SLC25A48	"FLJ44862, HDMCP"	ENSG00000145832	"Solute carrier family 25 member 48"	Q6ZT89	5	135579202-135889770	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 22.4;kidney: 11.7;skeletal muscle: 12.8"	"Cell type enhanced"	"Detected in some"	26	"Distal tubular cells: 8.3;Enterocytes: 4.5;Proximal tubular cells: 27.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.0;HEK 293: 4.2;HEL: 4.1;RPMI-8226: 3.7;SCLC-21H: 3.9;U-2 OS: 5.1"									HPA014674	Uncertain		Approved	"Intermediate filaments,Actin filaments"		NA	NA			"Intermediate filaments"	"Actin filaments"	"HPA014674: AB_1859512"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	1.0	0.8	10.8	1.0	13.0	0.9	1.6	1.3	18.8	0.9	2.0	10.3	0.0	2.0	1.0	0.7	1.3	0.7	0.9	0.9	11.9	8.1	11.7	1.3	0.7	1.0	22.4	4.1	0.7	3.3	0.8	0.4	1.1	5.6	1.3	1.8	0.0	3.5	0.6	12.8	3.2	4.1	0.7	5.4	0.9	0.8	1.2	15.2	0.0	1.0	0.5	0.7	0.8	0.3	0.6	1.0	2.1	1.0	0.8	0.7	0.2	0.4	0.3	0.1	0.3	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.4	0.7	0.1	0.4	0.0	0.1	0.5	5.0	0.0	0.0	0.7	4.2	4.1	0.6	0.8	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.1	0.0	0.0	1.7	0.8	0.0	0.1	0.1	0.0	3.7	0.3	0.6	3.9	0.4	0.7	0.5	1.0	1.3	1.8	0.6	0.5	0.4	5.1	0.3	0.2	1.7	0.5	0.2	0.4	0.4	0.3	2.1	0.3	0.7	0.5	0.5	0.6	0.5	0.5	0.4	0.3	0.6	0.6	0.7	1.5	0.8	1.0	1.0	0.5	0.2	10.8	13.0	1.3	9.9	11.9	8.1	22.4	4.1	5.6	15.2	0.0	0.0	0.0	0.0	2.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.8	0.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.2	0.1	2.9	0.0	27.1	0.1	0.0	0.0	0.1	0.5	0.6	0.1	0.0	1.6	0.1
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150942-113164137	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 60.2;salivary gland: 125.5"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 80.2;Kupffer cells: 82.1;Macrophages: 93.6;monocytes: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2"	"Group enriched"	"Detected in many"	36	"dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.2;hTCEpi: 33.7;hTERT-HME1: 23.1;LHCN-M2: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"		NA	NA			"Nuclear speckles"	"Plasma membrane, Intermediate filaments"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	15.7	8.0	10.0	8.1	20.5	7.0	8.5	3.2	15.0	3.0	8.4	45.1	27.1	5.2	2.0	6.0	4.6	3.0	4.5	3.4	18.2	9.4	9.8	11.2	10.0	6.2	34.3	10.5	2.8	7.8	17.9	1.2	10.2	22.3	2.1	4.4	1.0	125.5	21.8	6.7	18.5	9.9	3.8	48.5	14.1	4.5	5.4	26.2	1.2	2.8	2.9	5.8	3.9	4.1	0.3	21.2	54.5	60.2	0.2	1.2	13.4	5.5	2.5	1.4	2.0	22.2	9.1	4.8	4.2	5.4	5.1	4.9	1.8	1.7	0.3	0.8	3.5	8.3	20.6	2.0	12.0	4.8	2.8	0.8	0.3	1.2	2.9	8.5	2.2	1.2	10.2	33.7	11.9	23.1	2.7	2.7	2.7	1.6	3.0	26.6	5.3	2.1	1.3	0.7	2.8	2.3	0.4	20.1	0.4	1.7	3.4	1.3	2.2	5.8	17.8	1.7	1.2	6.4	2.0	2.5	2.8	1.9	9.2	3.6	1.9	3.9	0.2	8.8	2.9	2.8	0.8	36.6	3.6	0.9	50.5	1.2	0.2	1.0	1.0	21.2	0.3	0.8	0.8	54.5	0.2	60.2	0.5	0.6	13.4	10.0	20.5	3.2	15.0	18.2	9.4	34.3	10.5	22.3	26.2	8.9	8.6	18.0	5.3	33.0	6.9	0.4	2.5	10.7	5.7	1.8	33.4	80.2	3.3	10.7	2.3	6.7	17.4	0.0	6.6	5.8	13.3	7.9	0.0	18.7	55.9	6.4	3.4	17.2	82.1	2.0	14.7	93.6	0.0	89.2	3.2	8.2	13.8	7.0	8.9	17.4	9.1	19.4	8.9	30.6	5.1	33.5	36.0	8.3	3.5	4.2
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"brain: 45.1"	"Group enriched"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Club cells: 5.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Group enriched"	"Detected in some"	13	"basal ganglia: 13.8;pons and medulla: 45.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"RT4: 8.9;SCLC-21H: 2.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 26.3"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"		NA	NA			"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.3	2.4	0.1	1.6	13.8	0.0	0.3	0.1	0.4	3.3	5.2	0.1	0.3	2.3	1.6	0.7	1.0	0.2	0.5	1.2	0.2	2.2	0.9	0.2	0.9	0.0	0.3	0.5	0.8	0.5	0.0	0.1	0.0	45.1	0.8	2.5	1.0	0.9	4.2	0.1	0.1	2.5	3.1	10.0	0.1	1.7	0.3	0.8	0.0	4.0	0.3	0.1	4.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	0.1	0.4	0.2	2.2	0.3	0.5	45.1	0.8	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3
SMG7	"C1orf16, EST1C, KIAA0250, SGA56M, SMG-7"	ENSG00000116698	"SMG7, nonsense mediated mRNA decay factor"	Q92540	1	183472216-183598246	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029350	Supported		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA029350: AB_10603031"	"unprognostic (6.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"	14.6	14.3	20.7	17.1	25.3	30.9	17.6	35.8	29.3	17.6	18.1	19.9	6.6	16.8	16.6	13.6	19.1	22.1	12.9	20.0	17.8	14.8	18.2	18.7	15.6	19.7	16.0	23.1	22.7	18.7	25.9	20.2	18.7	15.9	15.1	20.4	15.9	17.2	14.5	19.2	20.5	17.8	15.2	14.4	18.9	18.3	52.1	15.1	31.6	19.9	12.7	23.9	14.5	22.3	9.3	11.7	11.2	9.6	9.5	10.3	8.0	21.5	13.1	19.0	14.8	13.0	12.3	31.7	13.3	24.5	14.8	11.3	19.4	16.9	30.4	15.3	16.4	13.5	23.4	25.5	19.7	17.6	13.5	11.2	24.6	14.2	15.7	13.2	32.1	15.7	11.2	18.1	20.3	47.1	12.1	16.2	16.9	30.4	21.5	15.3	21.8	22.5	14.2	32.9	25.8	7.5	14.3	21.3	23.7	11.4	20.2	25.6	20.0	20.5	29.1	15.8	33.9	29.0	13.1	15.4	16.8	17.5	16.6	18.8	23.6	27.6	25.2	13.7	18.2	17.9	3.1	9.3	9.5	9.7	9.6	8.9	9.3	8.8	9.5	10.7	8.5	9.9	10.3	11.2	9.5	5.0	11.7	7.8	8.0	20.7	25.3	35.8	29.3	17.8	14.8	16.0	23.1	15.9	15.1	20.8	19.4	14.9	8.8	24.0	22.5	27.4	20.4	21.4	19.4	26.2	29.5	9.9	8.3	11.4	52.6	24.5	30.7	0.0	13.5	13.1	10.8	13.7	20.9	41.4	11.4	28.6	33.1	24.5	36.2	38.5	14.1	24.4	10.1	4.6	20.4	9.3	13.7	20.3	11.7	10.6	18.0	38.8	16.5	37.0	19.6	23.5	9.0	15.3	16.3	17.0
SMYD2	"HSKM-B, KMT3C, ZMYND14"	ENSG00000143499	"SET and MYND domain containing 2"	Q9NRG4	1	214281102-214337131	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 75.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 109.6;Cytotrophoblasts: 142.7;Early spermatids: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029023	Uncertain		Approved	"Intermediate filaments,Mitochondria,Cytosol"		NA	NA			Cytosol	"Intermediate filaments, Mitochondria"	"HPA029023: AB_10601605"	"unprognostic (8.53e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (5.98e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.65e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.65e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.37e-2)"	5.9	5.7	8.8	5.6	7.3	2.7	10.0	5.0	23.9	4.9	4.7	2.1	3.1	4.8	3.8	6.7	7.3	10.4	4.5	75.7	7.0	8.4	7.7	9.7	8.1	8.0	5.3	10.0	4.7	7.8	2.9	7.5	10.6	6.9	4.6	5.8	3.1	6.2	3.0	29.5	4.3	4.7	3.8	4.7	6.2	6.2	8.9	2.2	8.0	7.8	5.1	5.6	5.2	4.0	9.3	5.5	8.1	5.9	17.6	14.5	7.3	24.5	7.1	9.7	6.8	10.0	17.5	41.3	13.9	11.5	17.6	20.0	28.0	21.0	12.7	14.3	15.7	9.6	11.6	9.2	25.8	17.1	10.6	10.7	4.1	12.0	22.3	9.0	17.8	2.9	18.7	14.6	12.2	9.7	12.2	12.7	12.2	12.9	3.2	15.7	12.8	12.4	11.2	8.7	14.4	9.7	7.7	23.5	10.8	17.4	18.0	9.6	22.4	10.8	38.9	28.6	23.3	30.3	11.9	14.6	13.7	20.2	7.5	21.5	13.1	4.9	14.6	17.8	14.2	15.6	6.7	5.9	8.1	9.5	3.2	11.2	9.3	14.5	12.7	5.5	4.8	12.7	11.6	0.6	17.6	1.2	3.8	14.5	7.3	8.8	7.3	5.0	23.9	7.0	8.4	5.3	10.0	6.9	2.2	17.9	11.9	11.2	14.0	18.3	3.8	109.6	22.9	48.2	12.5	3.5	0.0	142.7	26.6	32.4	113.6	10.8	12.7	0.0	17.4	93.2	12.2	8.9	3.5	15.5	33.9	14.3	4.1	22.1	17.4	93.5	10.9	9.9	15.1	10.8	15.2	15.2	22.5	10.5	3.5	27.8	4.6	12.9	15.7	15.2	43.7	15.7	71.9	12.8	20.8	7.6
SPIRE2	"KIAA1832, spir-2"	ENSG00000204991	"Spire type actin nucleation factor 2"	Q8WWL2	16	89818179-89871319	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 40.6"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 40.0;Mucus-secreting cells: 37.2;Paneth cells: 34.2;Syncytiotrophoblasts: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 21.5;T-47d: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041413, HPA049415"	Uncertain		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA			Nucleoplasm	"Vesicles, Intermediate filaments"	"HPA041413: AB_2677464, HPA049415: AB_2680755"	"unprognostic (2.92e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.07e-3)"	"unprognostic (6.96e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (9.77e-5)"	"unprognostic (2.10e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.95e-3)"	"unprognostic (7.21e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.59e-2)"	1.5	2.1	7.2	3.9	9.3	2.2	1.7	19.5	11.2	2.1	14.8	2.1	5.9	10.9	2.5	3.2	2.5	9.1	7.6	0.8	6.2	7.8	1.9	4.0	3.2	1.0	5.5	6.1	1.6	3.0	8.4	18.4	40.6	7.4	3.5	11.7	2.7	2.2	5.0	1.2	2.0	12.6	1.9	2.5	1.5	20.2	3.8	1.4	0.0	5.0	0.9	1.3	6.4	4.9	2.1	1.6	5.5	1.4	1.7	1.2	0.6	0.2	6.2	3.9	3.3	1.1	0.7	13.2	2.1	1.2	2.9	1.2	2.4	6.6	4.1	0.9	0.6	3.1	6.6	1.7	0.2	0.9	1.6	7.6	0.8	5.1	6.3	1.0	0.2	1.4	1.4	1.5	0.9	0.8	0.3	0.1	0.3	6.3	1.2	0.8	9.2	0.1	1.4	4.3	21.5	3.8	3.1	1.4	0.9	1.5	6.3	10.3	5.3	8.6	3.8	3.7	3.4	14.2	2.2	0.3	1.7	3.7	2.4	1.8	0.5	2.6	0.4	2.6	1.5	3.5	4.6	1.4	0.9	1.1	0.7	0.8	1.2	0.9	0.7	0.3	2.1	1.2	1.2	5.5	1.7	1.3	1.6	0.5	0.6	7.2	9.3	19.5	11.2	6.2	7.8	5.5	6.1	7.4	1.4	6.0	3.7	0.8	3.6	0.8	11.1	2.0	7.6	5.3	1.2	12.2	3.9	11.0	3.3	1.2	2.4	0.5	40.0	0.0	0.3	2.8	1.3	4.5	0.0	1.8	2.2	22.3	15.1	0.0	1.8	1.7	0.9	1.1	0.0	0.0	37.2	2.4	1.0	34.2	1.8	0.8	10.1	0.0	1.0	4.6	8.4	0.5	58.9	0.8	30.5	25.1
SRMS	"C20orf148, dJ697K14.1, PTK70, SRM"	ENSG00000125508	"Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites"	Q9H3Y6	20	63540810-63547504	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 10.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.5;MCF7: 4.7;OE19: 7.0;RT4: 9.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB044668, CAB044669, HPA073987"	Uncertain		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA			"Intermediate filaments"	"Actin filaments, Cytosol"	"CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650"	"unprognostic (2.26e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.75e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.54e-3)"	0.3	0.0	0.3	0.5	0.3	0.0	1.1	1.1	0.3	0.3	1.8	0.3	0.3	0.4	0.3	10.2	0.4	0.0	0.3	0.3	0.3	0.0	0.9	0.3	0.3	0.3	0.3	0.3	0.3	2.7	0.0	0.3	0.3	0.3	2.2	0.0	0.3	2.5	0.3	0.3	1.7	0.8	0.3	0.3	2.5	4.2	0.9	0.3	0.3	0.3	0.3	0.8	1.5	0.3	1.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	5.5	0.2	2.2	0.0	0.0	2.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.2	0.0	7.0	0.8	0.0	0.2	0.0	0.0	9.7	0.8	0.9	0.3	2.0	0.4	0.0	2.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	1.1	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SRRM3	FLJ37078	ENSG00000177679	"Serine/arginine repetitive matrix 3"		7	76201900-76287288	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"brain: 43.2"	"Group enriched"	"Detected in many"	13	"Bipolar cells: 127.8;Cone photoreceptor cells: 451.6;Horizontal cells: 162.1;Rod photoreceptor cells: 475.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SCLC-21H: 14.4;SH-SY5Y: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019337			Approved	"Plasma membrane,Intermediate filaments,Microtubules"		NA	NA			"Plasma membrane"	"Intermediate filaments, Microtubules"	"HPA019337: AB_1848909"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.15e-2)"	0.6	6.2	8.1	0.7	18.1	0.4	0.4	43.2	14.6	0.4	0.6	0.0	0.0	0.9	0.7	1.1	0.5	0.5	0.5	0.5	5.1		0.5	0.4	0.5	0.4	0.0	10.9	0.6	0.5	0.5	4.4	0.4	10.0	0.5	0.7	1.8	0.6	0.5	0.6	0.5	0.6	0.5	0.6	0.4	1.6	2.9	2.9	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.2	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	10.6	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0											0.0	0.0	0.0	5.1	1.8	127.8	6.9	0.0	0.0	0.0	0.0	451.6	0.3	0.0	1.4	18.9	0.0	0.0	0.0	2.1	7.0	2.7	1.2	0.0	0.0	0.4	162.1	11.6	0.6	0.0	23.9	2.0	0.0	3.3	0.0	0.0	14.5	1.2	0.0	2.1	0.3	475.2	0.0	1.4	5.4	2.6	1.0	1.8	0.0	0.0	4.7
STK3	"KRS1, MST2"	ENSG00000104375	"Serine/threonine kinase 3"	Q13188	8	98401403-98942827	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 118.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.3;granulocytes: 9.0;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"A-431: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007120, CAB025316"	Uncertain		Approved	"Intermediate filaments,Rods & Rings"		NA	NA			"Intermediate filaments, Rods & Rings"		"CAB025316: , HPA007120: AB_10601664"	"unprognostic (7.88e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-3)"	"unprognostic (9.68e-3)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (6.71e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (9.21e-5)"	"unprognostic (9.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.72e-2)"	16.5	16.6	6.5	8.1	12.4	2.5	20.5	2.6	10.6	17.2	13.1	10.5	14.2	4.6	22.2	13.1	9.0	16.0	12.6	10.0	7.4	4.1	14.7	12.0	16.2	10.8	12.8	3.6	22.8	10.7	15.1	18.9	53.1	9.9	15.0	6.0	8.2	10.8	16.4	11.6	10.0	10.8	23.5	12.9	8.2	9.5	10.1	11.4	3.4	10.6	7.9	5.9	16.4	24.3	1.9	8.3	9.0	8.7	1.8	1.8	2.9	37.3	7.0	7.5	9.8	24.2	12.1	7.5	13.0	11.7	12.2	10.6	5.2	15.9	0.0	11.4	12.9	6.4	15.1	5.2	11.2	19.7	9.0	6.6	10.0	3.5	3.5	8.3	3.3	8.7	8.0	19.4	6.2	17.0	8.0	5.2	5.9	4.2	5.4	8.8	4.7	8.3	4.0	2.2	25.8	2.7	7.4	6.4	3.2	13.8	4.7	1.9	4.3	8.3	9.6	8.0	10.0	7.9	5.4	3.9	8.2	5.2	12.4	7.2	4.3	6.5	2.7	7.4	4.2	13.0	2.1	8.6	4.5	1.3	8.7	1.4	1.9	0.8	1.8	8.3	1.3	1.1	0.7	9.0	1.8	5.4	3.4	0.1	2.9	6.5	12.4	2.6	10.6	7.4	4.1	12.8	3.6	9.9	11.4	35.7	32.0	4.7	38.6	38.8	6.0	15.1	22.9	33.5	42.1	27.9	13.7	36.5	19.9	17.3	118.9	30.2	17.6	0.0	16.5	49.2	41.3	37.6	16.2	18.4	16.1	9.5	8.7	22.1	14.6	63.7	84.3	20.2	23.6	7.2	7.6	15.1	19.7	9.5	69.6	20.3	14.2	38.8	39.6	17.0	11.9	35.4	54.1	8.2	9.3	31.1
STX19	MGC21382	ENSG00000178750	"Syntaxin 19"	Q8N4C7	3	94014369-94028610	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 24.1;Enterocytes: 18.8;Mucus-secreting cells: 26.4;Paneth cells: 34.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.5"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.6;HaCaT: 2.2;hTCEpi: 7.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA030604	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	Cytosol	"HPA030604: AB_10601268"	"unprognostic (7.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.32e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.87e-3)"	0.4	0.2	0.3	7.0	0.4	0.0	4.0	1.8	3.5	3.9	11.7	0.1	1.5	5.7	0.5	13.6	12.8	0.8	2.3	0.3	0.5	0.3	1.0	0.4	7.1	0.1	0.3	0.7	0.5	7.7	7.1	0.5	0.7	0.1	4.3	10.6	0.1	9.8	3.2	0.2	6.9	20.9	0.1	0.4	1.0	6.0	0.4	0.1	0.4	0.4	5.0	1.5	0.7	4.1	1.2	0.0	0.0	0.3	0.0	0.7	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	10.6	0.1	0.1	0.0	0.2	2.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.1	7.3	0.0	0.8	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.5	0.1	0.1	0.5	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.4	0.0	1.2	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.3	0.5	1.2	0.7	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.4	1.8	3.5	0.5	0.3	0.3	0.7	0.1	0.1	14.9	12.8	0.0	2.2	1.4	3.5	0.0	0.0	24.1	7.9	0.0	11.8	0.1	1.7	3.2	1.1	0.0	18.8	0.0	7.3	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.4	6.7	34.8	0.7	0.0	16.1	0.0	0.3	0.2	0.0	1.6	0.2	0.0	13.9	1.0
SUSD6	KIAA0247	ENSG00000100647	"Sushi domain containing 6"	Q92537	14	69611596-69715142	"Predicted membrane proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030464	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA030464: AB_10601128"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.70e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.10e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-1)"	25.4	17.4	9.2	26.0	11.9	40.2	19.5	36.4	12.3	12.1	25.0	15.5	14.8	17.2	13.0	31.0	27.0	16.1	19.6	13.2	11.4	8.4	16.7	11.6	30.9	25.3	15.1	8.2	13.4	20.9	13.7	14.6	14.1	13.9	16.0	13.4	14.6	26.6	17.5	10.6	22.5	36.7	14.0	14.1	30.9	17.3	9.1	12.9	12.7	23.4	14.8	27.4	16.4	15.3	4.1	5.3	23.1	9.1	2.9	4.2	5.0	10.8	2.8	4.1	3.7	8.4	6.2	7.5	6.2	13.1	3.5	3.4	3.3	9.7	12.8	7.0	7.7	2.8	15.3	2.3	12.7	3.3	21.8	1.7	10.4	2.2	5.5	13.6	1.7	27.0	9.9	12.7	5.9	11.1	3.8	7.2	4.0	3.1	11.4	4.9	5.3	2.5	4.5	0.8	6.4	2.9	4.3	3.6	5.1	6.8	5.6	1.7	2.8	5.1	14.8	2.2	3.1	6.0	4.7	11.1	8.2	4.9	5.1	2.5	8.0	1.7	9.1	5.3	5.8	4.3	8.9	7.5	8.3	4.1	7.3	4.2	3.9	3.6	2.5	5.3	4.1	3.5	2.5	23.1	2.9	9.1	3.0	3.2	5.0	9.2	11.9	36.4	12.3	11.4	8.4	15.1	8.2	13.9	12.9	11.9	28.8	5.7	25.4	0.0	16.6	11.8	35.7	20.1	20.5	17.4	19.6	3.8	6.6	22.7	0.6	24.8	36.2	23.3	21.3	1.5	7.9	43.6	8.1	12.8	21.0	14.3	7.0	19.6	57.1	1.5	4.9	22.6	0.0	2.8	14.9	3.8	31.1	21.2	6.3	13.3	21.3	25.8	14.4	4.4	14.6	0.0	7.7	13.8	7.8	41.2
SYNE2	"DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2"	ENSG00000054654	"Spectrin repeat containing nuclear envelope protein 2"	Q8WXH0	14	63852983-64226433	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding	"Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 111.4"	"Cell type enhanced"	"Detected in many"	7	"Rod photoreceptor cells: 579.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"cerebellum: 15.8;pons and medulla: 16.3"	"Cell type enhanced"	"Detected in many"		"eosinophil: 30.3"	"Group enriched"	"Detected in many"	10	"granulocytes: 30.3;T-cells: 16.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 44.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003435, HPA050204"	Enhanced		Approved	"Nuclear membrane,Intermediate filaments"		No	Yes			"Nuclear membrane, Intermediate filaments"		"HPA003435: AB_1080162, HPA050204: AB_2681051"	"unprognostic (1.93e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.24e-1)"	"prognostic favorable (3.56e-9)"	"unprognostic (5.05e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.80e-2)"	30.8	4.5	2.3	18.0	2.8	5.5	29.7	15.8	3.3	16.1	13.4	1.9	7.7	3.6	18.8	13.6	17.2	7.1	8.6	27.3	2.3	2.4	35.6	13.0	15.2	11.0	2.7	2.1	22.8	22.4	60.1	17.6	14.1	16.3	13.7	4.8	13.0	9.8	9.2	111.4	24.1	10.6	10.2	2.3	16.0	6.9	14.3	1.9	16.9	30.9	29.7	15.8	11.1	26.4	2.3	1.1	30.3	0.1	1.5	16.3	1.3	17.7	6.0	8.9	2.8	8.9	2.6	11.8	1.2	1.2	2.0	3.6	2.0	3.7	44.5	1.9	1.2	2.2	8.6	5.8	2.3	2.5	6.7	2.3	0.2	4.4	0.5	1.7	0.7	0.2	3.7	8.4	2.6	2.4	2.0	4.6	5.7	0.2	3.6	1.5	9.9	4.7	0.2	4.0	5.7	1.8	5.6	8.4	1.4	13.5	8.5	8.2	6.1	14.1	3.3	3.8	3.8	3.9	0.1	4.0	3.3	5.3	1.1	3.7	4.9	2.1	16.9	0.9	0.0	4.7	0.2	0.0	30.3	16.3	0.1	11.0	2.1	10.0	10.8	0.0	2.3	4.9	7.4	13.3	1.5	0.1	1.1	11.1	1.3	2.3	2.8	15.8	2.6	2.3	2.4	2.7	2.1	16.3	1.9	285.9	119.8	37.9	110.7	98.9	26.4	222.5	107.0	271.7	293.5	191.9	172.8	136.2	16.6	78.5	6.5	155.5	34.5	0.0	48.5	56.0	55.6	45.4	24.4	28.8	14.9	6.4	44.4	68.7	4.7	8.1	93.5	7.9	45.5	4.6	57.4	99.5	65.8	10.5	50.2	64.2	579.2	109.9	65.5	13.6	7.8	76.5	187.3	96.2	67.0	63.0
TBC1D16	"FLJ20748, MGC25062"	ENSG00000167291	"TBC1 domain family member 16"	Q8TBP0	17	79932343-80035848	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 290.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"intermediate monocyte: 4.6;naive B-cell: 1.5;non-classical monocyte: 4.7"	"Group enriched"	"Detected in many"	6	"B-cells: 1.5;monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.5;SK-MEL-30: 55.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024482, HPA065839"	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA024482: AB_1857790, HPA065839: AB_2685566"	"unprognostic (4.53e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.99e-3)"	32.2	8.1	10.1	7.8	18.2	1.0	32.6	25.5	11.2	10.7	8.6	6.0	28.4	7.5	11.9	20.9	9.8	12.8	9.3	10.0	8.1	7.8	18.1	13.2	8.5	13.7	8.7	5.6	11.8	18.7	9.3	6.6	7.1	8.2	17.3	5.8	15.4	25.5	24.2	4.5	15.8	7.9	10.8	8.1	8.7	7.6	5.2	9.5	2.7	9.7	7.0	3.9	9.2	14.6	1.5	0.3	0.1	4.7	0.1	0.5	0.3	8.2	7.9	12.3	14.4	52.5	27.7	2.3	4.8	4.8	3.0	3.5	14.8	2.9	0.0	3.4	8.1	5.8	2.6	12.9	4.5	2.3	0.4	6.1	0.0	3.6	6.8	8.9	0.1	1.1	31.1	8.0	6.6	4.8	4.9	13.0	5.6	1.9	5.6	5.7	5.1	2.1	0.7	14.7	10.8	4.3	6.9	7.8	4.7	3.6	10.2	12.6	16.3	4.3	12.1	55.7	8.0	7.9	3.7	8.7	10.7	7.7	8.4	4.2	17.2	3.0	0.9	4.6	3.1	13.5	0.0	0.3	0.0	0.1	4.6	0.5	0.0	0.1	0.2	0.3	1.5	0.2	0.3	0.1	0.1	4.7	0.0	0.0	0.3	10.1	18.2	25.5	11.2	8.1	7.8	8.7	5.6	8.2	9.5	0.0	9.3	0.8	3.6	4.8	6.6	7.2	17.8	2.7	2.3	7.0	9.8	5.2	8.3	13.8	1.0	9.0	3.2	0.0	19.3	1.1	12.8	9.6	7.0	16.2	3.0	290.8	30.5	15.4	43.0	1.6	5.5	3.8	72.6	1.0	6.4	21.5	16.9	2.8	7.4	10.0	7.4	6.5	10.5	0.2	3.4	4.0	1.6	3.8	5.0	5.7
TMEM81	"HC3107, KVLA2788, MGC75217, UNQ2788"	ENSG00000174529	"Transmembrane protein 81"	Q6P7N7	1	205083129-205084460	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.2"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 3.5;Early spermatids: 7.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA052515			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA052515: AB_2681858"	"unprognostic (9.19e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (6.65e-9)"	"unprognostic (8.91e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.67e-4)"	1.5	2.7	2.8	1.6	3.8	2.0	2.1	11.2	5.3	2.1	1.3			1.2	1.5	3.5	1.4	1.2	1.1	2.2	3.3	2.7	4.2	3.3	1.5	2.3	2.8		2.3	1.0	3.4	2.2	2.0		1.8	1.7		1.4	2.1	4.6	4.1	1.2	1.7	2.4	3.0	1.0	6.1			1.4		2.7	0.9	1.6	1.5	1.5	4.3	1.4	0.2	4.6	0.9	2.4	3.7	6.2	8.1	9.1	3.6	3.1	4.5	2.7	2.3	1.4	6.5	1.7	4.5	3.2	2.5	3.4	2.1	9.9	3.8	4.0	3.9	3.9	3.7	5.2	3.2	6.3	1.9	2.1	3.6	6.8	3.6	1.8	6.1	4.5	5.4	8.3	1.9	2.9	4.7	4.3	8.1	4.7	3.0	5.4	3.0	7.1	4.6	5.3	2.3	3.9	6.1	2.8	3.4	7.1	10.0	2.5	8.0	2.1	4.3	2.3	5.5	4.8	4.3	5.3	3.6	6.2	2.9	7.3	4.3	1.2	0.2	4.6	1.4	0.2	1.5	2.3	1.1	1.5	1.4	2.5	4.0	2.5	0.2	1.4	1.5	2.7	0.9											0.0	0.0	0.5	0.5	2.1	0.6	1.2	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.5	7.9	1.0	0.3	0.0	0.5	0.3	0.8	0.6	0.0	1.0	0.5	1.6	0.0	0.6	0.0	1.3	0.0	0.0	1.7	0.0	0.2	1.1	0.7	0.0	0.4	1.4	1.0	0.0	0.6	0.2	1.1	2.3	0.1	0.0	0.8	0.4
TNNI2	"AMCD2B, DA2B, FSSV"	ENSG00000130598	"Troponin I2, fast skeletal type"	P48788	11	1838989-1841680	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"skeletal muscle: 635.0;tongue: 527.7"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 241.7;Syncytiotrophoblasts: 72.9"	"Group enriched"	"Detected in many"	10	"cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 46.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.4;granulocytes: 26.7"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 23.2;hTCEpi: 66.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB018697, HPA055938"	Enhanced		Approved	"Plasma membrane,Intermediate filaments"		NA	NA		29000	"Plasma membrane"	"Intermediate filaments"	"CAB018697: AB_628400, HPA055938: AB_2682976"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-2)"	13.9	0.1	0.1	0.1	0.1	0.5	0.6	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	16.5	11.6	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.0	0.1	0.5	0.0	0.1	0.3	0.0	1.2	0.1	0.0	15.7	0.4	635.0	4.8	0.2	0.1	0.2	0.4	0.1	0.1	0.0	0.0	3.0	527.7	11.5	2.1	0.1	2.3	46.4	26.7	8.6	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	23.2	0.6	0.1	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.1	5.6	66.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	2.0	0.0	0.0	0.8	1.5	0.0	0.6	0.0	0.6	0.0	0.4	0.0	0.0	8.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	6.1	3.1	26.7	0.0	6.5	0.0	1.9	0.0	0.0	4.3	2.3	0.0	0.0	21.1	0.2	8.6	46.4	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	4.1	7.2	0.5	22.2	0.0	4.9	20.4	10.7	3.4	0.0	0.0	31.7	0.0	1.2	0.0	0.7	0.0	0.0	0.5	241.7	2.3	0.0	10.4	0.0	38.5	0.0	0.0	0.0	18.2	0.0	0.3	18.6	0.0	3.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	5.6	72.9	0.9	0.0	0.5
TOM1L2		ENSG00000175662	"Target of myb1 like 2 membrane trafficking protein"	Q6ZVM7	17	17843511-17972422	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 81.5"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022541, HPA023304"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA		66000	"Intermediate filaments"	"Golgi apparatus"	"HPA022541: AB_1858182, HPA023304: AB_1858183"	"unprognostic (2.32e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (2.58e-4)"	"prognostic favorable (1.92e-4)"	"unprognostic (3.19e-2)"	"prognostic favorable (6.21e-9)"	"unprognostic (7.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.51e-2)"	11.8	14.8	24.7	7.3	27.4	3.5	10.4	23.2	38.2	10.5	12.8	32.3	8.7	8.8	12.8	8.2	35.9	12.7	8.8	81.5	25.9	21.8	13.1	4.4	14.4	4.8	24.4	23.8	15.7	12.2	28.7	14.4	6.3	42.3	21.1	9.7	19.5	9.7	19.3	32.0	29.0	10.5	16.0	16.4	7.7	10.9	14.7	20.9	4.3	24.8	13.7	10.5	12.0	11.0	2.7	2.2	14.6	3.9	1.4	5.3	1.8	11.1	13.3	3.6	2.8	8.9	9.0	5.6	19.2	9.1	10.9	9.0	12.2	8.1	2.0	25.1	18.8	5.7	46.6	2.9	11.2	6.5	3.1	5.2	3.3	12.0	2.3	5.5	0.7	2.3	10.5	7.8	9.9	7.4	9.6	10.8	3.2	1.2	2.9	13.7	11.7	1.4	1.8	0.6	15.8	8.2	1.8	8.7	5.0	14.1	21.7	4.1	3.8	8.5	11.2	6.8	28.1	5.7	1.5	13.8	10.1	2.7	20.2	7.0	2.6	2.1	0.8	11.6	1.0	24.0	7.1	3.9	5.1	3.5	1.2	2.5	2.0	3.2	2.8	1.8	2.7	5.3	3.9	14.6	1.4	3.4	2.2	1.5	1.8	24.7	27.4	23.2	38.2	25.9	21.8	24.4	23.8	42.3	20.9	29.8	13.4	12.3	11.9	9.6	69.6	59.0	20.4	14.7	11.4	10.4	149.2	6.4	5.0	10.3	25.9	9.5	25.8	0.0	7.7	16.0	10.4	37.1	2.3	11.3	8.1	90.6	19.7	12.9	7.3	46.0	24.5	6.5	11.8	10.0	17.1	32.4	12.4	31.7	24.1	7.9	76.8	19.4	13.2	14.6	10.7	15.1	26.9	8.7	13.3	45.0
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111275-120185529	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 97.6;Basal keratinocytes: 241.7;Suprabasal keratinocytes: 402.6;Urothelial cells: 144.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Region enriched"	"Detected in single"	8	"pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 54.2;hTCEpi: 72.1;RT4: 28.5;SiHa: 40.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020053, HPA074841"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA020053: AB_1858280, HPA074841: "	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	0.3	0.2	0.1	0.0	0.1	0.1	7.3	0.0	0.1	30.4	0.6	0.2	1.6	0.3	3.1	2.9	176.3	3.7	0.8	0.1	0.1	0.1	0.5	0.4	1.4	0.0	0.0	0.0	0.4	0.2	0.0	2.2	24.4	1.1	11.1	0.5	0.0	25.5	4.8	0.9	90.1	0.2	1.6	0.3	0.0	0.2	0.7	0.0	7.5	0.1	113.6	93.6	9.6	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	3.4	0.0	0.8	0.0	0.1	54.2	0.0	12.4	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.0	72.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	28.5	0.2	0.9	40.5	5.7	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.0	97.6	241.7	0.0	1.1	2.5	33.5	13.6	0.0	0.0	37.9	0.0	1.3	21.4	0.4	2.1	0.0	3.9	5.0	5.4	34.5	1.1	0.0	4.4	0.0	2.4	0.0	0.0	78.0	0.6	1.7	21.9	0.0	2.3	0.0	33.2	0.8	0.0	0.2	0.0	0.0	7.2	0.6	1.4	402.6	20.7	0.0	1.4	144.0
TRIM32	"BBS11, HT2A, LGMD2H, TATIP"	ENSG00000119401	"Tripartite motif containing 32"	Q13049	9	116687302-116701300	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Limb-girdle muscular dystrophy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050060	Approved		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA050060: AB_2681000"	"unprognostic (2.47e-2)"	"unprognostic (7.06e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (4.53e-4)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.03e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.77e-2)"	9.5	9.1	6.6	5.8	11.5	0.8	8.0	23.2	17.1	12.8	7.9	7.2	6.2	6.7	17.0	8.0	8.8	15.9	8.2	8.9	5.7	7.3	6.2	5.0	6.3	8.4	5.7	9.8	12.6	12.5	12.2	7.7	7.0	9.1	10.3	7.4	10.4	10.9	9.2	23.9	6.6	8.9	12.9	5.3	6.9	6.8	6.5	2.2	9.4	8.4	6.2	8.3	11.1	8.8	6.1	3.5	0.2	2.6	5.6	16.0	4.7	6.5	15.0	8.9	9.8	18.1	13.0	6.7	12.2	13.4	13.9	11.7	10.0	7.2	6.8	5.4	18.7	10.4	14.0	10.8	13.7	12.7	5.9	5.2	3.6	9.7	6.1	9.4	2.4	12.0	11.2	12.4	13.1	7.8	15.4	9.0	7.6	5.0	5.8	16.3	8.4	6.4	0.0	8.1	15.8	9.1	7.6	24.0	4.4	5.7	15.3	8.9	4.5	9.6	6.7	6.9	9.4	18.5	2.4	11.1	13.0	10.4	9.5	9.1	9.5	2.5	10.6	10.8	1.6	12.7	0.0	1.3	0.0	9.3	2.6	7.2	6.1	8.2	7.4	1.8	4.4	8.3	8.4	0.2	5.6	2.1	3.5	16.0	4.7	6.6	11.5	23.2	17.1	5.7	7.3	5.7	9.8	9.1	2.2	6.0	1.1	3.0	5.1	3.8	11.5	6.1	7.6	6.7	5.7	8.7	0.0	6.0	1.7	7.8	2.8	2.4	2.4	0.0	7.0	3.6	6.5	2.8	2.3	3.9	5.8	1.6	4.1	2.5	2.7	1.3	4.9	1.4	1.7	1.0	5.2	4.1	4.9	3.5	11.3	2.2	4.5	0.0	3.6	9.8	11.1	3.1	6.2	4.6	4.9	3.4
TRIM52	RNF102	ENSG00000183718	"Tripartite motif containing 52"	Q96A61	5	181254417-181261139	"Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA054565, HPA056819"	Approved		Approved	"Nucleoli,Intermediate filaments"		NA	NA			Nucleoli	"Intermediate filaments"	"HPA054565: AB_2682525, HPA056819: AB_2683245"	"unprognostic (1.21e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.23e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.24e-3)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (2.96e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (4.07e-4)"	9.2	13.0	17.8	15.3	19.7	10.9	11.5	42.3	24.2	10.9	10.9	9.8	15.4	11.8	12.1	14.3	6.6	10.3	8.2	9.1	15.0	10.5	11.2	9.7	11.0	18.8	18.0	12.0	17.7	14.6	15.3	19.4	8.6	16.2	13.8	10.2	8.1	14.0	15.6	9.8	14.5	12.6	8.3	14.0	16.9	11.3	11.7	20.8	15.3	16.8	5.0	13.9	10.3	15.1	5.4	2.7	5.6	2.5	5.5	11.2	3.7	3.6	4.2	6.8	8.8	12.4	7.9	6.1	4.0	3.5	3.9	3.4	6.0	6.7	7.9	4.4	4.3	10.6	6.7	3.7	5.3	4.6	13.4	7.8	3.0	15.9	5.1	3.0	9.2	7.0	7.9	4.5	4.2	2.4	6.4	4.6	11.7	3.2	18.6	4.0	6.9	5.0	8.4	2.4	4.1	5.5	6.0	3.7	5.4	3.2	4.8	7.8	6.3	5.7	4.1	3.6	6.3	7.7	6.3	5.6	7.9	4.1	3.7	3.7	13.7	6.7	5.4	8.9	8.1	3.0	5.0	2.5	5.6	8.4	2.2	9.3	5.4	9.0	9.2	2.0	4.2	11.2	8.9	2.6	5.5	2.0	2.7	5.9	3.7	17.8	19.7	42.3	24.2	15.0	10.5	18.0	12.0	16.2	20.8	17.9	20.5	8.3	5.9	7.8	26.6	6.6	7.6	16.0	23.9	7.0	37.3	3.1	3.3	3.0	24.4	10.1	6.7	0.0	2.2	1.0	9.3	5.3	17.3	2.6	3.6	27.0	8.6	8.6	6.2	3.6	11.8	8.7	5.0	3.6	6.8	19.8	2.1	5.9	8.9	2.8	42.6	0.0	14.8	14.9	6.4	5.4	3.5	10.2	7.5	3.4
TTC26	"dyf-13, DYF13, FLJ12571, IFT56"	ENSG00000105948	"Tetratricopeptide repeat domain 26"	A0AVF1	7	139133744-139191986	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 89.7;Spermatocytes: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036338, HPA036339"	Enhanced		Approved	"Nuclear speckles,Intermediate filaments,Cytosol"		NA	NA			"Nuclear speckles, Intermediate filaments, Cytosol"		"HPA036338: AB_10673351, HPA036339: AB_10673386"	"unprognostic (3.40e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.46e-7)"	"unprognostic (1.72e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.56e-1)"	3.5	6.5	6.9	2.5	8.1	3.3	5.6	6.9	8.3	6.1	3.1	4.4	7.4	1.3	6.6	7.6	3.1	20.9	4.5	3.5	5.7	5.1	8.3	1.9	5.1	2.8	2.7	4.8	8.8	3.2	13.0	20.1	3.8	8.4	5.6	2.8	5.4	3.6	5.5	2.3	3.2	2.2	4.6	2.7	2.6	3.1	17.4	3.9	3.8	7.3	2.8	3.1	3.7	3.9	3.6	2.5	5.3	1.5	1.6	2.3	0.9	11.2	8.5	7.5	8.9	9.4	10.9	3.7	5.5	5.7	9.0	9.2	5.4	8.1	2.4	9.2	4.2	14.7	5.6	8.3	6.4	13.1	7.0	7.2	3.0	6.8	4.6	4.7	8.6	2.1	6.2	5.8	13.4	6.1	5.6	6.6	5.9	6.7	1.6	7.1	10.5	14.7	10.1	7.5	3.3	7.5	5.1	8.9	4.0	7.7	3.3	11.0	7.9	13.4	5.7	7.7	2.3	6.9	4.7	4.6	8.4	7.3	7.6	10.0	3.6	4.6	1.8	14.6	4.3	9.8	1.2	0.5	1.2	2.1	0.5	1.1	3.6	1.5	1.4	1.1	2.4	2.3	1.7	5.3	1.6	1.5	2.5	1.0	0.9	6.9	8.1	6.9	8.3	5.7	5.1	2.7	4.8	8.4	3.9	0.0	2.6	2.7	1.7	1.0	6.9	1.7	7.6	89.7	19.4	5.2	11.8	1.0	0.0	4.8	15.8	2.1	0.0	0.0	2.3	2.8	3.1	1.1	5.7	1.7	1.8	0.0	1.2	4.3	0.6	12.2	3.7	2.2	3.3	2.8	0.9	4.5	1.6	2.9	4.9	4.6	16.0	0.0	2.1	40.9	5.7	1.5	0.3	1.7	0.6	0.5
UAP1L1		ENSG00000197355	"UDP-N-acetylglucosamine pyrophosphorylase 1 like 1"	Q3KQV9	9	137077501-137084539	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 18.6;Horizontal cells: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044356	Approved		Approved	"Intermediate filaments,Cytosol"		No	No			"Intermediate filaments"	Cytosol	"HPA044356: AB_10959902"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.80e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.65e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.64e-3)"	10.5	14.7	13.6	9.8	20.6	5.0	16.3	3.4	17.5	13.0	8.8	22.1	8.6	10.0	7.3	9.7	5.9	5.8	9.4	11.3	14.7	8.1	12.5	3.1	11.6	12.2	24.9	9.3	3.9	10.5	8.5	14.7	10.9	14.2	12.8	6.7	14.1	15.2	10.9	2.5	9.0	9.4	6.6	13.5	20.3	10.8	3.5	29.1	1.4	13.3	4.9	10.3	11.4	13.9	2.1	1.8	0.6	3.7	0.3	3.0	1.2	0.4	2.8	0.0	7.5	13.0	6.1	2.2	3.8	10.1	10.8	7.6	5.4	1.2	1.7	2.3	3.9	19.7	5.8	14.1	0.9	2.2	4.6	1.2	3.7	4.2	5.2	29.0	0.0	15.3	4.4	1.0	6.1	5.1	5.1	8.4	3.5	1.1	8.6	7.2	6.2	0.3	3.7	1.2	13.2	4.0	5.9	0.1	5.2	4.3	0.5	4.5	2.8	0.9	21.2	8.6	1.9	11.4	10.2	6.6	19.6	4.2	13.6	1.8	9.5	13.5	3.6	17.0	4.0	5.5	0.4	3.7	0.1	0.8	2.0	3.0	2.1	0.4	1.3	1.8	1.0	1.0	1.3	0.6	0.3	0.0	1.1	1.7	1.2	13.6	20.6	3.4	17.5	14.7	8.1	24.9	9.3	14.2	29.1	0.0	5.9	2.9	0.5	5.5	4.8	3.5	7.6	0.0	1.2	0.0	2.0	0.3	10.0	1.3	0.1	2.1	0.2	0.0	0.8	4.6	4.4	1.9	4.6	0.2	18.6	19.1	1.7	7.4	12.7	0.0	2.3	8.1	8.5	5.4	1.7	6.5	0.9	1.9	3.5	3.1	4.7	0.0	3.4	0.5	1.5	3.9	1.1	2.6	2.3	0.1
USP47		ENSG00000170242	"Ubiquitin specific peptidase 47"	Q96K76	11	11841423-11959323	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029286, HPA029289"	Supported		Approved	"Vesicles,Intermediate filaments"		NA	NA			"Intermediate filaments"	Vesicles	"HPA029286: AB_10599852, HPA029289: AB_10601675"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.27e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	16.6	17.0	17.9	18.5	20.9	20.3	16.9	25.7	19.0	16.4	18.1	16.2	21.3	11.6	18.0	15.0	18.7	13.7	13.5	25.5	18.1	13.4	14.6	25.1	16.6	13.4	21.9	12.9	16.9	19.6	38.8	31.8	23.7	19.3	18.0	14.2	10.2	15.1	19.2	58.1	18.4	15.1	21.3	19.5	13.3	18.1	16.8	23.9	27.9	16.8	12.4	15.2	21.3	19.4	9.7	10.1	14.0	13.2	22.8	19.3	9.7	21.4	13.1	23.5	11.1	17.0	18.8	10.8	24.7	18.7	16.3	18.5	12.9	19.1	24.3	11.8	22.9	19.4	14.7	18.1	12.4	25.2	23.6	15.3	14.6	24.2	9.0	15.1	18.9	20.5	17.4	17.1	10.7	23.8	18.6	18.1	17.2	29.1	21.0	19.9	8.5	17.0	8.4	6.3	21.3	10.6	17.6	24.8	7.5	17.6	24.9	8.2	16.7	22.1	15.4	13.7	15.1	12.3	13.9	20.0	23.1	14.1	19.6	15.0	6.6	15.2	23.0	15.9	11.7	16.6	13.3	7.7	14.0	15.2	9.5	19.3	9.7	13.8	14.7	10.1	8.6	17.9	15.3	3.6	22.8	13.2	6.1	9.9	9.7	17.9	20.9	25.7	19.0	18.1	13.4	21.9	12.9	19.3	23.9	65.5	50.8	26.5	58.2	63.1	66.5	188.1	30.6	62.9	67.1	22.7	45.2	55.8	21.6	33.6	26.3	35.8	25.1	23.3	33.7	29.2	48.3	58.2	51.0	50.0	24.2	60.4	56.9	30.1	18.5	22.9	40.9	32.0	23.6	27.9	30.5	80.7	36.7	31.6	47.0	17.9	50.6	51.8	47.2	72.0	59.0	76.9	105.2	47.3	32.2	47.7
WDR37	KIAA0982	ENSG00000047056	"WD repeat domain 37"	Q9Y2I8	10	1049538-1132297	"Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 168.7;Late spermatids: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037376, HPA037565"	Enhanced		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA037376: AB_10672789, HPA037565: AB_10696937"	"unprognostic (1.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.51e-3)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.75e-5)"	"unprognostic (2.59e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.62e-2)"	"prognostic favorable (1.46e-6)"	"unprognostic (3.16e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (5.98e-2)"	10.6	17.4	26.3	11.4	24.2	24.5	10.4	19.4	35.4	7.4	9.2	11.8	10.1	9.8	9.4	12.1	9.9	9.3	8.3	22.1	25.7	14.1	9.7	10.7	10.9	14.6	12.0	29.5	12.4	11.4	12.1	16.3	8.8	16.0	9.5	9.0	10.6	8.9	7.6	21.9	14.9	11.9	8.9	11.7	23.3	11.6	23.3	16.8	7.1	12.8	8.1	12.5	7.7	8.5	7.3	6.7	7.5	8.6	14.0	14.1	6.3	9.4	6.8	8.9	7.3	8.6	12.5	6.8	12.2	6.5	7.3	7.3	8.7	8.2	5.1	7.7	15.4	1.5	9.3	4.7	13.8	6.4	6.9	8.5	11.4	6.7	5.8	6.2	6.9	13.1	15.9	10.6	10.4	3.8	8.9	16.2	9.7	7.7	5.6	11.6	8.3	7.1	5.2	5.1	7.2	4.4	11.5	5.3	8.0	10.2	10.2	4.2	8.8	5.7	10.4	9.3	7.1	9.9	13.5	21.6	6.0	2.3	19.4	9.5	12.6	10.5	6.7	13.7	7.6	4.3	7.5	6.3	4.7	14.1	8.5	12.0	7.3	8.1	10.4	6.7	6.7	9.1	10.3	6.0	14.0	8.6	6.3	6.8	6.3	26.3	24.2	19.4	35.4	25.7	14.1	12.0	29.5	16.0	16.8	3.0	7.2	6.2	10.5	11.8	14.2	22.2	0.0	2.7	7.9	10.4	11.8	5.3	0.0	4.0	168.7	9.6	5.6	0.0	5.2	3.5	5.5	10.7	11.5	6.7	8.0	7.9	10.3	31.9	20.6	73.7	11.5	12.1	15.1	3.6	8.4	6.1	6.4	7.6	17.0	3.3	14.2	6.5	9.5	11.6	15.8	10.8	9.5	10.2	5.7	11.6
WDR89	"C14orf150, MGC9907"	ENSG00000140006	"WD repeat domain 89"	Q96FK6	14	63597039-63641861	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000813	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA000813: AB_1078324"	"prognostic favorable (3.37e-4)"	"unprognostic (6.46e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.08e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.29e-1)"	13.2	12.6	11.5	11.6	13.4	4.6	13.7	19.3	18.8	12.5	10.3	9.5	7.4	8.0	14.6	11.5	10.5	11.9	8.6	8.1	11.0	10.7	14.8	16.1	9.1	17.8	15.7	11.6	15.0	14.0	16.2	16.3	12.9	12.3	12.0	12.1	8.3	8.7	8.4	13.2	10.8	8.9	10.5	11.8	13.8	8.5	8.6	14.4	21.0	16.9	7.6	17.0	11.6	10.2	7.0	4.3	0.6	3.6	8.4	14.0	4.9	25.1	11.0	13.7	7.3	8.3	9.0	19.6	10.2	5.6	10.3	11.5	7.8	11.9	24.5	8.4	3.0	7.1	11.7	16.7	9.9	18.3	15.8	9.6	16.6	6.9	9.7	10.5	21.1	11.5	8.2	12.8	11.8	17.7	6.4	10.0	18.2	13.5	13.6	7.7	12.6	17.6	12.0	12.3	18.0	21.9	13.0	13.9	13.7	11.4	9.7	11.7	9.6	10.9	11.7	7.7	13.8	13.5	11.5	6.8	12.5	11.8	8.1	12.1	7.9	5.8	15.0	5.6	15.5	8.8	0.0	2.5	0.3	8.2	2.5	10.5	7.0	8.7	7.5	4.3	6.9	14.0	12.1	0.6	8.4	3.6	2.8	8.7	4.9	11.5	13.4	19.3	18.8	11.0	10.7	15.7	11.6	12.3	14.4	8.9	4.1	4.5	10.0	8.7	6.6	4.0	5.1	1.4	9.1	5.2	3.9	9.1	11.6	6.2	2.2	5.8	2.6	0.0	4.8	11.5	4.5	6.4	1.1	7.8	5.6	1.6	3.5	6.2	6.0	3.6	4.0	4.0	3.3	3.6	4.2	6.5	3.2	0.0	6.0	6.2	8.2	12.9	4.3	6.2	12.6	9.5	5.8	5.2	5.0	5.5
ZFC3H1	"CCDC131, CSRC2, KIAA0546, MGC23401, PSRC2"	ENSG00000133858	"Zinc finger C3H1-type containing"	O60293	12	71609472-71667725	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007072, HPA007151"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA007072: AB_1846134, HPA007151: AB_1846133"	"unprognostic (3.90e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.07e-3)"	12.1	12.8	17.6	19.1	17.4	22.7	12.9	35.3	23.8	15.4	16.9	6.7	14.6	8.0	13.7	17.3	15.1	12.8	12.7	12.1	14.6	7.7	10.7	8.0	16.4	19.1	14.8	12.3	17.1	11.6	17.6	17.6	14.6	14.9	12.6	13.2	6.7	12.0	14.2	11.6	12.2	15.2	12.4	14.7	15.9	13.5	17.5	17.6	16.8	13.5	8.4	17.1	15.7	20.8	14.8	12.7	29.7	10.3	4.2	7.2	1.1	10.4	10.6	7.7	5.3	10.7	19.1	4.6	8.2	13.2	13.0	12.9	9.8	5.8	13.5	4.7	10.1	5.3	11.3	10.9	4.8	17.3	13.7	8.0	13.2	16.4	4.5	6.0	14.4	6.5	10.6	10.4	9.1	3.9	16.7	13.0	11.1	12.2	6.0	11.9	3.2	10.1	5.0	7.7	4.9	6.1	8.8	9.4	10.4	9.8	7.7	5.3	4.8	8.3	5.3	5.4	8.7	14.2	9.5	9.8	7.3	5.0	4.2	4.1	10.4	6.3	10.5	8.5	10.1	5.1	20.7	10.3	12.1	7.2	4.8	5.5	9.2	6.2	4.6	3.9	14.8	5.8	4.9	29.7	4.2	8.7	12.7	4.9	1.1	17.6	17.4	35.3	23.8	14.6	7.7	14.8	12.3	14.9	17.6	32.8	23.8	26.2	48.6	42.6	31.6	15.1	5.1	21.4	34.2	14.0	21.6	11.9	1.7	17.8	75.9	28.7	28.5	0.0	14.5	12.8	33.8	39.6	47.4	9.8	15.6	55.6	20.1	20.9	18.0	52.4	29.7	35.1	10.1	27.1	23.4	18.9	21.4	35.1	21.5	5.8	31.7	25.8	25.5	29.6	25.8	35.8	9.6	24.9	21.5	64.9
ZFP36	"G0S24, NUP475, RNF162A, TIS11, TTP"	ENSG00000128016	"ZFP36 ring finger protein"		19	39406813-39409412	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 1665.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 72.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 32.0;ASC TERT1: 41.6;hTCEpi: 50.6;Karpas-707: 43.7;U-266/70: 32.2;U-266/84: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006009	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA006009: AB_1859030"	"unprognostic (2.30e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.26e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (5.20e-1)"	"unprognostic (3.61e-3)"	"unprognostic (9.44e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.20e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (6.92e-3)"	109.7	49.3	7.7	112.8	40.3	90.1	63.0	7.5	26.2	60.2	52.9	25.4	12.4	22.8	47.3	23.9	121.7	98.2	78.0	32.5	28.8	7.9	23.2	43.8	124.6	24.9	10.9	2.3	53.9	21.5	29.3	31.4	20.8	47.7	55.8	26.4	45.3	34.3	46.6	82.9	61.6	58.0	56.4	50.0	35.1	42.7	27.8	8.4	15.5	35.5	106.5	58.3	114.5	57.7	12.0	15.4	72.5	19.3	3.8	9.5	7.9	6.9	4.3	1.1	0.9	32.0	41.6	2.1	5.5	6.8	3.3	2.4	3.7	7.5	4.5	1.6	9.6	3.1	3.6	0.6	10.3	1.0	5.0	0.4	1.9	3.3	2.3	18.4	1.7	12.2	17.2	50.6	2.4	18.4	4.0	1.8	5.0	2.5	43.7	5.6	6.4	3.0	4.3	0.4	20.2	0.7	4.7	0.6	8.5	3.7	12.6	0.4	1.1	2.5	6.3	1.3	1.8	4.4	9.8	2.7	4.2	1.5	7.5	1.5	32.2	43.3	4.8	3.8	3.7	1.6	23.9	14.9	15.0	9.5	15.6	7.7	11.2	8.0	9.5	15.4	12.0	9.2	8.7	72.5	3.8	19.3	11.8	9.2	7.9	7.7	40.3	7.5	26.2	28.8	7.9	10.9	2.3	47.7	8.4	390.1	865.0	231.9	792.8	1030.8	0.2	426.2	160.5	275.7	310.5	76.8	3.9	54.1	26.6	160.4	5.3	744.2	811.8	23.3	94.1	80.0	725.1	1061.8	658.8	174.2	657.2	1.6	607.3	243.7	446.3	5.2	516.4	1156.0	598.9	97.4	396.2	22.4	113.8	624.3	131.2	38.7	6.1	756.7	1665.5	1.2	3.3	1386.1	129.0	596.6	239.7	602.1
ZIK1	ZNF762	ENSG00000171649	"Zinc finger protein interacting with K protein 1"	Q3SY52	19	57578456-57593777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.7;NTERA-2: 20.0;REH: 14.3;U-266/84: 18.7"	"Low region specificity"	"Detected in all"							HPA059975	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA059975: AB_2684184"	"unprognostic (2.14e-2)"	"unprognostic (9.03e-3)"	"unprognostic (9.42e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.34e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-6)"	"unprognostic (6.21e-2)"	"unprognostic (5.15e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.50e-1)"	4.0	4.9	5.6	4.1	6.7	6.2	5.2	14.4	8.2	5.2	4.5	4.8	4.7	1.2	5.0	7.5	2.3	8.3	4.0	5.4	4.3	5.0	3.8	1.3	4.1	10.8	3.7	5.3	10.4	2.7	12.9	6.2	5.4	5.5	6.2	2.4	7.5	5.7	7.2	5.0	3.8	5.0	4.5	3.7	8.4	2.8	8.2	3.0	12.7	9.3	1.9	10.1	6.5	2.8	10.8	3.3	8.8	2.2	4.3	8.4	3.0	0.0	0.0	13.1	0.0	0.5	0.5	0.0	4.5	4.2	6.6	6.0	0.0	0.1	0.0	3.3	2.3	5.2	0.3	0.0	7.2	9.4	0.0	16.7	2.6	0.0	1.3	1.5	0.0	5.0	2.8	0.0	5.1	0.0	0.6	0.5	1.0	0.1	0.0	2.2	0.0	9.8	1.3	20.0	0.0	1.6	14.3	0.0	3.1	1.9	0.0	9.6	9.7	0.1	0.0	0.4	10.7	0.0	0.2	0.0	6.0	3.1	0.0	5.3	0.1	18.7	4.9	0.0	0.0	5.9	2.1	1.8	8.8	2.2	2.2	4.4	8.0	4.3	2.8	2.9	10.8	8.4	3.9	0.5	4.3	1.8	3.3	4.9	3.0	5.6	6.7	14.4	8.2	4.3	5.0	3.7	5.3	5.5	3.0	0.0	0.0	1.3	1.6	0.9	3.4	2.0	5.1	0.0	1.2	5.2	0.0	2.0	3.3	2.7	1.7	2.1	0.0	0.0	0.2	0.7	1.3	1.0	3.5	0.0	1.6	3.2	0.0	2.5	1.0	2.2	2.0	0.9	0.0	1.0	0.0	4.5	0.3	0.0	2.1	0.4	4.4	6.5	0.9	0.7	4.9	0.6	1.0	2.6	0.0	1.1
ZKSCAN5	"ZFP95, ZNF914, ZSCAN37"	ENSG00000196652	"Zinc finger with KRAB and SCAN domains 5"	Q9Y2L8	7	99504651-99534700	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003201	Uncertain		Approved	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA003201: AB_10610701"	"unprognostic (2.47e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (7.59e-6)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.35e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (3.42e-1)"	6.3	7.2	8.4	5.9	11.8	5.4	8.1	16.5	12.6	7.2	6.1	12.9	3.8	3.7	7.7	8.4	5.4	7.6	5.9	7.4	9.8	8.2	7.4	6.6	6.8	6.7	9.9	8.2	8.9	7.6	10.5	9.0	7.7	9.8	7.6	6.4	6.8	4.7	8.8	9.5	5.2	5.3	9.9	7.2	6.9	5.5	17.8	10.2	12.5	8.7	4.6	8.6	7.3	5.8	1.7	4.0	4.7	2.8	3.8	4.7	2.4	5.6	9.5	11.4	15.1	8.5	6.3	4.6	9.8	10.0	12.1	11.9	6.5	5.3	9.7	9.3	7.6	14.8	4.1	10.5	6.9	12.3	5.8	5.0	6.1	6.4	6.1	8.6	9.1	10.3	5.6	9.6	10.5	16.2	7.7	8.6	8.9	12.9	13.6	13.0	7.2	13.0	10.0	9.8	5.2	7.7	8.0	10.1	8.2	7.6	5.7	8.0	13.0	9.3	8.1	7.1	9.7	5.0	7.0	7.7	15.3	11.1	12.2	8.3	9.1	12.9	15.2	6.8	6.2	13.6	1.3	1.5	4.7	4.7	2.8	4.1	1.7	1.7	2.3	4.0	0.9	3.5	3.7	0.3	3.8	1.7	1.6	2.9	2.4	8.4	11.8	16.5	12.6	9.8	8.2	9.9	8.2	9.8	10.2	6.0	2.7	7.1	1.6	2.4	5.4	5.0	0.0	1.4	6.8	3.5	13.7	2.9	0.0	2.6	3.9	3.5	3.8	0.0	2.9	2.8	3.4	2.0	5.7	3.0	2.8	9.5	5.8	5.5	3.5	1.6	3.7	3.9	0.0	2.8	2.7	8.1	3.8	0.0	5.3	2.1	6.3	6.5	3.1	10.9	5.9	2.5	2.2	3.5	2.3	0.9
ZNF132	pHZ-12	ENSG00000131849	"Zinc finger protein 132"	P52740	19	58432814-58440222	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	7	"Cholangiocytes: 2.5;Cone photoreceptor cells: 3.9;Horizontal cells: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA008726	Uncertain		Approved	"Vesicles,Intermediate filaments"		NA	NA			Vesicles	"Intermediate filaments"	"HPA008726: AB_1080664"	"unprognostic (4.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (4.51e-1)"	"prognostic favorable (7.26e-13)"	"unprognostic (2.70e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.72e-1)"	2.9	4.7	4.0	2.5	5.9	0.8	5.1	11.8	8.5	5.9	4.1	6.6	4.5	2.5	4.2	7.2	3.5	7.9	4.7	5.9	6.0	4.5	6.2	2.1	3.6	3.3	4.4	5.5	7.6	4.3	15.3	12.1	3.7	5.9	6.1	2.4	5.4	5.8	6.7	3.7	4.7	2.6	5.9	4.2	4.5	3.6	7.2	6.0	3.1	10.8	2.8	4.3	5.7	6.3	3.9	2.9	2.0	2.6	2.6	5.7	2.1	1.7	2.1	4.8	1.7	5.6	4.6	0.2	3.7	4.5	3.0	2.7	0.1	1.5	4.5	0.3	4.4	3.0	1.8	0.0	5.4	2.1	0.7	8.2	0.8	1.4	1.1	5.0	1.7	3.0	5.2	1.9	5.2	3.2	3.5	2.6	0.7	0.7	0.5	5.6	0.6	1.0	0.1	4.9	0.6	1.7	0.6	1.1	1.3	1.8	2.0	4.3	4.4	1.5	1.3	1.5	5.4	0.3	4.4	3.3	3.1	0.4	0.8	0.7	5.9	1.1	0.0	1.5	0.1	1.9	0.0	1.9	2.0	2.2	2.2	5.7	2.9	2.9	1.2	2.9	3.9	4.6	3.7	0.2	2.6	2.6	2.4	2.5	2.1	4.0	5.9	11.8	8.5	6.0	4.5	4.4	5.5	5.9	6.0	0.0	0.3	0.0	0.5	0.0	0.8	2.2	2.5	0.0	0.0	0.0	3.9	0.4	0.0	0.4	2.2	0.0	0.0	0.0	0.3	0.1	0.4	0.9	1.1	1.0	0.4	3.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.7	1.2	1.5	0.0	0.4	1.4	0.4	0.3	0.3	0.0	0.0	0.2
ZNF175	OTK18	ENSG00000105497	"Zinc finger protein 175"	Q9Y473	19	51571298-51592508	"Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 25.5;RT4: 23.2;TIME: 23.4"					"Low region specificity"	"Detected in all"			HPA002717	Uncertain		Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA002717: AB_1080681"	"unprognostic (9.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.33e-3)"	"unprognostic (9.94e-2)"	"unprognostic (6.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (3.50e-3)"	6.1	6.7	11.2	6.1	12.6	4.7	8.4	26.2	16.0	7.7	6.5	7.1	9.4	8.4	9.2	8.5	5.5	7.6	4.9	6.6	12.7	7.4	7.3	6.4	8.0	8.7	11.1	10.3	14.5	7.3	19.8	10.9	12.1	11.4	7.6	6.1	6.4	9.1	9.5	6.4	5.5	7.9	8.1	8.8	9.7	6.7	15.0	11.7	9.2	10.8	5.0	9.2	8.7	11.9	2.1	4.6	0.6	1.3	0.9	2.2	0.7	1.8	3.2	3.3	3.4	3.5	4.8	0.0	4.1	5.3	3.9	4.7	3.3	2.8	3.3	2.4	4.1	2.4	3.1	3.5	2.8	7.0	0.0	5.2	25.5	5.0	1.1	3.0	4.2	16.4	1.9	2.7	7.9	3.9	19.8	6.2	3.3	8.5	3.5	4.2	0.0	4.5	3.2	1.8	2.2	3.3	0.0	4.2	1.6	2.1	23.2	4.1	3.0	3.9	1.3	2.5	2.7	1.0	3.5	23.4	6.0	2.7	1.4	4.0	4.6	8.4	3.4	16.6	2.5	3.0	0.1	1.3	0.0	1.7	0.5	1.8	1.9	1.6	1.4	1.4	2.1	2.2	1.7	0.6	0.9	0.3	4.6	0.3	0.7	11.2	12.6	26.2	16.0	12.7	7.4	11.1	10.3	11.4	11.7	6.0	4.8	2.4	1.5	1.0	6.1	3.1	2.5	5.3	7.9	5.2	2.0	6.3	1.7	1.6	9.5	2.9	2.0	0.0	1.4	1.2	2.6	1.6	13.9	2.1	2.7	15.9	1.7	5.5	6.6	7.0	3.1	2.0	3.3	1.8	1.2	2.3	4.5	0.0	2.5	1.4	7.4	0.0	2.1	5.8	4.1	1.3	10.1	1.8	2.1	0.7
ZNF189		ENSG00000136870	"Zinc finger protein 189"	O75820	9	101398873-101410660	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 61.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034814	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA034814: AB_10601030"	"unprognostic (3.87e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"prognostic favorable (5.32e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.57e-2)"	15.6	15.8	15.1	6.3	28.2	2.8	11.6	13.9	15.9	9.5	9.0	16.8	9.0	8.6	10.0	61.6	5.5	7.8	16.3	10.9	18.7	9.3	10.6	12.5	6.8	6.8	15.4	11.4	11.8	23.0	11.2	23.6	6.3	14.1	10.3	7.5	5.0	6.7	9.4	11.6	4.4	9.7	9.7	25.1	9.9	8.7	9.3	16.1	8.5	9.6	3.7	10.2	6.1	8.0	3.6	2.2	4.1	3.0	3.6	4.7	1.9	5.5	4.6	15.0	10.9	13.5	9.5	7.2	8.0	12.3	9.4	8.2	9.7	4.4	7.5	5.4	9.6	9.9	10.9	7.5	7.6	8.4	9.9	5.2	8.2	7.2	20.6	10.1	8.5	7.2	11.5	10.5	8.3	13.0	12.9	11.6	9.2	9.7	10.9	13.8	3.1	10.2	3.7	10.8	12.3	5.2	7.3	21.5	5.7	8.9	6.5	15.6	9.8	8.6	6.0	8.6	10.3	4.9	10.9	9.7	9.2	6.7	7.6	6.1	10.4	16.0	3.6	8.0	3.4	9.3	1.3	2.5	4.1	2.3	3.0	2.4	2.8	4.0	4.7	2.2	3.6	4.7	4.1	1.4	3.6	2.3	1.7	2.0	1.9	15.1	28.2	13.9	15.9	18.7	9.3	15.4	11.4	14.1	16.1	8.9	5.4	2.4	7.4	8.8	7.9	20.2	22.9	8.1	12.5	1.8	3.9	3.6	8.3	5.3	1.9	9.0	4.9	0.0	15.9	1.7	8.0	5.2	9.2	7.8	4.7	7.9	5.2	8.0	14.0	1.5	10.3	6.6	6.8	1.8	5.3	6.7	8.4	4.9	10.3	11.4	3.3	12.9	9.2	6.2	3.4	5.6	1.6	5.4	3.6	3.5
ZNF404		ENSG00000176222	"Zinc finger protein 404"	Q494X3	19	43872363-43901385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	6	"Alveolar cells type 2: 5.6;granulocytes: 6.9;Horizontal cells: 4.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.6;U-2 OS: 31.2"					"Low region specificity"	"Detected in all"			"HPA032014, HPA063607"	Uncertain		Supported	"Nucleoli,Nucleoli rim,Intermediate filaments"		NA	Yes			"Nucleoli, Nucleoli rim"	"Intermediate filaments"	"HPA032014: AB_10602591, HPA063607: AB_2732705"	"unprognostic (3.76e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-5)"	"unprognostic (1.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.80e-3)"	0.9	2.2	4.6	0.7	4.8	0.1	2.6	5.8	4.8	1.5	2.5			0.2	2.0	10.9	1.2	3.7	2.2	6.0	4.6	4.4	1.5	1.0	1.8	3.1	6.0		7.5	0.8	2.6	8.2	2.6		4.6	1.6		2.6	2.2	1.5	2.9	1.0	1.8	7.0	3.9	1.9	3.4			2.6		1.2	1.5	1.1	1.9	0.9	1.9	0.4	2.1	1.9	0.6	2.3	0.3	2.4	0.3	6.0	8.6	1.4	3.2	1.6	2.0	2.8	0.2	0.8	0.0	3.4	1.5	0.0	0.3	0.4	1.6	2.8	0.3	2.3	0.8	0.0	0.9	2.2	0.2	0.6	5.1	3.9	1.5	1.4	7.0	1.7	0.0	0.1	0.0	1.9	0.2	0.0	0.0	1.9	0.1	0.5	0.0	1.3	0.4	2.0	1.5	1.3	1.0	1.3	0.6	1.6	4.5	0.1	0.9	0.7	2.9	31.2	2.6	1.8	4.1	5.3	0.0	4.1	0.0	1.6	0.0	0.3	1.9	0.7	0.0	0.8	0.9	1.4	0.0	0.4	1.9	1.9	1.5	0.0	2.1	0.4	0.9	1.3	0.6											0.0	5.6	0.0	0.5	0.0	3.7	4.0	0.0	1.4	0.0	0.0	0.0	1.2	0.0	0.5	0.9	0.4	0.2	0.0	0.2	1.0	0.8	0.6	6.9	0.0	0.6	4.8	2.4	1.3	0.3	0.0	0.9	0.1	0.0	0.0	0.6	3.5	0.2	0.0	3.2	0.3	2.5	0.0	1.0	1.6	1.9	0.0	0.8	0.0	0.8	0.6
ZNF557	MGC4054	ENSG00000130544	"Zinc finger protein 557"	Q8N988	19	7069444-7087968	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003151, HPA029291"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No			"Nucleoplasm, Intermediate filaments"	Cytosol	"HPA003151: AB_1859344, HPA029291: AB_10602357"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-3)"	"unprognostic (5.29e-2)"	"prognostic favorable (5.70e-4)"	"unprognostic (2.56e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (2.51e-2)"	"unprognostic (2.51e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.81e-3)"	6.8	9.2	7.2	8.1	9.4	13.1	8.5	12.4	9.9	7.0	6.5	11.1	7.2	5.1	9.5	7.7	8.7	8.5	6.0	5.5	5.9	5.6	6.9	10.3	6.8	9.7	7.6	8.1	9.8	9.0	7.0	12.9	6.7	9.2	7.5	6.4	7.2	9.2	10.5	5.3	7.2	7.6	7.6	6.7	11.7	8.0	8.4	9.8	21.7	9.0	4.0	11.3	7.0	7.1	10.7	11.1	9.3	6.7	13.7	11.5	4.0	3.6	4.4	4.1	8.4	6.3	4.7	3.4	3.9	5.0	5.1	6.9	5.1	2.5	7.1	6.9	4.8	3.6	5.0	8.0	5.1	4.8	9.1	4.9	10.2	7.9	2.7	4.5	10.3	10.9	6.2	6.0	5.6	7.6	4.5	4.7	6.6	4.2	12.8	7.5	5.3	7.9	3.1	3.9	3.9	6.2	5.6	6.1	4.2	3.2	9.5	4.8	5.9	5.8	4.3	4.4	3.9	3.5	6.3	7.0	4.4	3.3	8.6	4.1	12.2	9.3	6.8	4.9	5.5	3.5	9.3	6.7	8.6	9.5	5.5	10.6	7.6	10.3	8.6	7.2	10.7	11.5	9.6	7.4	13.7	5.2	11.1	9.3	4.0	7.2	9.4	12.4	9.9	5.9	5.6	7.6	8.1	9.2	9.8	3.0	4.1	8.8	5.9	1.3	8.3	4.5	2.5	5.3	7.9	7.0	0.0	5.2	13.3	6.0	0.8	5.3	4.5	23.3	5.4	3.8	4.0	5.1	8.1	4.0	5.3	15.9	5.2	7.4	7.3	0.0	4.0	6.4	0.0	4.6	6.6	5.2	5.0	3.7	5.3	6.7	6.4	0.0	4.8	15.9	16.4	1.1	4.8	6.4	5.1	6.4
ZNF573	FLJ30921	ENSG00000189144	"Zinc finger protein 573"	Q86YE8	19	37735833-37817300	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 26.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042776	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	Cytosol	"HPA042776: AB_10961399"	"unprognostic (3.79e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.60e-2)"	6.2	6.4	7.3	4.2	8.6	7.2	7.6	14.1	9.5	6.3	4.6	8.6	5.2	4.3	7.5	10.8	4.8	5.0	6.8	5.3	5.8	4.1	5.3	4.2	6.0	4.1	10.0	5.7	8.4	6.8	6.7	11.7	5.7	6.2	5.5	4.9	5.9	6.4	5.6	5.3	7.8	5.3	6.9	6.8	5.3	7.5	10.0	9.5	4.5	9.8	4.0	6.2	7.4	6.2	6.3	3.3	3.3	2.6	3.6	5.7	1.0	1.0	3.7	2.8	2.4	1.4	3.4	1.2	2.3	2.8	0.9	2.2	3.6	2.8	3.5	2.3	2.1	1.1	2.2	2.8	3.9	3.5	1.8	1.9	4.1	5.5	1.8	1.4	3.3	2.7	3.1	1.4	4.9	2.1	1.9	2.8	2.1	1.8	1.7	0.7	1.4	2.7	2.0	4.6	1.1	0.4	2.8	5.7	1.2	0.2	1.6	3.8	3.7	4.7	1.6	0.4	1.8	3.5	3.1	1.0	3.2	3.4	2.8	3.9	4.2	5.4	5.7	0.8	0.4	2.7	3.2	1.0	3.3	4.2	1.2	3.4	3.4	3.5	4.5	1.9	6.3	5.7	4.4	0.4	3.6	2.6	3.3	2.0	1.0	7.3	8.6	14.1	9.5	5.8	4.1	10.0	5.7	6.2	9.5	0.0	4.6	2.7	1.9	1.5	14.0	9.6	2.5	2.7	1.2	3.5	11.8	3.0	1.7	2.0	26.5	4.5	1.0	0.0	0.6	2.7	3.3	2.1	0.0	1.5	3.2	15.9	1.2	1.8	1.0	13.1	8.1	1.7	3.3	1.0	1.4	8.1	1.1	0.0	6.0	1.9	10.6	0.0	2.8	5.2	8.2	2.3	1.4	4.3	2.4	1.1
ZNF619	FLJ90764	ENSG00000177873	"Zinc finger protein 619"	Q8N2I2	3	40477113-40490236	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 3.8;Collecting duct cells: 3.5;Rod photoreceptor cells: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA045094	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			Nucleoplasm	"Intermediate filaments"	"HPA045094: AB_10959900"	"unprognostic (7.16e-2)"	"unprognostic (5.94e-1)"	"unprognostic (8.38e-3)"	"unprognostic (5.42e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-3)"	"unprognostic (8.28e-6)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.38e-2)"	8.8	7.6	6.3	9.2	9.5	9.0	9.2	7.9	8.7	7.0	6.7	13.3	8.4	7.3	9.3	6.6	6.4	8.4	8.9	6.9	7.8	5.8	7.1	8.1	9.6	18.0	12.7	9.2	9.4	12.3	14.0	6.6	6.3	7.3	7.0	8.2	9.7	8.6	10.4	8.5	7.3	7.5	7.6	9.6	9.0	7.3	3.8	9.3	6.0	10.2	5.0	9.4	8.0	6.8	4.1	4.5	5.1	4.5	5.2	5.1	2.7	2.7	4.0	4.7	4.1	6.9	7.2	1.7	3.6	4.5	7.0	7.0	1.2	3.9	0.3	2.3	3.4	3.2	3.0	4.3	7.5	7.6	4.8	1.6	8.3	3.2	1.9	7.2	5.8	7.5	5.8	5.6	7.1	10.5	6.2	6.5	0.3	5.5	3.9	4.3	3.4	0.1	2.6	2.5	3.4	3.6	1.6	4.8	4.5	2.9	6.3	3.0	3.1	4.1	6.0	3.2	4.4	4.8	3.9	4.9	5.1	4.0	2.8	4.1	2.2	2.8	0.3	3.1	3.6	5.4	2.8	3.2	5.1	3.0	4.5	3.3	3.3	3.0	3.8	4.5	4.1	3.1	3.9	3.8	5.2	4.3	2.8	5.1	2.7	6.3	9.5	7.9	8.7	7.8	5.8	12.7	9.2	7.3	9.3	0.0	0.6	0.0	0.7	0.2	3.8	0.8	0.0	1.4	0.0	3.5	2.0	1.2	0.0	1.1	0.0	1.1	1.0	0.0	1.3	0.8	0.6	0.5	0.0	0.5	1.0	0.0	0.0	1.8	1.0	0.0	1.1	0.2	0.0	1.0	0.7	2.9	0.6	0.0	0.4	1.3	3.7	0.0	0.5	1.0	1.3	0.1	0.3	0.0	1.0	0.6
ZNF880		ENSG00000221923	"Zinc finger protein 880"	Q6PDB4	19	52369917-52385795	"Predicted intracellular proteins, Transcription factors"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 21.2;SuSa: 20.9"									HPA077316			Approved	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"HPA077316: AB_2686833"	"unprognostic (2.66e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.99e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (4.33e-8)"	"unprognostic (4.14e-2)"	"unprognostic (4.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.60e-3)"	14.7	12.7	12.4	12.2	21.8	17.3	16.3	22.9	14.6	16.5	13.0	13.6	10.8	6.9	16.0	20.3	13.3	14.7	12.5	20.1	13.9	10.5	13.0	4.4	13.3	15.9	12.2	7.4	22.7	9.4	4.0	18.2	12.4	14.3	20.8	10.8	18.1	12.9	16.8	11.3	12.6	11.6	16.8	13.4	16.1	11.6	11.2	13.3	24.5	22.2	12.1	16.5	27.9	11.4	25.4	20.3	27.7	7.2	12.1	20.4	8.7	0.1	0.8	10.7	8.3	5.8	16.5	11.6	7.0	7.6	4.9	9.8	0.2	4.7	0.1	2.5	12.2	10.3	1.6	0.0	6.4	8.3	0.1	12.6	0.3	0.5	0.0	6.9	0.2	8.8	12.3	8.1	9.2	0.0	0.6	7.8	0.9	0.8	0.3	9.4	0.6	1.1	0.7	14.4	0.0	1.7	0.7	21.2	0.7	13.8	11.0	7.9	10.0	0.0	2.0	3.0	20.9	0.4	2.1	6.2	0.3	0.2	2.1	6.4	0.4	3.9	0.3	0.2	0.2	13.6	27.7	6.6	15.1	13.3	6.2	17.3	23.2	16.9	14.6	10.2	25.4	20.4	17.8	2.7	12.1	7.2	20.3	17.2	8.7	12.4	21.8	22.9	14.6	13.9	10.5	12.2	7.4	14.3	13.3	11.9	3.8	10.7	13.7	5.3	16.5	11.7	7.6	10.7	18.2	19.2	11.8	8.8	24.9	14.7	10.6	10.8	2.1	0.0	12.9	12.5	7.8	21.9	9.3	1.0	5.9	22.3	0.0	9.8	5.9	3.1	12.7	11.0	8.5	16.2	5.1	11.3	17.7	7.0	6.0	6.3	15.7	19.4	13.0	3.3	7.9	6.1	12.0	12.5	3.1	22.2
ZYG11B	"FLJ13456, ZYG11"	ENSG00000162378	"Zyg-11 family member B, cell cycle regulator"	Q9C0D3	1	52726467-52827342	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.9"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 97.3;Horizontal cells: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028156	Uncertain		Approved	"Golgi apparatus,Intermediate filaments"		NA	NA			"Golgi apparatus, Intermediate filaments"		"HPA028156: AB_10602360"	"unprognostic (2.54e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (1.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.04e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.08e-2)"	"prognostic favorable (9.80e-7)"	"unprognostic (2.22e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.57e-2)"	8.9	9.1	10.8	5.6	15.6	7.1	7.7	22.3	21.7	9.9	10.4	9.1	5.6	4.7	11.0	6.5	9.7	7.3	6.8	15.9	10.7	15.4	12.9	17.7	7.7	5.0	10.1	11.6	11.3	6.5	12.7	9.1	7.2	16.4	9.8	7.9	10.1	6.1	9.2	63.9	6.5	5.8	12.3	8.4	5.7	6.3	8.4	7.7	6.9	12.7	11.4	5.7	9.2	7.0	2.2	2.2	5.7	2.4	2.1	3.8	1.0	8.1	7.4	9.4	11.7	17.3	15.1	8.2	9.2	11.8	7.3	6.8	6.3	2.7	7.8	9.3	17.8	9.9	4.2	10.7	8.0	11.7	6.5	7.0	10.0	8.5	3.9	9.2	7.5	6.2	10.7	8.8	10.5	7.4	10.3	12.7	1.8	8.9	1.6	13.2	3.4	2.9	4.7	9.7	4.0	7.7	5.0	17.8	7.1	7.5	12.9	4.3	8.7	16.0	10.0	8.5	12.5	6.0	5.8	14.5	11.4	6.7	11.2	5.7	6.8	8.2	6.0	7.8	5.1	7.3	1.0	2.4	2.7	2.1	1.3	2.3	2.2	2.6	1.6	2.2	2.1	3.8	2.7	5.7	2.1	2.0	1.7	3.0	1.0	10.8	15.6	22.3	21.7	10.7	15.4	10.1	11.6	16.4	7.7	23.8	24.5	6.9	9.4	10.1	48.7	78.7	17.8	6.7	12.5	14.0	19.6	20.1	6.6	10.4	4.6	18.0	13.5	0.0	9.5	9.4	18.4	19.6	8.1	97.3	18.3	92.2	9.8	35.6	30.1	6.4	22.7	14.5	20.3	4.6	10.9	21.7	13.8	15.6	29.0	25.4	23.0	25.8	19.4	9.4	26.9	12.8	29.1	5.7	13.6	13.9